<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2025.1521126</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Advancing clinical biochemistry: addressing gaps and driving future innovations</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Cao</surname> <given-names>Haiou</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2897145/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Oghenemaro</surname> <given-names>Enwa Felix</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2862237/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Latypova</surname> <given-names>Amaliya</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Abosaoda</surname> <given-names>Munthar Kadhim</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
<xref ref-type="author-notes" rid="fn004"><sup>&#x2020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zaman</surname> <given-names>Gaffar Sarwar</given-names></name>
<xref ref-type="aff" rid="aff8"><sup>8</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2969760/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Devi</surname> <given-names>Anita</given-names></name>
<xref ref-type="aff" rid="aff9"><sup>9</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2894730/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Oncology, Heilongjiang Beidahuang Group General Hospital, Harbin</institution>, <addr-line>Heilongjiang</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Delta State University</institution>, <addr-line>Abraka</addr-line>, <country>Nigeria</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Medical and Technical Information Technology, Bauman Moscow State Technical University</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Mathematics and Natural Sciences, Gulf University for Science and Technology</institution>, <addr-line>Mishref</addr-line>, <country>Kuwait</country></aff>
<aff id="aff5"><sup>5</sup><institution>College of Pharmacy, The Islamic University</institution>, <addr-line>Najaf</addr-line>, <country>Iraq</country></aff>
<aff id="aff6"><sup>6</sup><institution>College of Pharmacy, The Islamic University of Al Diwaniyah</institution>, <addr-line>Al Diwaniyah</addr-line>, <country>Iraq</country></aff>
<aff id="aff7"><sup>7</sup><institution>College of Pharmacy, The Islamic University of Babylon</institution>, <addr-line>Babylon</addr-line>, <country>Iraq</country></aff>
<aff id="aff8"><sup>8</sup><institution>Department of Clinical Laboratory Science, College of Applied Medical Sciences, King Khalid University</institution>, <addr-line>Abha</addr-line>, <country>Saudi Arabia</country></aff>
<aff id="aff9"><sup>9</sup><institution>Department of Applied Sciences, Chandigarh Engineering College, Chandigarh Group of Colleges-Jhanjeri</institution>, <addr-line>Mohali</addr-line>, <country>India</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Felisbina Luisa Queiroga, University of Tr&#x00E1;s-os-Montes and Alto Douro, Portugal</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Johanna Mora, Bristol Myers Squibb, United States</p><p>Ricardo Marcos, University of Porto, Portugal</p><p>Hugo Vilhena, University of Porto, Portugal</p></fn>
<corresp id="c001">&#x002A;Correspondence: Haiou Cao, <email>luzifeng212@163.com</email></corresp>
<corresp id="c002">Enwa Felix Oghenemaro, <email>felixenwa@delsu.edu.ng</email></corresp>
<fn fn-type="other" id="fn004"><p><sup>&#x2020;</sup>ORCID: Munthar Kadhim Abosaoda, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0009-0003-5552-7918">orcid.org/0009-0003-5552-7918</ext-link></p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>04</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>12</volume>
<elocation-id>1521126</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>11</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>03</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Cao, Oghenemaro, Latypova, Abosaoda, Zaman and Devi.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Cao, Oghenemaro, Latypova, Abosaoda, Zaman and Devi</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Modern healthcare depends fundamentally on clinical biochemistry for disease diagnosis and therapeutic guidance. The discipline encounters operational constraints, including sampling inefficiencies, precision limitations, and expansion difficulties. Recent advancements in established technologies, such as mass spectrometry and the development of high-throughput screening and point-of-care technologies, are revolutionizing the industry. Modern biosensor technology and wearable monitors facilitate continuous health tracking, Artificial Intelligence (AI)/machine learning (ML) applications enhance analytical capabilities, generating predictive insights for individualized treatment protocols. However, concerns regarding algorithmic bias, data privacy, lack of transparency in decision-making (&#x201C;black box&#x201D; models), and over-reliance on automated systems pose significant challenges that must be addressed for responsible AI integration. However, significant limitations remain&#x2014;substantial implementation expenses, system incompatibility issues, and information security vulnerabilities intersect with ethical considerations regarding algorithmic fairness and protected health information. Addressing these challenges demands coordinated efforts between clinicians, scientists, and technical specialists. This review discusses current challenges in clinical biochemistry, explicitly addressing the limitations of reference intervals and barriers to implementing innovative biomarkers in medical settings. The discussion evaluates how advanced technologies and multidisciplinary collaboration can overcome these constraints while identifying research priorities to enhance diagnostic precision and accessibility for better healthcare delivery.</p>
</abstract>
<kwd-group>
<kwd>clinical biochemistry</kwd>
<kwd>biomarkers</kwd>
<kwd>point-of-care system</kwd>
<kwd>artificial intelligence</kwd>
<kwd>personalized medicine</kwd>
<kwd>mass spectrometry</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="230"/>
<page-count count="18"/>
<word-count count="14942"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Precision Medicine</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>1 Introduction</title>
<p>Laboratory medicine relies on clinical biochemistry, analyzing biological fluids like blood, urine, and cerebrospinal fluid for disease assessment and treatment guidance. This discipline examines diverse biochemical indicators&#x2014;metabolites, hormones, electrolytes, and enzymes&#x2014;generating vital information that shapes medical interventions, enhances patient care and supports precision medicine approaches (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). This field has several applications, including traditional molecular diagnostics and complex biochemical assays. The main objective of clinical biochemistry is to gather precise and dependable statistics, enabling healthcare practitioners to make better-informed decisions, guide treatments, and predict patient outcomes (<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>Biochemical testing is vital in medical assessment, providing critical diagnosis and patient management data. While both speed and precision are essential for timely decision-making, achieving rapid turnaround times sometimes requires a careful balance between the two. In emergency situations, such as acute myocardial infarction or sepsis, rapid preliminary results can guide immediate therapeutic decisions; however, these results are always followed by confirmatory tests using highly accurate methods to ensure diagnostic reliability. In non-emergency cases, accuracy remains paramount, as any compromise could lead to severe consequences, such as a false-negative result for a cancer marker, which may delay critical treatment. Therefore, accuracy is never sacrificed when diagnostic precision is crucial for patient outcomes (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). These analytical results are integral to guiding therapeutic strategies and informing patient care. For example, the early detection of cardiac biomarkers in patients with chest symptoms can be life-saving (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). However, delays or errors in biochemical tests can result in misdiagnosis, incorrect treatment, and potential harm to patients (<xref ref-type="bibr" rid="B8">8</xref>). Current methods in clinical biochemistry include immunoassays, chromatography, spectrophotometry, and mass spectrometry (MS), a well-established analytical tool that continues to advance with novel applications and improved instrumentation (<xref ref-type="bibr" rid="B9">9</xref>&#x2013;<xref ref-type="bibr" rid="B11">11</xref>). <xref ref-type="fig" rid="F1">Figure 1</xref> provides a comparative overview of traditional and Novel Technologies in clinical biochemistry, illustrating how advancements in MS, next-generation sequencing, and digital Polymerase Chain Reaction (PCR) have significantly improved sensitivity, speed, and data complexity management, although at a higher cost.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>Comparison of traditional and novel technologies in clinical biochemistry. This figure compares Traditional Technologies (manual spectrophotometry, enzyme-linked immunosorbent assays, basic chromatography), Advanced Applications of Established Technologies (mass spectrometry, MS), and Truly Novel Technologies [next-generation sequencing and digital Polymerase Chain Reaction (PCR)] in clinical biochemistry. While MS is a well-established technology, its advanced applications, such as in proteomics and metabolomics, have significantly enhanced its role in modern diagnostic practices, distinguishing it from traditional methodologies.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-12-1521126-g001.tif"/>
</fig>
<p>Spectrophotometric analysis is widely adopted due to its cost-effectiveness and operational simplicity. However, sample quality issues, particularly turbid or hemolyzed specimens, may compromise measurement accuracy (<xref ref-type="bibr" rid="B9">9</xref>). While chromatographic and MS techniques provide superior analyte specificity and detection sensitivity&#x2014;especially valuable for therapeutic drug monitoring, toxicological screening, and metabolic profiling&#x2014;these methods typically require extensive specimen processing, increasing time and resource demands (<xref ref-type="bibr" rid="B12">12</xref>). Although immunological assays offer targeted detection capabilities, measurement interference from cross-reactive species and heterophilic antibodies (including HAMA) can affect result reliability (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). Advancing clinical biochemistry requires novel methodological approaches. Recent developments in Micro total analysis system (&#x03BC;TAS) technology, microfluidic platforms, and improved immunological detection systems show promise in addressing current analytical limitations. However, specific technical challenges persist&#x2014;most notably matrix effects from heterophilic antibodies&#x2014;emphasizing the continued need for research into more reliable diagnostic methodologies (<xref ref-type="bibr" rid="B15">15</xref>). <xref ref-type="table" rid="T1">Table 1</xref> compares the principles, advantages, and limitations of the traditional and Novel Technologies in clinical biochemistry.</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>Comparison of analytical techniques in clinical biochemistry.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Technology</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Principle</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Advantages</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Limitations</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Sample volume</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Throughput</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Cost</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">References</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Spectrophotometry</td>
<td valign="top" align="left">Absorption of light by analytes in solution</td>
<td valign="top" align="left">Simple, inexpensive</td>
<td valign="top" align="left">Limited sensitivity and specificity</td>
<td valign="top" align="left">Low</td>
<td valign="top" align="left">High</td>
<td valign="top" align="left">Low</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Chromatography</td>
<td valign="top" align="left">Separation of components in a mixture due to their differential distribution between two phases</td>
<td valign="top" align="left">Highly specific, suitable for complex molecules</td>
<td valign="top" align="left">Time-consuming; requires extensive sample preparation; high skill required</td>
<td valign="top" align="left">Medium</td>
<td valign="top" align="left">Medium</td>
<td valign="top" align="left">High</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Immunoassays</td>
<td valign="top" align="left">Antigen-antibody interactions</td>
<td valign="top" align="left">High specificity, wide analyte range</td>
<td valign="top" align="left">Cross-reactivity, interference</td>
<td valign="top" align="left">Low</td>
<td valign="top" align="left">High</td>
<td valign="top" align="left">Medium</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Mass spectrometry</td>
<td valign="top" align="left">Separation and detection of ionized analytes</td>
<td valign="top" align="left">High sensitivity and specificity; recent advancements enable applications in metabolomics and proteomics</td>
<td valign="top" align="left">Expensive instrumentation, complex sample preparation</td>
<td valign="top" align="left">Low</td>
<td valign="top" align="left">Low&#x2013;medium</td>
<td valign="top" align="left">High</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B22">22</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Lab-on-a-Chip (&#x03BC;TAS)</td>
<td valign="top" align="left">Miniaturized laboratory processes on a chip</td>
<td valign="top" align="left">Portable, fast, low sample volume required; potential for point-of-care applications</td>
<td valign="top" align="left">Limited multiplexing capability: some matrix interference issues remain</td>
<td valign="top" align="left">Very low</td>
<td valign="top" align="left">High</td>
<td valign="top" align="left">Medium-high</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>)</td>
</tr>
</tbody>
</table></table-wrap>
<p>Current clinical biochemistry faces persistent methodological challenges despite technological progress. A significant concern is the inadequate reference ranges for many biochemical parameters, particularly among pediatric and geriatric populations (<xref ref-type="bibr" rid="B25">25</xref>). While these intervals are crucial for interpreting results, they vary considerably across biological, demographic, and analytical factors. Programs like CALIPER have advanced the development of pediatric reference intervals, though similar initiatives are still needed for other demographic groups (<xref ref-type="bibr" rid="B26">26</xref>). The integration of emerging biomarkers into standard clinical protocols poses another critical challenge. Although these novel indicators have the potential for diagnostics and personalized medicine, practical implementation faces obstacles such as analytical standardization, regulatory compliance, and economic viability. Addressing these barriers requires coordinated action among scientific investigators, medical practitioners, regulatory authorities, and health policy experts to optimize patient benefit (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>). Clinical biochemistry has the potential for transformative progress by integrating advanced technologies.</p>
<p>Analytical methods at the nanoscopic level enable the detection and characterization of nanoparticles and similar biological structures within human systems, including exosomes, liposomal formations, virus-mimicking particles, and protein clusters (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>). These nanometric entities are essential in normal physiology and disease development (<xref ref-type="bibr" rid="B30">30</xref>). Extracellular vesicles in the nanometer range, particularly exosomes, serve as diagnostic indicators for early-stage malignancies, neurological disorders, and cardiac pathologies (<xref ref-type="bibr" rid="B31">31</xref>). Likewise, nanoscale protein assemblies known as amyloid fibrils are associated with neurodegenerative conditions such as Alzheimer&#x2019;s and Parkinson&#x2019;s (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). Using nano-focused analytical techniques provides healthcare professionals and researchers with highly sensitive detection capabilities, facilitating early and accurate disease identification (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>). AI systems can improve result interpretation and provide a deep understanding of complex biological phenomena through automated data analysis (<xref ref-type="bibr" rid="B36">36</xref>). Bioinformatics integrates molecular biology, genetics, and genomics to characterize biological systems and disease processes (<xref ref-type="bibr" rid="B37">37</xref>). This review discusses recent technological advancements in clinical biochemistry, identifies current limitations, and proposes future research directions. By assessing the demand for fast and accurate biochemical tests in diagnostic medicine, exploring available techniques and their shortcomings, and discussing forthcoming tools, we aim to contribute to ongoing efforts to improve the quality of laboratory analyses and maximize the benefits of biomedical research.</p>
</sec>
<sec id="S2">
<title>2 Current gaps in clinical biochemistry</title>
<sec id="S2.SS1">
<title>2.1 Technological limitations</title>
<p>Despite significant advances, traditional clinical biochemistry techniques such as spectrophotometry, chromatography, and immunoassays are severely limited in their application to modern healthcare. They have insufficient sensitivity, cross-reactivity, delayed results, and high cost, which limit their use in routine testing and precision medicine (<xref ref-type="bibr" rid="B38">38</xref>).</p>
<sec id="S2.SS1.SSS1">
<title>2.1.1 Sensitivity and specificity challenges</title>
<p>Spectrophotometry is one of the most commonly used techniques in biochemical testing because it is relatively inexpensive and easy to perform. However, it lacks the sensitivity and specificity to identify biomarkers at low concentrations that are useful for early disease diagnosis. For example, in the diagnosis of cancer and metabolic disorders, studies have shown that MS provides up to 1,000 times lower detection levels for some analytes compared to spectrophotometric methods (<xref ref-type="bibr" rid="B39">39</xref>). This difference is important in diseases such as pancreatic cancer, where early detection of markers such as CA19-9 can significantly improve outcomes (<xref ref-type="bibr" rid="B40">40</xref>). In addition, immunoassays, which are often used to detect proteins, hormones, and disease markers, can have problems with cross-reactivity and interference from the sample. This can result in false-positive or false-negative results. A review of immunoassay performance in clinical applications found that cross-reactivity rates varied from 0.1% to 3%, with some assays reaching up to 15% in complicated biological samples (<xref ref-type="bibr" rid="B41">41</xref>). Such errors can lead to incorrect diagnosis or treatment, particularly in endocrine and infectious disease testing (<xref ref-type="bibr" rid="B42">42</xref>).</p>
</sec>
<sec id="S2.SS1.SSS2">
<title>2.1.2 Speed and reproducibility issues</title>
<p>Turnaround time (TAT) is an important consideration in clinical testing. Spectrophotometric assays typically process samples within 5&#x2013;10 min, but immunoassays require 2&#x2013;3 h per run, which can delay clinical decisions (<xref ref-type="bibr" rid="B43">43</xref>). Such delays are of particular concern in emergency care settings, such as emergency departments, where rapid test results for cardiac problems (such as troponin levels in myocardial infarction) or indications of sepsis can be life-saving (<xref ref-type="bibr" rid="B44">44</xref>). In addition to speed, reproducibility and standardization remain critical in biochemical analysis. Variability in reagents, technique and calibration can affect the reliability of test results. Inter-laboratory variability constitutes a significant consideration within the domain of clinical biochemistry, given its capacity to influence the interpretation of results and the subsequent management of patients (<xref ref-type="bibr" rid="B45">45</xref>). While variability exists among different testing sites, accredited laboratories adhere to stringent quality control measures, including internal and external quality assurance programs, to ensure analytical accuracy and precision (<xref ref-type="bibr" rid="B46">46</xref>). Standards and guidelines for laboratories, such as those established by the Clinical and Laboratory Standards Institute (CLSI) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), delineate acceptable variability limits for each analyte (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>). Consequently, while certain studies have documented higher coefficients of variation for specific analytes in particular settings, these observations might not be universally applicable to all accredited laboratories that adhere to standardized performance criteria (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>).</p>
</sec>
<sec id="S2.SS1.SSS3">
<title>2.1.3 Cost and implementation barriers</title>
<p>Although MS and chromatography-based methods offer better analytical precision, high instrument costs, lengthy sample preparation, and the need for experienced operators are limiting factors in their wider acceptance in routine diagnostics (<xref ref-type="bibr" rid="B51">51</xref>). The main barrier is the economic impact on low- and middle-income countries, where access to advanced diagnostic tools is still limited. This makes the use of sophisticated techniques such as next-generation sequencing (NGS) or high-throughput screening (HTS) difficult (<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>). To address the cost and difficulty of clinical biochemistry, scientists are developing low-cost analytical devices that are both accurate and inexpensive. This will make sophisticated tests more accessible to more people (<xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B55">55</xref>). In addition, efforts to increase the automation of laboratory processes aim to improve efficiency, minimize human error, and reduce reliance on highly trained personnel, thereby streamlining operations in both low and high resource settings (<xref ref-type="bibr" rid="B55">55</xref>). In addition, strengthening regulatory frameworks and standardization is critical to ensure consistency and reliability across diverse healthcare systems, facilitating the seamless integration of new technologies into routine daily clinical practice (<xref ref-type="bibr" rid="B48">48</xref>).</p>
</sec>
<sec id="S2.SS1.SSS4">
<title>2.1.4 Emerging solutions and future directions</title>
<p>Emerging technologies such as microfluidic-based lab-on-a-chip (&#x03BC;TAS) platforms and point-of-care testing (POCT) devices offer promising ways to overcome technological limitations. Such platforms allow for miniaturized, rapid testing with dramatically reduced sample volumes and are therefore well suited to remote and resource-limited settings (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>). However, limitations such as lack of multiplexing capability, standardization, and regulatory approval processes still need to be addressed before widespread clinical use (<xref ref-type="bibr" rid="B58">58</xref>). AI and ML in clinical biochemistry can address these issues technologically. AI-based data analysis can make diagnoses more accurate, improve test consistency, and streamline laboratory procedures, thereby reducing errors and variability (<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B59">59</xref>). Collaboration among researchers, clinicians, and industry stakeholders is needed to translate these technological advances into daily clinical practice (<xref ref-type="bibr" rid="B57">57</xref>).</p>
</sec>
</sec>
<sec id="S2.SS2">
<title>2.2 Clinical challenges</title>
<p>Clinical biochemistry encounters various challenges that significantly influence patient care and health outcomes. One critical issue is the prolonged TAT for essential biochemical tests, especially in acute care settings where timely interventions are crucial (<xref ref-type="bibr" rid="B1">1</xref>). For instance, delays in cardiac biomarker results, such as troponin tests, can negatively impact patient outcomes in suspected acute myocardial infarction cases (<xref ref-type="bibr" rid="B60">60</xref>). Similarly, the lack of sensitive and specific biomarkers for early disease detection, including pancreatic cancer, with a 5-year survival rate of only 9%, is a significant obstacle to timely diagnosis and improved prognosis (<xref ref-type="bibr" rid="B61">61</xref>). The absence of definitive early biomarkers for Alzheimer&#x2019;s disease further impedes timely intervention, limiting the ability to detect the disease before symptoms manifest (<xref ref-type="bibr" rid="B62">62</xref>). Pregnancy-related physiological changes necessitate the establishment of specialized reference intervals for biochemical parameters. For example, The diagnosis and management of pregnancy complications necessitates the assessment of hormone levels, including thyroid-stimulating hormone (TSH) and thyroid hormones (free T4 and total T4) (<xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B64">64</xref>). The literature has proposed various reference values for TSH, aiming to enhance diagnostic accuracy by considering the direct effects of pregnancy on thyroid hormone metabolism (<xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B66">66</xref>). However, in standard clinical practice, TSH testing is often accompanied by additional T4 hormone assessments, as these provide a more precise assessment of maternal thyroid function and fetal wellbeing (<xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B68">68</xref>).</p>
<p>Standardizing biochemical tests across laboratories and healthcare systems is crucial for ensuring consistent and reliable results for patient care. The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) is involved in global initiatives to harmonize test results (<xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B70">70</xref>). Challenges in achieving this standardization include variations in methodologies, reagents, and calibration practices, which can lead to discrepancies in results and affect patient diagnosis and treatment (<xref ref-type="bibr" rid="B48">48</xref>). Metrological traceability to higher-order references is essential for the equivalence of the measurement results. However, its correct implementation is hindered by the complexity of the task and the need for improved collaboration among stakeholders, including reference providers, <italic>in vitro</italic> Diagnostics (IVD) manufacturers, and laboratory professionals (<xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B69">69</xref>). Enhancing education, training, and regulatory alignment are crucial steps toward overcoming these challenges and achieving global harmonization of biochemical tests to improve patient outcomes (<xref ref-type="bibr" rid="B69">69</xref>). Integrating biochemical data with other clinical information sources, such as genomic data and imaging studies, is critical for advancing personalized medicine.</p>
<p>Electronic health records (EHRs) are pivotal for improving data accessibility; however, effectively combining diverse datasets for comprehensive patient assessment remains a significant challenge (<xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>). Resource limitations significantly impact the adoption of new biochemical technologies, particularly in low-income and middle-income countries. Advanced techniques, such as MS and NGS, while offering superior analytical capabilities, require substantial financial investment and specialized expertise. A survey by the World Health Organization found that only 65% of low-income countries had access to elemental biochemistry analyzers, let alone advanced technologies (<xref ref-type="bibr" rid="B73">73</xref>). Modern research areas like metabolomics and proteomics generate extensive datasets that challenge traditional laboratory practices. These disciplines demand advanced data interpretation and clinical implementation expertise, creating significant training requirements for laboratory personnel. Integrating complex molecular information into practical healthcare requires specialized knowledge to translate biological profiles into actionable clinical insights (<xref ref-type="bibr" rid="B74">74</xref>&#x2013;<xref ref-type="bibr" rid="B76">76</xref>). These advanced methods require specialized training programs to ensure staff proficiency and clear guidelines for interpreting results to translate technological advancements into improved patient care (<xref ref-type="bibr" rid="B77">77</xref>). Bioinformatics is crucial for analyzing chemical information acquired through MS for clinical analysis, highlighting the importance of data interpretation and integration in complex biological samples (<xref ref-type="bibr" rid="B74">74</xref>). Furthermore, the application of AI in interpreting omics data for disease diagnosis and developing network atlases to analyze biochemical relationships between organs demonstrates the evolving landscape of clinical bioinformatics (<xref ref-type="bibr" rid="B74">74</xref>). As the field progresses, it has become essential to establish comprehensive training programs and guidelines to maximize the benefits of these advanced technologies to enhance patient outcomes and clinical decision-making.</p>
<p>Addressing these complex challenges requires a collaborative approach that involves clinicians, biochemists, and bioinformaticians. Clinical biochemistry can significantly improve patient outcomes and enhance healthcare delivery by developing rapid point-of-care diagnostics, identifying and validating new biomarkers, establishing reference intervals specific to different populations, and implementing effective data management systems.</p>
</sec>
<sec id="S2.SS3">
<title>2.3 Data management issues</title>
<p>Clinical biochemistry has made considerable advancements; however, it still faces challenges in utilizing large amounts of data. Restrictions in data management and analysis impede efforts to enhance patient care. Data integration and interoperability are significant obstacles because incompatible data formats and technologies create silos that hinder patient records and research (<xref ref-type="bibr" rid="B1">1</xref>). The extended amount and complexity of biochemical assay data overwhelm conventional methods for data analysis, such as manual interpretation, essential statistical tools, and spreadsheet-based approaches, which are often inadequate for processing large, multidimensional datasets generated by modern assays (<xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B79">79</xref>). This wastes crucial information. It is crucial to understand diseases and treatments (<xref ref-type="bibr" rid="B80">80</xref>). Robust data management systems and bioinformatics platforms are vital answers. These solutions must incorporate diverse types of data. It incorporates EHRs, laboratory information systems, and omics data (<xref ref-type="bibr" rid="B81">81</xref>). Standardized data formats and seamless data communication are crucial for breaking down information silos (<xref ref-type="bibr" rid="B81">81</xref>). Overcoming these challenges will unlock the full potential of big data in clinical biochemistry, enabling better data integration and analysis, which will drive the development of tailored medicine. This, in turn, facilitates automated patient data analysis, risk prediction, and individualized therapy (<xref ref-type="bibr" rid="B82">82</xref>, <xref ref-type="bibr" rid="B83">83</xref>). Bioinformatic technologies with actionable information will empower clinicians and improve patient outcomes and advancements in this field. Although challenges still exist, the evolving world of data management and analysis presents a significant opportunity. These advancements will usher in an era of personalized medicine characterized by accurate diagnosis, effective therapies, and enhanced patient care (<xref ref-type="bibr" rid="B84">84</xref>).</p>
</sec>
</sec>
<sec id="S3">
<title>3 Novel technologies in clinical biochemistry</title>
<sec id="S3.SS1">
<title>3.1 HTS and automation</title>
<p>Medical laboratories use computerized equipment to detect abnormalities. This equipment has revolutionized clinical biochemistry by making tests significantly faster and more accurate. These machines can process numerous samples daily, reduce manual work, and expedite diagnoses. Automated analyzers eliminate human errors and yield reliable results (<xref ref-type="bibr" rid="B85">85</xref>). Consequently, microfluidics and lab-on-a-chip technologies have transformed biochemical testing. These models combine laboratory activities into a single microchip, enabling the rapid screening of diverse samples with fewer reagents (<xref ref-type="bibr" rid="B86">86</xref>). Lab-on-a-chip devices conduct complex biomedical tests on-site and deliver swift results. As shown in <xref ref-type="fig" rid="F2">Figure 2</xref>, AI plays a pivotal role in integrating various innovative technologies, such as bioinformatics tools, quantum sensors, NGS, and micrototal analysis systems. These technologies and advancements in tools like MS are transforming traditional clinical biochemistry practices.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>Integration of artificial intelligence (AI) with emerging and established biochemical tools in clinical biochemistry. <xref ref-type="fig" rid="F2">Figure 2</xref> shows AI&#x2019;s transformative role in clinical biochemistry instrumentation and methodologies. Machine learning algorithms enhance conventional analytical techniques, such as chromatographic separation and mass spectrometric analysis, by providing automated visual processing, improved signal detection, heightened analytical sensitivity, and sophisticated interpretation of complex samples. AI integration extends to advanced technologies, including rapid genetic analysis through next-generation sequencing (NGS), continuous physiological monitoring via wearable devices, and metabolic assessment using quantum sensing platforms. Furthermore, AI capabilities support bioinformatics applications for comprehensive data synthesis and patient classification, enable precise quantification through digital Polymerase Chain Reaction (PCR), and support miniaturized analytical systems for rapid diagnostic testing. This technological convergence advances laboratory medicine by optimizing analytical performance, operational efficiency, and diagnostic utility.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-12-1521126-g002.tif"/>
</fig>
</sec>
<sec id="S3.SS2">
<title>3.2 Advanced analytical techniques</title>
<p>Mass spectrometry is a well-established and indispensable tool in clinical biochemistry due to its unparalleled ability to detect and measure biomolecules with high sensitivity and specificity. Recent advancements in MS, such as improved resolution, miniaturization, and novel proteomics and metabolomics applications, further enhance its utility in clinical diagnostics (<xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B88">88</xref>).</p>
<p>Nuclear Magnetic Resonance (NMR) spectroscopy, a well-established analytical technology, plays a valuable role in clinical biochemistry by providing detailed insights into biomolecules, including their structure and behavior. Its non-destructive nature allows for repeated measurements, making it particularly useful for longitudinal studies. Advances in NMR applications, such as metabolomics and structural biology, have expanded its utility in understanding disease mechanisms and identifying potential drug targets (<xref ref-type="bibr" rid="B89">89</xref>). NGS has changed genomic and metabolic profiling. It provides unmatched data depth and breadth. NGS examines genomic variants, helps to identify disease-causing mutations, and enables personalized medicine. Rapid genome sequencing has opened new avenues of research and diagnosis (<xref ref-type="bibr" rid="B90">90</xref>).</p>
<p>Researchers have made critical strategic changes in clinical biochemistry by introducing new methods for determining hemoglobin A1c (HbA1c) in diabetes control (<xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B92">92</xref>). The HbA1c biomarker is important for assessing long-term glycemic control, as it indicates blood glucose levels over the preceding 2&#x2013;3 months (<xref ref-type="bibr" rid="B93">93</xref>). Traditional HbA1c methods like high-performance liquid chromatography (HPLC) are standard, but these methods have been constrained by interference from hemoglobin variants and sample prep time (<xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B94">94</xref>).</p>
<p>In recent years, the development of high-throughput and automated capillary electrophoresis and MS has led to significant advancements in reducing analytical variability (<xref ref-type="bibr" rid="B95">95</xref>). For example, HPLC is the most effective method for separating HbA1c from other hemoglobin variants that have been demonstrated to interfere with blood tests (<xref ref-type="bibr" rid="B96">96</xref>). This technique has been demonstrated to be effective in populations affected by hemoglobinopathies (<xref ref-type="bibr" rid="B97">97</xref>). In addition, matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) MS is advanced as the most sensitive technique of quantification and method for detecting HbA1c while eliminating modified hemoglobin species (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B98">98</xref>).</p>
<p>Point-of-care (POC) testing has been further advanced by providing compact immunoassay-based analyzers that can perform the tests within minutes (<xref ref-type="bibr" rid="B99">99</xref>). The Abbott Afinion 2 and Siemens DCA Vantage devices are among those that have proven promising results (<xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B100">100</xref>). They are a foundation for new methods alongside traditional laboratory-based techniques that allow real-time diabetes management in clinical and primary settings (<xref ref-type="bibr" rid="B101">101</xref>). Integrating these new analytical techniques enhances diagnostic accuracy, allowing for better patient monitoring and personalized treatment strategies (<xref ref-type="bibr" rid="B102">102</xref>).</p>
</sec>
<sec id="S3.SS3">
<title>3.3 Point-of-care testing (POCT)</title>
<p>Point-of-care testing has transformed healthcare delivery through accessible diagnostic capabilities at patient treatment sites. These compact, user-oriented platforms facilitate immediate result generation, enabling rapid clinical decision-making and minimizing follow-up requirements (<xref ref-type="bibr" rid="B103">103</xref>). POCT implementation demonstrates utility in geographically remote or resource-constrained environments, enhancing healthcare accessibility and intervention timeliness (<xref ref-type="bibr" rid="B104">104</xref>). Treatment modalities have evolved significantly, particularly in diabetic care protocols (<xref ref-type="bibr" rid="B105">105</xref>). The introduction of CGM technology in the early 2000s marked a shift from conventional capillary blood sampling methods, allowing for continuous glucose level monitoring (<xref ref-type="bibr" rid="B106">106</xref>). Subsequent advancements, including pre-calibrated sensing elements, improved measurement accuracy, increased sensor durability, and compatibility with automated insulin delivery systems, have fundamentally reshaped diabetes management strategies (<xref ref-type="bibr" rid="B107">107</xref>). These developments enable precise insulin dosing while minimizing patient intervention, leading to better glycemic control and improved patient wellbeing (<xref ref-type="bibr" rid="B108">108</xref>). POCT in infectious disorders enables rapid diagnosis and appropriate treatment, limiting disease transmission and improving patient outcomes (<xref ref-type="bibr" rid="B109">109</xref>, <xref ref-type="bibr" rid="B110">110</xref>). POCT devices are user-friendly, portable, and provide quick results, revolutionizing healthcare delivery by facilitating faster diagnosis, reducing costs, and increasing patient satisfaction (<xref ref-type="bibr" rid="B103">103</xref>). Moreover, integrating rapid diagnostic technologies such as molecular diagnostics and handheld PCR machines expands healthcare services to remote areas and ensures prompt pathogen identification for timely treatment initiation in resource-limited settings (<xref ref-type="bibr" rid="B109">109</xref>). The bedside application of point-of-care ultrasound (POCUS) significantly enhances diagnostic accuracy in infectious disorders, aids in the antibiotic selection, identifies sources of infection, and guides non-surgical invasive procedures that impact patient care and treatment outcomes (<xref ref-type="bibr" rid="B110">110</xref>). These findings highlight the transformative power of POCT in healthcare delivery and effective management of infectious diseases.</p>
<p>POCT devices utilize various technologies, including biosensors, lateral flow tests, and microfluidic devices. Biosensors such as glucose and electrochemical sensors employ biological recognition components to detect and quantify specific analytes (<xref ref-type="bibr" rid="B111">111</xref>, <xref ref-type="bibr" rid="B112">112</xref>). Lateral flow assays (LFAs) are widely used for rapid diagnostic testing due to their simplicity and affordability (<xref ref-type="bibr" rid="B113">113</xref>). Traditional LFAs rely on the capillary flow of the sample through a membrane strip containing immobilized antibodies or other recognition features, such as nitrocellulose membranes (<xref ref-type="bibr" rid="B114">114</xref>). Innovations in LFA technology incorporate advanced design elements to optimize performance. The integration of SS Mem technology uses specialized surface architecture to enhance capillary action, facilitating faster sample migration and uniform distribution while minimizing surface retention (<xref ref-type="bibr" rid="B115">115</xref>). These modifications reduce analysis times, decrease background interference, and improve analytical sensitivity. Concurrent developments in microfluidic platforms enable precise fluid control through engineered channels, optimizing reagent interactions while conserving specimen volume (<xref ref-type="bibr" rid="B116">116</xref>). This technological convergence enhances LFA capabilities for detecting trace analytes, broadens quantitative measurement ranges, and expands their utility in decentralized diagnostic applications across various pathological conditions (<xref ref-type="bibr" rid="B117">117</xref>). Microfluidic devices, or lab-on-a-chip systems, consolidate multiple laboratory operations on a small substrate, enabling complex analysis with minimal sample quantities (<xref ref-type="bibr" rid="B118">118</xref>). These developments address the limitations of traditional LFAs and offer a viable alternative for improving their performance and reliability in various applications, such as food verification and POCT. Although POCT offers numerous benefits, it also presents significant drawbacks and limitations. Quality control and standardization are crucial for obtaining accurate and reliable test results, particularly in decentralized settings (<xref ref-type="bibr" rid="B117">117</xref>, <xref ref-type="bibr" rid="B119">119</xref>). Operator training and adherence to correct procedures are essential for reducing errors and ensuring the accurate interpretation of test results. Furthermore, POCT data must be integrated with EHRs and laboratory information systems (LIS) to ensure seamless data management and continuity of care (<xref ref-type="bibr" rid="B120">120</xref>, <xref ref-type="bibr" rid="B121">121</xref>).</p>
<p>Strategic approaches to addressing these constraints include implementing standardized quality measures, developing structured training protocols, and enhancing data management system integration (<xref ref-type="bibr" rid="B122">122</xref>, <xref ref-type="bibr" rid="B123">123</xref>). Oversight bodies maintain stringent standards for POCT device validation through comprehensive evaluation protocols. The FDA&#x2019;s regulatory framework in the United States categorizes these instruments according to potential risk, with most POCT systems designated as Class II devices necessitating 510(k) submission documentation demonstrating comparability to previously sanctioned instruments (<xref ref-type="bibr" rid="B124">124</xref>, <xref ref-type="bibr" rid="B125">125</xref>). FDA guidelines establish specific criteria for analytical performance validation, emphasizing measurement reliability and operational accessibility across various testing environments. CLIA regulations further mandate simplified testing procedures and minimal risk potential for waived assessments (<xref ref-type="bibr" rid="B126">126</xref>, <xref ref-type="bibr" rid="B127">127</xref>).</p>
<p>The European regulatory landscape underwent a significant transformation with the implementation of IVDR (EU 2017/746), superseding the previous IVDD framework. This updated regulation implements enhanced requirements for clinical validation, performance verification, and continuous monitoring protocols. The IVDR framework introduces stratified risk assessment, mandating third-party conformity evaluation for high risk diagnostic platforms. Manufacturers must provide comprehensive technical documentation while ensuring adherence to GSPR standards. Both regulatory frameworks prioritize patient safety, analytical precision, and operational reliability in POC applications, establishing robust quality assurance mechanisms for market authorization (<xref ref-type="bibr" rid="B128">128</xref>&#x2013;<xref ref-type="bibr" rid="B130">130</xref>).</p>
<p>Future developments in POCT anticipate advancement in multiplexed analytical capabilities, enabling concurrent detection of multiple parameters from individual samples (<xref ref-type="bibr" rid="B131">131</xref>). Integration with wearable devices and mHealth platforms will enhance continuous monitoring capabilities and data acquisition. Additionally, incorporating AI and ML methodologies will optimize result interpretation and clinical decision support, advancing diagnostic efficiency (<xref ref-type="bibr" rid="B132">132</xref>).</p>
</sec>
<sec id="S3.SS4">
<title>3.4 Biosensors and wearable technologies</title>
<p>Integrating biosensor technology and wearable devices has revolutionized clinical biochemistry through continuous, real-time physiological monitoring capabilities, enhancing personalized medical care approaches (<xref ref-type="bibr" rid="B133">133</xref>). While POCT systems deliver rapid diagnostic information at patient sites for immediate clinical decisions, biosensors, and wearable platforms facilitate sustained, minimally invasive parameter tracking. POCT applications primarily serve separate diagnostic purposes, whereas biosensor and wearable systems enable extended health surveillance and remote patient monitoring protocols (<xref ref-type="bibr" rid="B134">134</xref>, <xref ref-type="bibr" rid="B135">135</xref>).</p>
<p>Biosensor advancement optimizes detection sensitivity and minimizes specimen requirements for sustained biological monitoring applications. These platforms combine biological recognition components with signal transduction elements to generate quantifiable measurements from biochemical interactions. Electrochemical biosensor systems, exemplified in glucose monitoring applications, quantify enzymatic reaction-generated electrical signals correlating with glucose levels (<xref ref-type="bibr" rid="B136">136</xref>, <xref ref-type="bibr" rid="B137">137</xref>). CGM systems represent significant technological progress, providing dynamic glucose measurements that enhance diabetic care management (<xref ref-type="bibr" rid="B138">138</xref>). Advanced biosensor platforms expand monitoring capabilities beyond glycemic control, including cardiac markers, ionic parameters, and additional clinical indicators. Optical biosensor technologies utilize photometric alterations induced by biological processes, enabling non-invasive monitoring of electrolytes in dermal fluid and interstitial compartments. Wearable platforms incorporate biosensor elements within smart devices and fitness monitoring systems, facilitating data transmission to mobile health platforms and Internet of Things (IoT) networks, thus enabling remote patient monitoring and therapeutic customization (<xref ref-type="bibr" rid="B139">139</xref>&#x2013;<xref ref-type="bibr" rid="B141">141</xref>). Current biosensor and wearable technologies face significant implementation challenges, including measurement precision, biological compatibility, information security, and patient adherence. Regulatory bodies, such as ISO and FDA, provide comprehensive guidelines to ensure these devices meet established safety standards, performance metrics, and quality parameters (<xref ref-type="bibr" rid="B142">142</xref>, <xref ref-type="bibr" rid="B143">143</xref>). Emerging developments in this field include minimally invasive sensing platforms, integrated multi-parameter monitoring systems, and the convergence of biosensor technology with AI for dynamic data processing and predictive analytics. Continuous measurement of biochemical indicators and comprehensive patient information allows AI systems to identify patterns, predict health risks, and generate individualized recommendations (<xref ref-type="bibr" rid="B144">144</xref>). Cross-disciplinary research initiatives promote technological advancements and clinical implementation, enhancing disease detection capabilities and therapeutic outcomes (<xref ref-type="bibr" rid="B145">145</xref>). <xref ref-type="table" rid="T2">Table 2</xref> provides an overview of emerging technological applications in clinical biochemistry, focusing on biosensors and wearable innovations.</p>
<table-wrap position="float" id="T2">
<label>TABLE 2</label>
<caption><p>Applications of novel technologies in clinical biochemistry.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Technology</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Applications</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Mass spectrometry</td>
<td valign="top" align="left">Proteomics, metabolomics, drug monitoring, toxicology</td>
</tr>
<tr>
<td valign="top" align="left">Next-generation sequencing</td>
<td valign="top" align="left">Genetic testing, cancer genomics, microbial identification</td>
</tr>
<tr>
<td valign="top" align="left">Microfluidics/&#x03BC;TAS</td>
<td valign="top" align="left">POCT, HTS, biomarker analysis</td>
</tr>
<tr>
<td valign="top" align="left">Biosensors</td>
<td valign="top" align="left">Continuous glucose monitoring, cardiac monitoring, disease biomarker detection</td>
</tr>
<tr>
<td valign="top" align="left">Artificial intelligence</td>
<td valign="top" align="left">Predictive diagnostics, personalized medicine, data integration, workflow optimization</td>
</tr>
</tbody>
</table></table-wrap>
</sec>
<sec id="S3.SS5">
<title>3.5 AI and ML</title>
<p>Artificial intelligence and ML have revolutionized clinical biochemistry. They transformed data processing and interpretation (<xref ref-type="bibr" rid="B146">146</xref>). These technologies use advanced AI algorithms to dissect intricate datasets precisely using modern analytical techniques. Their analysis revealed patterns, correlations, and insights beyond human expertise. This has proven beneficial in metabolomics, proteomics, and genomics, where large and complex datasets challenge traditional methods (<xref ref-type="bibr" rid="B147">147</xref>).</p>
<p>Implementing AI-driven systems in clinical biochemistry facilitates personalized diagnostic modeling through advanced algorithmic analysis. These platforms enable refined risk prediction, early disease detection, and metabolic-based patient stratification by processing diverse patient datasets, including clinical observations, biochemical measurements, and molecular signatures (<xref ref-type="bibr" rid="B148">148</xref>, <xref ref-type="bibr" rid="B149">149</xref>). This personalized approach enhances diagnostic accuracy and timeliness, supporting early disease recognition and intervention. The resulting improvement in diagnostic capabilities allows clinicians to implement targeted assessment strategies, ultimately optimizing patient care pathways (<xref ref-type="bibr" rid="B150">150</xref>, <xref ref-type="bibr" rid="B151">151</xref>). Deep learning architectures, particularly those using neural network frameworks, excel in biomarker discovery, disease diagnostics, and therapeutic target identification (<xref ref-type="bibr" rid="B152">152</xref>, <xref ref-type="bibr" rid="B153">153</xref>). Variants of neural networks, specifically Convolutional Neural Networks (CNNs) and Deep Neural Networks (DNNs), outperform conventional analytical methods in early cancer detection using proteomic datasets (<xref ref-type="bibr" rid="B154">154</xref>). Research has also highlighted the effectiveness of deep learning systems, including 2D CNN architectures, in accurately predicting anticancer peptide sequences with improved sensitivity and specificity (<xref ref-type="bibr" rid="B155">155</xref>). Recent technological advancements include MTS&#x2019;s novel AI-enhanced pathology platform, designed to streamline laboratory diagnostic processes. This system employs sophisticated ML algorithms for histopathological image analysis, enabling automated identification of pathological features, such as malignant tissue patterns, with high diagnostic precision. Integrating advanced image recognition with predictive analytics enhances workflow efficiency, reduces diagnostic uncertainty, and improves disease classification (<xref ref-type="bibr" rid="B156">156</xref>, <xref ref-type="bibr" rid="B157">157</xref>). Natural Language Processing (NLP) techniques have been instrumental in extracting valuable information from unstructured clinical notes and literature, enabling knowledge discovery and the development of decision support systems in healthcare (<xref ref-type="bibr" rid="B158">158</xref>).</p>
<p>Artificial intelligence integration with LIS transforms operational paradigms through enhanced workflow automation and data management capabilities. AI-enhanced LIS platforms streamline fundamental laboratory processes, including specimen management, testing coordination, and documentation protocols, significantly reducing manual administrative demands (<xref ref-type="bibr" rid="B159">159</xref>). Incorporating AI algorithms within LIS frameworks enables predictive equipment maintenance by analyzing operational metrics and identifying potential system failures early, minimizing operational disruptions and maintenance costs. Advanced analytical capabilities further enhance LIS functionality by identifying operational constraints, detecting result irregularities, and generating strategic recommendations for process improvement. Furthermore, AI-augmented LIS platforms promote system interoperability by integrating diverse analytical instrumentation and clinical platforms, facilitating seamless information exchange across healthcare networks (<xref ref-type="bibr" rid="B160">160</xref>). This comprehensive data integration ensures immediate accessibility of laboratory results for clinical personnel, enhancing collaborative care delivery and treatment outcomes.</p>
<p>Artificial Intelligence applications in laboratory medicine optimize the entire workflow, support decision-making, and improve diagnostic outcomes, with AI models showing exceptional predictive capabilities for early sepsis detection and prognostication (<xref ref-type="bibr" rid="B161">161</xref>). Furthermore, AI-driven clinical decision platforms enhance diagnostic capabilities by comprehensively analyzing biochemical parameters and identifying significant correlations and patterns denoting various pathological conditions, including metabolic disorders, endocrine dysfunction, and malignancies (<xref ref-type="bibr" rid="B162">162</xref>, <xref ref-type="bibr" rid="B163">163</xref>). These systems automate the identification of biochemical abnormalities, generate potential diagnostic considerations, and establish case prioritization protocols (<xref ref-type="bibr" rid="B163">163</xref>). In cardiac diagnostics, AI algorithms evaluate temporal troponin variations, assess myocardial injury risk profiles, and recommend appropriate clinical responses. These platforms provide tailored, evidence-based diagnostic guidance by dynamically integrating individualized patient metrics and contemporary clinical protocols. This technological enhancement reduces cognitive demands on practitioners, improves diagnostic accuracy, optimizes clinical workflows, and facilitates better therapeutic outcomes (<xref ref-type="bibr" rid="B164">164</xref>, <xref ref-type="bibr" rid="B165">165</xref>).</p>
</sec>
</sec>
<sec id="S4">
<title>4 Challenges and limitations of adopting novel technologies</title>
<p>While emerging technologies have the potential to advance clinical biochemistry significantly, their implementation is not without challenges and limitations. These include regulatory difficulties, integration with current systems, data management issues, and cost considerations.</p>
<sec id="S4.SS1">
<title>4.1 Regulatory challenges</title>
<p>In clinical biochemistry, adhering to existing rules when developing new technologies is essential to ensure safety, efficacy, and ethical standards (<xref ref-type="bibr" rid="B166">166</xref>). Regulatory bodies like the FDA, EMA, and CLSI are vital for assessing and approving different technologies and prioritizing safety, efficacy, and quality. Procedures can vary because of the unique features and challenges of technologies such as <italic>in vitro</italic> diagnostic equipment, biosensors, and AI-based software (<xref ref-type="bibr" rid="B167">167</xref>, <xref ref-type="bibr" rid="B168">168</xref>). The regulation of new devices, such as ML and AI, involves algorithm transparency, data privacy, and adapting evolving models. Partnerships between organizations, such as the Global Harmonization Task Force (GHTF) and the International Medical Device Regulators Forum (IMDRF), are necessary to address these challenges on a global scale (<xref ref-type="bibr" rid="B169">169</xref>). Using real-world evidence, medical devices must be monitored after market authorization to ensure proper functioning, safety, and quality (<xref ref-type="bibr" rid="B170">170</xref>). Compliance with regulatory requirements, sound risk management strategies, and quality assurance standards are fundamental to patient safety and healthcare innovation (<xref ref-type="bibr" rid="B171">171</xref>). Involving stakeholders, promoting open communication channels, and fostering active cooperation are essential for regulatory compliance and healthcare product safety. Access to innovation promptly depends on navigating the regulatory environment, which, if not properly overseen, could hinder adoption or compromise patient safety (<xref ref-type="bibr" rid="B171">171</xref>). To address these challenges, developers, regulators, and healthcare professionals must work together to ensure that standards are appropriate for encouraging innovation while safeguarding patient wellbeing (<xref ref-type="bibr" rid="B172">172</xref>).</p>
</sec>
<sec id="S4.SS2">
<title>4.2 Costs</title>
<p>Adopting new technologies in clinical biochemistry, such as POCT devices and wearable biosensors, requires substantial initial investments in expensive instruments and advanced software that incorporate AI/ML algorithms (<xref ref-type="bibr" rid="B135">135</xref>, <xref ref-type="bibr" rid="B173">173</xref>). Although these initial costs are significant, the long-term savings and economic benefits are considerable. These include enhanced efficiency, reduced TAT, better patient outcomes, and lower healthcare costs (<xref ref-type="bibr" rid="B135">135</xref>). These technologies facilitate the early detection of diseases, prevent costly complications, and significantly save healthcare systems (<xref ref-type="bibr" rid="B135">135</xref>). It is essential to conduct comprehensive cost-effectiveness analyses to justify such investments. These analyses offer a holistic economic value assessment and help prioritize technologies with the most significant long-term benefits (<xref ref-type="bibr" rid="B174">174</xref>). Strategies such as equipment sharing, outsourcing analyses, and leveraging cloud-based solutions can optimize costs. Investigating reimbursement opportunities and establishing partnerships can help mitigate the financial burden (<xref ref-type="bibr" rid="B135">135</xref>). Ultimately, the economic impact goes beyond individual providers and contributes to systemic cost savings, improved patient access to advanced diagnostics, and enhanced healthcare delivery (<xref ref-type="bibr" rid="B174">174</xref>).</p>
</sec>
<sec id="S4.SS3">
<title>4.3 Training</title>
<p>Laboratory professionals and doctors should receive extensive training to effectively implement advanced clinical biochemistry technologies. These training programs should cover theoretical knowledge, practical skills, data analysis, and the interpretation of results from cutting-edge tools, such as mass spectrometers and NGS platforms (<xref ref-type="bibr" rid="B175">175</xref>). Training can be provided through workshops, online courses, simulation-based learning, and mentorship programs. Manufacturers and vendors typically offer initial and ongoing training on their equipment. Specialized courses provided by academic institutions and professional groups can help bridge knowledge gaps (<xref ref-type="bibr" rid="B176">176</xref>). Interdisciplinary training involving laboratory personnel and doctors can improve communication regarding the capabilities and limitations of new technologies. This will make laboratory data more meaningful for clinical decision-making, leading to better collaboration between the two sides (<xref ref-type="bibr" rid="B177">177</xref>). Continuous education is crucial for professionals to keep up with the rapid pace of modern innovation. This ensures they maintain high-performance levels by consistently updating their knowledge base through retraining activities and assessing their capabilities, such as competency exams. Furthermore, training should address data privacy, ethics, and bioinformatics concerns because new technologies generate increasingly complex datasets that require analysis (<xref ref-type="bibr" rid="B178">178</xref>, <xref ref-type="bibr" rid="B179">179</xref>). Flexible learning options and prioritizing critical skills can mitigate challenges in implementing training programs, such as time constraints and budget limitations. International collaborations and exchanges can provide additional knowledge-sharing opportunities and skill development (<xref ref-type="bibr" rid="B180">180</xref>). Practical assessment of training outcomes is crucial to ensure that programs meet their objectives. This can be achieved through practical evaluations, knowledge tests, and monitoring of laboratory performance metrics. By prioritizing comprehensive and ongoing training, clinical biochemistry laboratories can maximize the benefits of innovative technologies, leading to improved patient care and outcomes (<xref ref-type="bibr" rid="B181">181</xref>, <xref ref-type="bibr" rid="B182">182</xref>).</p>
</sec>
<sec id="S4.SS4">
<title>4.4 Ethical and social implications</title>
<p>Integrating modern technology into clinical biochemistry raises significant ethical and societal concerns. AI algorithms must be transparent, neutral, and regularly audited to ensure fair healthcare delivery (<xref ref-type="bibr" rid="B183">183</xref>). Privacy concerns regarding the use of personal data in analytics require robust data protection rules and compliance with regulations such as the General Data Protection Regulation (GDPR) (<xref ref-type="bibr" rid="B184">184</xref>). In healthcare, incorporating big data and AI-driven analysis necessitates evolving informed consent processes to address complexities and potential inequities (<xref ref-type="bibr" rid="B185">185</xref>, <xref ref-type="bibr" rid="B186">186</xref>). Ethical issues surrounding genetic testing and personalized medicine, including genetic privacy and the right not to know, must be carefully addressed (<xref ref-type="bibr" rid="B187">187</xref>). Striking a delicate balance between individual privacy and the public health benefits of data sharing presents ongoing challenges that must be effectively managed (<xref ref-type="bibr" rid="B188">188</xref>). To address these complex concerns, healthcare workers should receive ongoing ethical training and be supervised by ethics committees to ensure proper management of the ethical implications of these technologies (<xref ref-type="bibr" rid="B189">189</xref>).</p>
</sec>
<sec id="S4.SS5">
<title>4.5 Risks and ethical considerations of AI in clinical biochemistry</title>
<p>Artificial intelligence has great potential to increase accuracy and efficiency in clinical biochemistry (<xref ref-type="bibr" rid="B190">190</xref>). However, they also create important dangers and moral difficulties. One of the most significant concerns is algorithmic bias, which refers to a model&#x2019;s training on datasets not fully representative of the patient population (<xref ref-type="bibr" rid="B191">191</xref>). Patients can be diagnosed and treated differently. Studies have found that AI-based diagnostic tools may show biases that can impair patients who are already under-represented in the datasets used for training. In addition, &#x201C;black box&#x201D; AI models do not offer the transparency needed to allow clinicians to understand how they develop their results. Explainability holds great importance in the context of clinical responsibility (<xref ref-type="bibr" rid="B192">192</xref>, <xref ref-type="bibr" rid="B193">193</xref>).</p>
<p>Moreover, automation should not replace human expertise but rather complement it. Overreliance on AI-driven systems without adequate human oversight can introduce risks, particularly in cases in which AI misinterpretations lead to incorrect diagnoses or inappropriate treatment choices (<xref ref-type="bibr" rid="B194">194</xref>). Regulatory bodies such as the FDA and EMA emphasize critically validating and monitoring AI applications in healthcare for their reliability and safety before their various uses (<xref ref-type="bibr" rid="B195">195</xref>). AI models are trained on large datasets that sometimes include sensitive patient information. Therefore, severe regulations must be imposed to ensure data privacy and security. The GDPR and the Health Insurance Portability and Accountability Act (HIPAA) have been discussed (<xref ref-type="bibr" rid="B195">195</xref>). A human-in-the-loop (HITL) approach is recommended, in which AI only assists clinicians in decision-making but does not replace them (<xref ref-type="bibr" rid="B196">196</xref>). Future improvements could focus on transparent and interpretable AI models, better dataset diversity, and solid regulations ensuring that AI fits ethical and clinical norms. Clinical biochemistry can benefit from AI while providing care for patients and professional supervision.</p>
</sec>
</sec>
<sec id="S5">
<title>5 Bridging the gaps with novel technologies</title>
<sec id="S5.SS1">
<title>5.1 Improved sensitivity and specificity</title>
<p>Technological advancements in clinical biochemistry have significantly enhanced the sensitivity and specificity of diagnostic tests. These improvements allow for the precise detection and quantification of biomarkers even at extremely low concentrations, aiding in the early diagnosis of diseases. High sensitivity assays, such as immunoassays and mass spectrometry-based techniques, have revolutionized the detection of cardiac markers, tumor markers, and infectious agents (<xref ref-type="bibr" rid="B197">197</xref>, <xref ref-type="bibr" rid="B198">198</xref>). The improved sensitivity of these technologies reduces false-negative results, ensuring that patients with conditions are accurately identified. Similarly, enhanced specificity minimizes false-positive results, reducing unnecessary follow-up tests and interventions. These advances are particularly significant in domains such as oncology, where early and accurate detection of biomarkers can directly impact treatment success and patient outcomes (<xref ref-type="bibr" rid="B199">199</xref>, <xref ref-type="bibr" rid="B200">200</xref>). Integrating AI and ML further enhances diagnostic accuracy by analyzing complex datasets and identifying subtle patterns within biochemical data. These technologies improve the reliability of test results and reduce variability associated with manual interpretation (<xref ref-type="bibr" rid="B201">201</xref>). Combining high sensitivity assays with advanced computational tools allows clinical laboratories to achieve unprecedented diagnostic precision across various diseases (<xref ref-type="bibr" rid="B201">201</xref>, <xref ref-type="bibr" rid="B202">202</xref>).</p>
</sec>
<sec id="S5.SS2">
<title>5.2 Timeliness and efficiency</title>
<p>Clinical biochemistry advances have markedly enhanced diagnostic efficiency and timeliness. Laboratory automation streamlines operational workflows, minimizes manual processing errors, and reduces result TAT (<xref ref-type="bibr" rid="B203">203</xref>). POCT systems deliver immediate diagnostic results in bedside and outpatient environments, eliminating traditional testing delays related to specimen transport and centralized analysis (<xref ref-type="bibr" rid="B204">204</xref>). These technological developments minimize intervals between specimen collection and result availability, proving essential during emergencies like cardiac episodes or sepsis, where prompt intervention directly impacts survival rates (<xref ref-type="bibr" rid="B205">205</xref>). Such rapid analytical capabilities enhance clinical outcomes while optimizing healthcare delivery systems. LIS integration further amplifies operational efficiency through automated data processing and enhanced laboratory-clinical communication protocols (<xref ref-type="bibr" rid="B206">206</xref>).</p>
</sec>
<sec id="S5.SS3">
<title>5.3 Personalized medicine</title>
<p>Modern clinical biochemistry technologies serve as fundamental drivers in personalized medicine advancement. These platforms enable precise biomarker detection, facilitating individually tailored therapeutic approaches (<xref ref-type="bibr" rid="B207">207</xref>). Advanced analytical methods, including NGS and MS, comprehensively analyze genetic, proteomic, and metabolomic profiles, revealing disease mechanisms and patient-specific variations (<xref ref-type="bibr" rid="B208">208</xref>). Patient-specific medicine optimizes treatment effectiveness while minimizing adverse reactions through molecular profile-guided therapy selection. This methodology demonstrates value in oncology, where targeted interventions address tumor-specific genetic alterations (<xref ref-type="bibr" rid="B209">209</xref>). Enhanced capability to predict therapeutic responses and disease trajectories enables evidence-based clinical decisions, advancing care quality and patient outcomes (<xref ref-type="bibr" rid="B210">210</xref>). AI integration and large-scale data analytics strengthen personalized medicine by identifying complex patterns within extensive clinical datasets, optimizing treatment protocols, and improving response prediction accuracy. These innovations transform healthcare delivery by transitioning from standardized protocols toward individualized therapeutic approaches.</p>
</sec>
<sec id="S5.SS4">
<title>5.4 Data integration and management</title>
<p>Data integration and management are crucial for utilizing innovative technologies in clinical biochemistry. Advanced bioinformatics tools enhance data interoperability, facilitating the seamless integration of diverse data sources and platforms (<xref ref-type="bibr" rid="B211">211</xref>). This information is vital to comprehensive patient records and collaborative research. AI is pivotal for integrating multi-omics data, such as genomics, proteomics, and metabolomics. AI algorithms can rapidly analyze complex datasets and identify patterns and correlations beyond human capabilities (<xref ref-type="bibr" rid="B81">81</xref>). A thorough understanding of patient health and disease is essential in precision medicine. AI-driven predictive analytics can identify patients at high risk of requiring early intervention (<xref ref-type="bibr" rid="B212">212</xref>). Moreover, implementing AI in LIS optimizes data and improves diagnosis, efficiency, and personalized medicine (<xref ref-type="bibr" rid="B213">213</xref>).</p>
</sec>
</sec>
<sec id="S6">
<title>6 Case studies and current applications</title>
<sec id="S6.SS1">
<title>6.1 Successful integration of novel technologies</title>
<p>Introducing new technology has revolutionized clinical biochemistry and improved diagnosis and operational efficiency. Micro total analysis systems (&#x03BC;TAS) paired with electrochemistry enable the accurate and rapid assessment of biomarkers, which are crucial for early detection and treatment. Integrated diagnostic systems that combine biochemical and molecular diagnostics offer a comprehensive understanding of patient cases, allowing for targeted and customized therapeutic approaches. One way in which these innovations have improved patient care is by expediting the diagnosis and initiation of treatment, particularly in acute therapy situations. This is achieved by streamlining laboratory processes through upgraded biochemical tests, reducing TAT, enhancing diagnostic capabilities, improving patient outcomes, and optimizing resource use (<xref ref-type="bibr" rid="B214">214</xref>, <xref ref-type="bibr" rid="B215">215</xref>).</p>
</sec>
<sec id="S6.SS2">
<title>6.2 Comparative analysis of traditional vs. novel technologies</title>
<p>The cost-effectiveness of innovative technologies is crucial to their widespread acceptance in clinical biochemistry. Although the initial investment may be substantial, long-term benefits usually outweigh these costs (<xref ref-type="bibr" rid="B216">216</xref>). For instance, while &#x03BC;TAS devices can be costly to implement, they reduce reagent usage and the workforce, thus lowering operational costs and increasing throughput. Furthermore, these technologies greatly enhance clinical outcomes (<xref ref-type="bibr" rid="B217">217</xref>). In contrast, traditional biochemical diagnostics, although reliable, often lack the necessary sensitivity and specificity for early identification of illness. Advanced diagnostic platforms, such as those that incorporate immunodetection, can simultaneously identify multiple biomarkers and provide a comprehensive disease profile. This precision is particularly significant in diseases such as osteoarthritis, where early identification can significantly improve patient outcomes (<xref ref-type="bibr" rid="B218">218</xref>).</p>
</sec>
</sec>
<sec id="S7">
<title>7 Future directions and research potential</title>
<sec id="S7.SS1">
<title>7.1 Future trends in clinical biochemistry</title>
<p>Clinical biochemistry&#x2019;s trajectory aims to integrate and refine modern technological platforms to optimize diagnostic precision, healthcare accessibility, and personalized patient care. Advancing beyond current methodologies, including MS analysis, NGS technologies, biosensor applications, and AI systems, the field anticipates a shift toward automated processes, continuous monitoring, and comprehensive analytical platforms. These innovations facilitate faster diagnostics with improved accuracy, ultimately enhancing therapeutic outcomes (<xref ref-type="bibr" rid="B144">144</xref>). Emerging developments include high-throughput analytical systems designed to process larger sample volumes with greater efficiency and shorter processing times (<xref ref-type="bibr" rid="B219">219</xref>). Laboratory workflow enhancements through automation and system miniaturization will increase diagnostic accessibility across various healthcare settings. Specifically, advanced microfluidic systems and integrated diagnostic platforms are expected to provide cost-effective, portable analytical solutions for centralized and distributed testing environments. Integrating multi-omics data&#x2014;encompassing genomic, proteomic, and metabolomic analyses&#x2014;significantly advances clinical applications (<xref ref-type="bibr" rid="B220">220</xref>). This comprehensive approach, enhanced by AI and ML, enables a deeper understanding of pathological mechanisms, facilitating tailored therapeutic strategies. AI applications will continue improving predictive diagnostics through pattern recognition in complex datasets, enabling early pathology detection and refined risk assessment protocols. Biosensor platforms and wearable technologies are set to become essential components of routine healthcare delivery, allowing for sustained, non-invasive monitoring of biochemical and physiological parameters. Integrating mobile health infrastructure with IoT frameworks&#x2014;networks of interconnected devices that communicate and share data in real-time&#x2014;will improve access to clinical data, thereby enhancing chronic disease management and preventive care strategies (<xref ref-type="bibr" rid="B221">221</xref>).</p>
<p>A growing focus is on developing sustainable and economically viable diagnostic methodologies. Initiatives to reduce environmental impact, such as optimizing reagent use and waste management, align with sustainability goals. Scaled manufacturing processes and optimized resource allocation will improve access to advanced diagnostic platforms. This field&#x2019;s evolution emphasizes patient-centered care, leveraging technological advancements to provide accessible and personalized healthcare services. Collaboration among research communities, clinical practitioners, and industry partners is crucial for driving innovation, overcoming technological limitations, and ensuring equitable access to diagnostic capabilities across diverse healthcare environments.</p>
</sec>
<sec id="S7.SS2">
<title>7.2 Collaborative research and development</title>
<p>The successful integration of innovative technologies in clinical biochemistry depends heavily on extensive interdisciplinary collaboration. Molecular biology, physics, engineering, and clinical medicine professionals must collaborate to develop groundbreaking diagnostic instruments and approaches (<xref ref-type="bibr" rid="B222">222</xref>). Academic institutions play a fundamental role in conducting primary research and training for scientists. Industry partners transform this research into market-ready solutions, whereas clinical institutions validate and implement these technologies in real-time. The synergistic relationships among these sectors accelerate technological development and acceptance, ensuring alignment with clinical demands and regulatory standards (<xref ref-type="bibr" rid="B223">223</xref>).</p>
</sec>
<sec id="S7.SS3">
<title>7.3 Regulatory and ethical considerations</title>
<p>Regulatory obstacles often impede the use of innovative technologies for clinical biochemistry. Regulators are responsible for ensuring the safety and reliability of new diagnostic instruments while keeping pace with rapid technological advancements (<xref ref-type="bibr" rid="B224">224</xref>). Streamlining regulations and promoting open dialog can accelerate technology adoption. Ethical considerations, including data privacy and patient consent concerns, are vital in implementing new diagnostic technologies. Protecting patient data and using them for intended purposes is crucial. Furthermore, obtaining informed consent is essential for building trust in healthcare practices, especially when utilizing advanced technologies, such as genomics or quantum computing (<xref ref-type="bibr" rid="B225">225</xref>, <xref ref-type="bibr" rid="B226">226</xref>).</p>
</sec>
<sec id="S7.SS4">
<title>7.4 Education and training</title>
<p>The rapid integration of new technologies into clinical biochemistry necessitates a comprehensive overview of healthcare professionals&#x2019; education and training programs. Clinical biochemists, laboratory technicians, and clinicians must have the knowledge and skills to apply and interpret these emerging technologies [163] effectively. This will involve updating the curriculum to include theory and practice in new analytical methods, data analysis techniques, and ethical considerations (<xref ref-type="bibr" rid="B227">227</xref>). Furthermore, future medical and laboratory education systems should focus on integrating innovative technologies to prepare professionals to manage such dynamic technological environments. Hands-on training, simulations, and case studies are crucial to understanding these innovations and their impact on patient care (<xref ref-type="bibr" rid="B228">228</xref>). By developing a culture of lifelong learning and aligning educational programs with technological advancements, the healthcare community can optimize patient care and drive innovation.</p>
</sec>
<sec id="S7.SS5">
<title>7.5 Creating comprehensive reference intervals</title>
<p>Reference intervals must be established for various populations, including pediatric and geriatric groups. These intervals are crucial for a precise diagnosis and treatment. To ensure that the reference intervals are applicable across different age groups and demographics, initiatives such as CALIPER should be expanded to encompass diverse populations.</p>
</sec>
<sec id="S7.SS6">
<title>7.6 Promoting cost-effective solutions</title>
<p>Cost-effective and scalable technologies can make advanced diagnostics more accessible to a broader range of healthcare facilities. These diagnostic tools, which are cost-effective and scalable, connect researchers to real-world solutions, thereby advancing the field of discovery (<xref ref-type="bibr" rid="B229">229</xref>).</p>
</sec>
</sec>
<sec id="S8" sec-type="conclusion">
<title>8 Conclusion</title>
<p>Incorporating recent advancements in established technologies and novel tools into clinical biochemistry may aid the early detection and treatment of patients. To successfully integrate these technologies, addressing the present gaps, such as legislative barriers, costs, training requirements, and ethical considerations, is critical. To encourage cost-effective solutions, collaboration must be strengthened, investing in R&#x0026;D, education and training programs updated, and innovation-driven through these procedures. Continued research in nanotechnology, bioinformatics, and AI will help improve healthcare efficiency and personalization. The use of AI in clinical biochemistry has both advantages and disadvantages that must be considered. AI systems rely on data to learn patterns that characterize optimal care. If the data are biased, then the AI will be. Also, &#x201C;black boxes&#x201D; with bad interpretability and clinical accountability concerns hinder AI-driven models. Data manufactured by abusers constructed without consent and AI replacing human expertise risks are worthy of examination before uptake. In the future, researchers should concentrate on building explainable AI models. In addition, improved regulatory frameworks in SDHS will help to ensure effective interdisciplinary engagement.</p>
</sec>
</body>
<back>
<sec id="S9" sec-type="author-contributions">
<title>Author contributions</title>
<p>HC: Writing &#x2013; original draft. EO: Project administration, Supervision, Writing &#x2013; review and editing. AL: Writing &#x2013; review and editing. MA: Conceptualization, Writing &#x2013; original draft. GZ: Writing &#x2013; review and editing. AD: Writing &#x2013; review and editing.</p>
</sec>
<sec id="S10" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. The Deanship of Research and Graduate Studies at King Khalid University helped fund this work through a Large Research Project under grant number RGP2/230/45.</p>
</sec>
<ack><p>We thank the Deanship of Research and Graduate Studies at King Khalid University for funding this work through a Large Research Project under grant number RGP2/230/45.</p>
</ack>
<sec id="S11" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="S12" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The authors declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="S13" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahsan</surname> <given-names>H</given-names></name></person-group>. <article-title>Clinical chemistry and biochemistry: The role of biomarkers and biomolecules.</article-title> <source><italic>Asian J Sci Educ.</italic></source> (<year>2022</year>) <volume>4</volume>:<fpage>17</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.24815/ajse.v4i1.24431</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lloyd</surname> <given-names>R.</given-names></name></person-group> <source><italic>Clinical Chemistry. Pathology: Historical and Contemporary Aspects.</italic></source> <publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer</publisher-name> (<year>2023</year>). p. <fpage>189</fpage>&#x2013;<lpage>95</lpage>.</citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olver</surname> <given-names>P</given-names></name> <name><surname>Bohn</surname> <given-names>M</given-names></name> <name><surname>Adeli</surname> <given-names>K</given-names></name></person-group>. <article-title>Central role of laboratory medicine in public health and patient care.</article-title> <source><italic>Clin Chem Lab Med.</italic></source> (<year>2023</year>) <volume>61</volume>:<fpage>666</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1515/cclm-2022-1075</pub-id> <pub-id pub-id-type="pmid">36436024</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hartikainen</surname> <given-names>T</given-names></name> <name><surname>Westermann</surname> <given-names>D</given-names></name></person-group>. <article-title>Advances in rapid diagnostic tests for myocardial infarction patients.</article-title> <source><italic>Expert Rev Mol Diagn.</italic></source> (<year>2023</year>) <volume>23</volume>:<fpage>391</fpage>&#x2013;<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1080/14737159.2023.2207740</pub-id> <pub-id pub-id-type="pmid">37099443</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kyriazidis</surname> <given-names>I</given-names></name> <name><surname>Jakob</surname> <given-names>D</given-names></name> <name><surname>Vargas</surname> <given-names>J</given-names></name> <name><surname>Franco</surname> <given-names>O</given-names></name> <name><surname>Degiannis</surname> <given-names>E</given-names></name> <name><surname>Dorn</surname> <given-names>P</given-names></name><etal/></person-group> <article-title>Accuracy of diagnostic tests in cardiac injury after blunt chest trauma: A systematic review and meta-analysis.</article-title> <source><italic>World J Emerg Surg.</italic></source> (<year>2023</year>) <volume>18</volume>:<fpage>36</fpage>. <pub-id pub-id-type="doi">10.1186/s13017-023-00504-9</pub-id> <pub-id pub-id-type="pmid">37245048</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>A</given-names></name> <name><surname>Kumar</surname> <given-names>J</given-names></name> <name><surname>Goud</surname> <given-names>B</given-names></name></person-group>. <article-title>Liver function tests: Biochemical overview for clinical correlation.</article-title> <source><italic>Indian J Med Biochem.</italic></source> (<year>2021</year>) <volume>25</volume>:<fpage>31</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.5005/jp-journals-10054-0171</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname> <given-names>R</given-names></name> <name><surname>Kucera</surname> <given-names>C</given-names></name> <name><surname>Nery</surname> <given-names>C</given-names></name> <name><surname>Lacbawan</surname> <given-names>F</given-names></name> <name><surname>Salazar</surname> <given-names>D</given-names></name> <name><surname>Tanpaiboon</surname> <given-names>P</given-names></name></person-group>. <article-title>Biotinidase biochemical and molecular analyses: Experience at a large reference laboratory.</article-title> <source><italic>Pediatr Int.</italic></source> (<year>2024</year>) <volume>66</volume>:<fpage>e15726</fpage>. <pub-id pub-id-type="doi">10.1111/ped.15726</pub-id> <pub-id pub-id-type="pmid">38299772</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname> <given-names>J</given-names></name></person-group>. <article-title>All tests can sometimes cause more harm than good.</article-title> <source><italic>BMJ.</italic></source> (<year>2017</year>) <volume>358</volume>:<fpage>j4070</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.j4070</pub-id> <pub-id pub-id-type="pmid">28864628</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dadi</surname> <given-names>M</given-names></name> <name><surname>Yasir</surname> <given-names>M.</given-names></name></person-group> <source><italic>Spectroscopy and Spectrophotometry: Principles and Applications for Colorimetric and Related Other Analysis.</italic></source> <publisher-loc>London</publisher-loc>: <publisher-name>IntechOpen</publisher-name> (<year>2022</year>).</citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ko&#x010D;ov&#x00E1; Vl&#x010D;kov&#x00E1;</surname> <given-names>H</given-names></name> <name><surname>Pila&#x0159;ov&#x00E1;</surname> <given-names>V</given-names></name> <name><surname>Svobodov&#x00E1;</surname> <given-names>P</given-names></name> <name><surname>Pl&#x00ED;&#x0161;ek</surname> <given-names>J</given-names></name> <name><surname>&#x0160;vec</surname> <given-names>F</given-names></name> <name><surname>Nov&#x00E1;kov&#x00E1;</surname> <given-names>L</given-names></name></person-group>. <article-title>Current state of bioanalytical chromatography in clinical analysis.</article-title> <source><italic>Analyst.</italic></source> (<year>2018</year>) <volume>143</volume>:<fpage>1305</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1039/c7an01807j</pub-id> <pub-id pub-id-type="pmid">29461553</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>N</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name> <name><surname>Li</surname> <given-names>M</given-names></name> <name><surname>Liu</surname> <given-names>M</given-names></name> <name><surname>Jin</surname> <given-names>Y</given-names></name> <name><surname>Xu</surname> <given-names>H</given-names></name></person-group>. <article-title>Simultaneous determination of UDCA and its major metabolites in human plasma with surrogate matrix by a rapid and specific LC-MS/MS method.</article-title> <source><italic>J Chromatogr B Analyt Technol Biomed Life Sci.</italic></source> (<year>2023</year>) <volume>1223</volume>:<fpage>123726</fpage>. <pub-id pub-id-type="doi">10.1016/j.jchromb.2023.123726</pub-id> <pub-id pub-id-type="pmid">37148852</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>H</given-names></name> <name><surname>Liu</surname> <given-names>H</given-names></name> <name><surname>Kuo</surname> <given-names>Y</given-names></name> <name><surname>Yang</surname> <given-names>D</given-names></name> <name><surname>Ting</surname> <given-names>T</given-names></name> <name><surname>Chen</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Rapid and sensitive dilute-and-shoot analysis using LC-MS-MS for identification of multi-class psychoactive substances in human urine.</article-title> <source><italic>J Pharm Biomed Anal.</italic></source> (<year>2023</year>) <volume>233</volume>:<fpage>115443</fpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2023.115443</pub-id> <pub-id pub-id-type="pmid">37210892</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mogaka</surname> <given-names>E</given-names></name> <name><surname>Karaku&#x015E;</surname> <given-names>R</given-names></name> <name><surname>Ba&#x011E;Ria&#x00C7;Ik</surname> <given-names>E</given-names></name></person-group>. <article-title>Interference in immunoassays.</article-title> <source><italic>Gazi Sa&#x011F;l&#x0131;k Bilimleri Dergisi.</italic></source> (<year>2023</year>) <volume>8</volume>:<fpage>22</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.52881/gsbdergi.1062257</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dupont</surname> <given-names>D</given-names></name></person-group>. <article-title>Immunochemical methods.</article-title> <source><italic>Encyclopedia Dairy Sci.</italic></source> (<year>2022</year>) <volume>2</volume>:<fpage>400</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-818766-1.00167-7</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>K</given-names></name> <name><surname>He</surname> <given-names>X</given-names></name> <name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Pan</surname> <given-names>T</given-names></name> <name><surname>He</surname> <given-names>R</given-names></name> <name><surname>Kong</surname> <given-names>F</given-names></name><etal/></person-group> <article-title>Recent progress of microfluidic chips in immunoassay.</article-title> <source><italic>Front Bioeng Biotechnol.</italic></source> (<year>2022</year>) <volume>10</volume>:<fpage>1112327</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2022.1112327</pub-id> <pub-id pub-id-type="pmid">36619380</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname> <given-names>D</given-names></name> <name><surname>Todt</surname> <given-names>M</given-names></name> <name><surname>Davis</surname> <given-names>H</given-names></name></person-group>. <article-title>A low-cost quantitative absorption spectrophotometer.</article-title> <source><italic>J Chem Educ.</italic></source> (<year>2012</year>) <volume>89</volume>:<fpage>1432</fpage>&#x2013;<lpage>5</lpage>.</citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akash</surname> <given-names>M</given-names></name> <name><surname>Rehman</surname> <given-names>K.</given-names></name></person-group> <source><italic>Introduction to Spectrophotometric Techniques. Essentials of Pharmaceutical Analysis.</italic></source> <publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer</publisher-name> (<year>2020</year>) p. <fpage>19</fpage>&#x2013;<lpage>27</lpage>.</citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mahrous</surname> <given-names>E</given-names></name> <name><surname>Chen</surname> <given-names>R</given-names></name> <name><surname>Zhao</surname> <given-names>C</given-names></name> <name><surname>Farag</surname> <given-names>M</given-names></name></person-group>. <article-title>Lipidomics in food quality and authentication: A comprehensive review of novel trends and applications using chromatographic and spectroscopic techniques.</article-title> <source><italic>Crit Rev Food Sci Nutr.</italic></source> (<year>2024</year>) <volume>64</volume>:<fpage>9058</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1080/10408398.2023.2207659</pub-id> <pub-id pub-id-type="pmid">37165484</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van den Hurk</surname> <given-names>R</given-names></name> <name><surname>Pursch</surname> <given-names>M</given-names></name> <name><surname>Stoll</surname> <given-names>D</given-names></name> <name><surname>Pirok</surname> <given-names>B</given-names></name></person-group>. <article-title>Recent trends in two-dimensional liquid chromatography.</article-title> <source><italic>TrAC Trends Anal Chem.</italic></source> (<year>2023</year>) <volume>166</volume>:<fpage>117166</fpage>. <pub-id pub-id-type="doi">10.1016/j.trac.2023.117166</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname> <given-names>W</given-names></name></person-group>. <article-title>Immunoassays for therapeutic drug monitoring and clinical toxicology. Methods of therapeutic drug monitoring including pharmacogenetics.</article-title> <source><italic>Handb Anal Separations.</italic></source> (<year>2020</year>) <volume>7</volume>:<fpage>97</fpage>&#x2013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-444-64066-6.00005-8</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>G</given-names></name> <name><surname>Velgos</surname> <given-names>S</given-names></name> <name><surname>Boddapati</surname> <given-names>S</given-names></name> <name><surname>Sierks</surname> <given-names>M</given-names></name></person-group>. <article-title>Probing antibody-antigen interactions.</article-title> <source><italic>Microbiol Spectr.</italic></source> (<year>2014</year>) <volume>2</volume>:<fpage>AID</fpage>&#x2013;<lpage>0010&#x2013;2013</lpage>. <pub-id pub-id-type="doi">10.1128/microbiolspec.AID-0010-2013</pub-id> <pub-id pub-id-type="pmid">26082105</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Waddell Smith</surname> <given-names>R</given-names></name></person-group>. <article-title>Mass spectrometry.</article-title> <edition>Third ed</edition>. In: <person-group person-group-type="editor"><name><surname>Siegel</surname> <given-names>JA</given-names></name> <name><surname>Saukko</surname> <given-names>PJ</given-names></name> <name><surname>Knupfer</surname> <given-names>GC</given-names></name></person-group> <role>editors</role>. <source><italic>Encyclopedia of Forensic Sciences.</italic></source> <publisher-loc>Cambridge, MA</publisher-loc>: <publisher-name>Academic Press</publisher-name> (<year>2023</year>). p. <fpage>464</fpage>&#x2013;<lpage>73</lpage>.</citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>X</given-names></name> <name><surname>Guo</surname> <given-names>G</given-names></name> <name><surname>Wu</surname> <given-names>X</given-names></name> <name><surname>Wu</surname> <given-names>Q</given-names></name> <name><surname>Liu</surname> <given-names>F</given-names></name> <name><surname>Zhang</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>Advances in integration, wearable applications, and artificial intelligence of biomedical microfluidics systems.</article-title> <source><italic>Micromachines (Basel).</italic></source> (<year>2023</year>) <volume>14</volume>:<fpage>972</fpage>. <pub-id pub-id-type="doi">10.3390/mi14050972</pub-id> <pub-id pub-id-type="pmid">37241596</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ortseifen</surname> <given-names>V</given-names></name> <name><surname>Viefhues</surname> <given-names>M</given-names></name> <name><surname>Wobbe</surname> <given-names>L</given-names></name> <name><surname>Gr&#x00FC;nberger</surname> <given-names>A</given-names></name></person-group>. <article-title>Microfluidics for biotechnology: Bridging gaps to foster microfluidic applications.</article-title> <source><italic>Front Bioeng Biotechnol.</italic></source> (<year>2020</year>) <volume>8</volume>:<fpage>589074</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2020.589074</pub-id> <pub-id pub-id-type="pmid">33282849</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname> <given-names>S</given-names></name> <name><surname>Wei</surname> <given-names>L</given-names></name> <name><surname>Shi</surname> <given-names>X</given-names></name> <name><surname>Sun</surname> <given-names>D</given-names></name> <name><surname>Shi</surname> <given-names>T</given-names></name> <name><surname>Lv</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>Reference intervals of biochemical analytes in healthy adults from northern China: A population-based cross-sectional study.</article-title> <source><italic>Medicine (Baltimore).</italic></source> (<year>2023</year>) <volume>102</volume>:<fpage>e35575</fpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000035575</pub-id> <pub-id pub-id-type="pmid">37861546</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stukas</surname> <given-names>S</given-names></name> <name><surname>Cooper</surname> <given-names>J</given-names></name> <name><surname>Higgins</surname> <given-names>V</given-names></name> <name><surname>Holmes</surname> <given-names>D</given-names></name> <name><surname>Adeli</surname> <given-names>K</given-names></name> <name><surname>Wellington</surname> <given-names>C</given-names></name></person-group>. <article-title>Pediatric reference intervals for serum neurofilament light and glial fibrillary acidic protein using the Canadian Laboratory initiative on pediatric reference intervals (CALIPER) cohort.</article-title> <source><italic>Clin Chem Lab Med.</italic></source> (<year>2024</year>) <volume>62</volume>:<fpage>698</fpage>&#x2013;<lpage>705</lpage>. <pub-id pub-id-type="doi">10.1515/cclm-2023-0660</pub-id> <pub-id pub-id-type="pmid">37882772</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname> <given-names>C</given-names></name> <name><surname>Schindler</surname> <given-names>S</given-names></name> <name><surname>Henson</surname> <given-names>R</given-names></name> <name><surname>Wolk</surname> <given-names>D</given-names></name> <name><surname>Shaw</surname> <given-names>L</given-names></name> <name><surname>Agboola</surname> <given-names>F</given-names></name><etal/></person-group> <article-title>Correlational analyses of biomarkers that are harmonized through a bridging study due to measurement errors.</article-title> <source><italic>Stat Methods Med Res.</italic></source> (<year>2024</year>) <volume>33</volume>:<fpage>185</fpage>&#x2013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1177/09622802231215810</pub-id> <pub-id pub-id-type="pmid">37994004</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Al-Dewik</surname> <given-names>N</given-names></name> <name><surname>Younes</surname> <given-names>S</given-names></name> <name><surname>Essa</surname> <given-names>M</given-names></name> <name><surname>Pathak</surname> <given-names>S</given-names></name> <name><surname>Qoronfleh</surname> <given-names>M</given-names></name></person-group>. <article-title>Making biomarkers relevant to healthcare innovation and precision medicine.</article-title> <source><italic>Processes.</italic></source> (<year>2022</year>) <volume>10</volume>:<fpage>1107</fpage>. <pub-id pub-id-type="doi">10.3390/pr10061107</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>L</given-names></name> <name><surname>Liu</surname> <given-names>C</given-names></name> <name><surname>Qi</surname> <given-names>M</given-names></name> <name><surname>Cheng</surname> <given-names>L</given-names></name> <name><surname>Wang</surname> <given-names>L</given-names></name> <name><surname>Li</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>Recent progress of nanostructure-based enrichment of circulating tumor cells and downstream analysis.</article-title> <source><italic>Lab Chip.</italic></source> (<year>2023</year>) <volume>23</volume>:<fpage>1493</fpage>&#x2013;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1039/d2lc00890d</pub-id> <pub-id pub-id-type="pmid">36776104</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chakraborty</surname> <given-names>S</given-names></name> <name><surname>Bera</surname> <given-names>D</given-names></name> <name><surname>Roy</surname> <given-names>L</given-names></name> <name><surname>Ghosh</surname> <given-names>C</given-names></name></person-group>. <article-title>Biomimetic and bioinspired nanostructures.</article-title> In: <person-group person-group-type="author"><name><surname>Sen</surname> <given-names>M</given-names></name> <name><surname>Mukherjee</surname> <given-names>M</given-names></name></person-group> <role>editors</role>. <source><italic>Bioinspired and Green Synthesis of Nanostructures.</italic></source> <publisher-loc>Hoboken, NJ</publisher-loc>: <publisher-name>John Wiley &#x0026; Sons</publisher-name> (<year>2023</year>). p. <fpage>353</fpage>&#x2013;<lpage>404</lpage>.</citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Phan</surname> <given-names>T</given-names></name> <name><surname>Reed</surname> <given-names>J</given-names></name></person-group>. <article-title>Extracellular vesicles as next-generation therapeutics and biomarkers in amyloidosis: A new frontier.</article-title> <source><italic>Front Biomaterials Sci.</italic></source> (<year>2024</year>) <volume>2</volume>:<fpage>1343658</fpage>. <pub-id pub-id-type="doi">10.3389/fbiom.2023.1343658</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname> <given-names>S</given-names></name> <name><surname>Patranabis</surname> <given-names>S</given-names></name></person-group>. <article-title>Emerging role of extracellular vesicles in intercellular communication in the brain: Implications for neurodegenerative diseases and therapeutics.</article-title> <source><italic>Cell Biochem Biophys.</italic></source> (<year>2024</year>) <volume>82</volume>:<fpage>379</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1007/s12013-024-01221-z</pub-id> <pub-id pub-id-type="pmid">38300375</pub-id></citation></ref>
<ref id="B33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noori</surname> <given-names>L</given-names></name> <name><surname>Filip</surname> <given-names>K</given-names></name> <name><surname>Nazmara</surname> <given-names>Z</given-names></name> <name><surname>Mahakizadeh</surname> <given-names>S</given-names></name> <name><surname>Hassanzadeh</surname> <given-names>G</given-names></name> <name><surname>Caruso Bavisotto</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>Contribution of extracellular vesicles and molecular chaperones in age-related neurodegenerative disorders of the CNS.</article-title> <source><italic>Int J Mol Sci.</italic></source> (<year>2023</year>) <volume>24</volume>:<fpage>927</fpage>. <pub-id pub-id-type="doi">10.3390/ijms24020927</pub-id> <pub-id pub-id-type="pmid">36674442</pub-id></citation></ref>
<ref id="B34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neuer</surname> <given-names>A</given-names></name> <name><surname>Herrmann</surname> <given-names>I</given-names></name> <name><surname>Gogos</surname> <given-names>A</given-names></name></person-group>. <article-title>Biochemical transformations of inorganic nanomedicines in buffers, cell cultures and organisms.</article-title> <source><italic>Nanoscale.</italic></source> (<year>2023</year>) <volume>15</volume>:<fpage>18139</fpage>&#x2013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1039/d3nr03415a</pub-id> <pub-id pub-id-type="pmid">37946534</pub-id></citation></ref>
<ref id="B35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>F</given-names></name> <name><surname>Zheng</surname> <given-names>B</given-names></name> <name><surname>Zheng</surname> <given-names>N</given-names></name> <name><surname>Alfaiz</surname> <given-names>F</given-names></name> <name><surname>Ali</surname> <given-names>H</given-names></name> <name><surname>Al Garalleh</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>Smart nano generation of transgenic algae expressing white spot syndrome virus in shrimps for inner ear-oral infection treatments using the spotted hyena optimizer (SHO)-Long short-term memory algorithm.</article-title> <source><italic>Environ Res.</italic></source> (<year>2024</year>) <volume>243</volume>:<fpage>117519</fpage>. <pub-id pub-id-type="doi">10.1016/j.envres.2023.117519</pub-id> <pub-id pub-id-type="pmid">37972807</pub-id></citation></ref>
<ref id="B36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Radha</surname> <given-names>C</given-names></name> <name><surname>Midunkumar</surname> <given-names>R</given-names></name> <name><surname>Muralibabu</surname> <given-names>S</given-names></name> <name><surname>Partheeban</surname> <given-names>V</given-names></name> <name><surname>Praveenkumar</surname> <given-names>T</given-names></name></person-group>. <article-title>Role of artificial intelligence in big data analytics.</article-title> <source><italic>Int J Adv Res Sci Commu Technol.</italic></source> (<year>2024</year>) <volume>4</volume>:<fpage>586</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.48175/IJARSCT-170</pub-id></citation></ref>
<ref id="B37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname> <given-names>H</given-names></name> <name><surname>Chavda</surname> <given-names>V</given-names></name> <name><surname>Soniwala</surname> <given-names>M</given-names></name></person-group>. <article-title>Applications of bioinformatics tools in medicinal biology and biotechnology.</article-title> <source><italic>Bioinformatics Tools Pharma Drug Product Development.</italic></source> (<year>2023</year>):<fpage>95</fpage>&#x2013;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1002/9781119865728.ch1</pub-id></citation></ref>
<ref id="B38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>D</given-names></name> <name><surname>Li</surname> <given-names>H</given-names></name> <name><surname>Ma</surname> <given-names>X</given-names></name> <name><surname>Zou</surname> <given-names>Y</given-names></name> <name><surname>Mu</surname> <given-names>D</given-names></name><etal/></person-group> <article-title>Liquid chromatography-tandem mass spectrometry in clinical laboratory protein measurement.</article-title> <source><italic>Clin Chim Acta.</italic></source> (<year>2024</year>) <volume>562</volume>:<fpage>119846</fpage>. <pub-id pub-id-type="doi">10.1016/j.cca.2024.119846</pub-id> <pub-id pub-id-type="pmid">38969085</pub-id></citation></ref>
<ref id="B39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Demicheva</surname> <given-names>E</given-names></name> <name><surname>Dordiuk</surname> <given-names>V</given-names></name> <name><surname>Polanco Espino</surname> <given-names>F</given-names></name> <name><surname>Ushenin</surname> <given-names>K</given-names></name> <name><surname>Aboushanab</surname> <given-names>S</given-names></name> <name><surname>Shevyrin</surname> <given-names>V</given-names></name><etal/></person-group> <article-title>Advances in mass spectrometry-based blood metabolomics profiling for non-cancer diseases: A comprehensive review.</article-title> <source><italic>Metabolites.</italic></source> (<year>2024</year>) <volume>14</volume>:<fpage>54</fpage>. <pub-id pub-id-type="doi">10.3390/metabo14010054</pub-id> <pub-id pub-id-type="pmid">38248857</pub-id></citation></ref>
<ref id="B40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>R</given-names></name> <name><surname>Ren</surname> <given-names>S</given-names></name> <name><surname>Li</surname> <given-names>C</given-names></name> <name><surname>Guo</surname> <given-names>K</given-names></name> <name><surname>Lu</surname> <given-names>Z</given-names></name> <name><surname>Tian</surname> <given-names>L</given-names></name><etal/></person-group> <article-title>Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study.</article-title> <source><italic>Cancer Med.</italic></source> (<year>2023</year>) <volume>12</volume>:<fpage>5158</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1002/cam4.5296</pub-id> <pub-id pub-id-type="pmid">36161527</pub-id></citation></ref>
<ref id="B41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wauthier</surname> <given-names>L</given-names></name> <name><surname>Plebani</surname> <given-names>M</given-names></name> <name><surname>Favresse</surname> <given-names>J</given-names></name></person-group>. <article-title>Interferences in immunoassays: Review and practical algorithm.</article-title> <source><italic>Clin Chem Lab Med.</italic></source> (<year>2022</year>) <volume>60</volume>:<fpage>808</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1515/cclm-2021-1288</pub-id> <pub-id pub-id-type="pmid">35304841</pub-id></citation></ref>
<ref id="B42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>A</given-names></name> <name><surname>Honour</surname> <given-names>J</given-names></name></person-group>. <article-title>Unusual results from immunoassays and the role of the clinical endocrinologist.</article-title> <source><italic>Clin Endocrinol (Oxf).</italic></source> (<year>2006</year>) <volume>64</volume>:<fpage>234</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2265.2006.02439.x</pub-id> <pub-id pub-id-type="pmid">16487430</pub-id></citation></ref>
<ref id="B43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowen</surname> <given-names>R</given-names></name> <name><surname>Bertholf</surname> <given-names>R</given-names></name> <name><surname>Holmquist</surname> <given-names>B</given-names></name></person-group>. <article-title>Maximizing the value of laboratory tests.</article-title> <source><italic>Handb Diagnostic Endocrinol.</italic></source> (<year>2021</year>):<fpage>1</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-818277-2.00001-7</pub-id></citation></ref>
<ref id="B44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruffing</surname> <given-names>U</given-names></name> <name><surname>Mickeler</surname> <given-names>S</given-names></name> <name><surname>Kraft</surname> <given-names>M</given-names></name> <name><surname>Findeisen</surname> <given-names>P</given-names></name></person-group>. <article-title>Analytical performance evaluation of a new integrated clinical chemistry and immunoassay analyzer.</article-title> <source><italic>Pract Lab Med.</italic></source> (<year>2024</year>) <volume>41</volume>:<fpage>e00427</fpage>. <pub-id pub-id-type="doi">10.1016/j.plabm.2024.e00427</pub-id> <pub-id pub-id-type="pmid">39310744</pub-id></citation></ref>
<ref id="B45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chowdhury</surname> <given-names>P</given-names></name> <name><surname>Medhi</surname> <given-names>H</given-names></name> <name><surname>Bhattacharyya</surname> <given-names>K</given-names></name> <name><surname>Hussain</surname> <given-names>C</given-names></name></person-group>. <article-title>Guidelines to establish the quality assurance, analytical parameters, and inter-laboratory studies.</article-title> <edition>2nd ed</edition>. In: <person-group person-group-type="author"><name><surname>Barcelo</surname> <given-names>D</given-names></name> <name><surname>Pico</surname> <given-names>Y</given-names></name></person-group> <role>editors</role>. <source><italic>Sample Handling and Trace Analysis of Pollutants.</italic></source> <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name> (<year>2025</year>). p. <fpage>435</fpage>&#x2013;<lpage>55</lpage>.</citation></ref>
<ref id="B46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chaudhry</surname> <given-names>A</given-names></name> <name><surname>Inata</surname> <given-names>Y</given-names></name> <name><surname>Nakagami-Yamaguchi</surname> <given-names>E</given-names></name></person-group>. <article-title>Quality analysis of the clinical laboratory literature and its effectiveness on clinical quality improvement: A systematic review.</article-title> <source><italic>J Clin Biochem Nutr.</italic></source> (<year>2023</year>) <volume>73</volume>:<fpage>108</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.3164/jcbn.23-22</pub-id> <pub-id pub-id-type="pmid">37700849</pub-id></citation></ref>
<ref id="B47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rotgers</surname> <given-names>E</given-names></name> <name><surname>Linko</surname> <given-names>S</given-names></name> <name><surname>Theodorsson</surname> <given-names>E</given-names></name> <name><surname>Kouri</surname> <given-names>T</given-names></name></person-group>. <article-title>Clinical decision limits as criteria for setting analytical performance specifications for laboratory tests.</article-title> <source><italic>Clin Chim Acta.</italic></source> (<year>2023</year>) <volume>540</volume>:<fpage>117233</fpage>. <pub-id pub-id-type="doi">10.1016/j.cca.2023.117233</pub-id> <pub-id pub-id-type="pmid">36693582</pub-id></citation></ref>
<ref id="B48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>W</given-names></name> <name><surname>Myers</surname> <given-names>G</given-names></name> <name><surname>Cobbaert</surname> <given-names>C</given-names></name> <name><surname>Young</surname> <given-names>I</given-names></name> <name><surname>Theodorsson</surname> <given-names>E</given-names></name> <name><surname>Wielgosz</surname> <given-names>R</given-names></name><etal/></person-group> <article-title>Overcoming challenges regarding reference materials and regulations that influence global standardization of medical laboratory testing results.</article-title> <source><italic>Clin Chem Lab Med.</italic></source> (<year>2023</year>) <volume>61</volume>:<fpage>48</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1515/cclm-2022-0943</pub-id> <pub-id pub-id-type="pmid">36239374</pub-id></citation></ref>
<ref id="B49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>W</given-names></name> <name><surname>Zhang</surname> <given-names>Z</given-names></name> <name><surname>Zhang</surname> <given-names>C</given-names></name> <name><surname>Zhao</surname> <given-names>H</given-names></name> <name><surname>Yuan</surname> <given-names>S</given-names></name> <name><surname>Liu</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Evaluation of coefficients of variation for clinical chemistry tests based on internal quality control data across 5,425 laboratories in China from 2013 to 2022.</article-title> <source><italic>Ann Lab Med.</italic></source> (<year>2024</year>) <volume>44</volume>:<fpage>245</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.3343/alm.2023.0236</pub-id> <pub-id pub-id-type="pmid">38014482</pub-id></citation></ref>
<ref id="B50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname> <given-names>A</given-names></name> <name><surname>Gross</surname> <given-names>A</given-names></name> <name><surname>Budd</surname> <given-names>J</given-names></name> <name><surname>Miller</surname> <given-names>W</given-names></name></person-group>. <article-title>Influence of reagent lots and multiple measuring systems on estimating the coefficient of variation from quality control data; implications for uncertainty estimation and interpretation of QC results.</article-title> <source><italic>Clin Chem Lab Med.</italic></source> (<year>2020</year>) <volume>58</volume>:<fpage>1829</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1515/cclm-2020-0320</pub-id> <pub-id pub-id-type="pmid">32883061</pub-id></citation></ref>
<ref id="B51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname> <given-names>S</given-names></name> <name><surname>French</surname> <given-names>D</given-names></name> <name><surname>Jannetto</surname> <given-names>P</given-names></name> <name><surname>Rappold</surname> <given-names>B</given-names></name> <name><surname>Clarke</surname> <given-names>W</given-names></name></person-group>. <article-title>Liquid chromatography-tandem mass spectrometry for clinical diagnostics.</article-title> <source><italic>Nat Rev Methods Primers.</italic></source> (<year>2022</year>) <volume>2</volume>:<fpage>96</fpage>. <pub-id pub-id-type="doi">10.1038/s43586-022-00175-x</pub-id> <pub-id pub-id-type="pmid">36532107</pub-id></citation></ref>
<ref id="B52"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Misra</surname> <given-names>S</given-names></name> <name><surname>Aguilar-Salinas</surname> <given-names>C</given-names></name> <name><surname>Chikowore</surname> <given-names>T</given-names></name> <name><surname>Konradsen</surname> <given-names>F</given-names></name> <name><surname>Ma</surname> <given-names>R</given-names></name> <name><surname>Mbau</surname> <given-names>L</given-names></name><etal/></person-group> <article-title>The case for precision medicine in the prevention, diagnosis, and treatment of cardiometabolic diseases in low-income and middle-income countries.</article-title> <source><italic>Lancet Diabetes Endocrinol.</italic></source> (<year>2023</year>) <volume>11</volume>:<fpage>836</fpage>&#x2013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/S2213-8587(23)00164-X</pub-id> <pub-id pub-id-type="pmid">37804857</pub-id></citation></ref>
<ref id="B53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jinks</surname> <given-names>T</given-names></name> <name><surname>Subramaniam</surname> <given-names>S</given-names></name> <name><surname>Bassetti</surname> <given-names>M</given-names></name> <name><surname>Gales</surname> <given-names>A</given-names></name> <name><surname>Kullar</surname> <given-names>R</given-names></name> <name><surname>Metersky</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Opportunities to enhance diagnostic testing and antimicrobial stewardship: A qualitative multinational survey of healthcare professionals.</article-title> <source><italic>Infect Dis Ther.</italic></source> (<year>2024</year>) <volume>13</volume>:<fpage>1621</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1007/s40121-024-00996-1</pub-id> <pub-id pub-id-type="pmid">38829440</pub-id></citation></ref>
<ref id="B54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chakraborty</surname> <given-names>S</given-names></name></person-group>. <article-title>Democratizing nucleic acid-based molecular diagnostic tests for infectious diseases at resource-limited settings &#x2013; From point of care to extreme point of care.</article-title> <source><italic>Sensors Diagnostics.</italic></source> (<year>2024</year>) <volume>3</volume>:<fpage>536</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1039/D3SD00304C</pub-id></citation></ref>
<ref id="B55"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thakur</surname> <given-names>V</given-names></name> <name><surname>Akerele</surname> <given-names>O</given-names></name> <name><surname>Randell</surname> <given-names>E</given-names></name></person-group>. <article-title>Lean and six sigma as continuous quality improvement frameworks in the clinical diagnostic laboratory.</article-title> <source><italic>Crit Rev Clin Lab Sci.</italic></source> (<year>2023</year>) <volume>60</volume>:<fpage>63</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1080/10408363.2022.2106544</pub-id> <pub-id pub-id-type="pmid">35978530</pub-id></citation></ref>
<ref id="B56"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname> <given-names>C</given-names></name> <name><surname>Chang</surname> <given-names>D</given-names></name></person-group>. <article-title>Artificial intelligence in point-of-care biosensing: Challenges and opportunities.</article-title> <source><italic>Diagnostics (Basel).</italic></source> (<year>2024</year>) <volume>14</volume>:<fpage>1100</fpage>. <pub-id pub-id-type="doi">10.3390/diagnostics14111100</pub-id> <pub-id pub-id-type="pmid">38893627</pub-id></citation></ref>
<ref id="B57"><label>57.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Das</surname> <given-names>S</given-names></name> <name><surname>Mazumdar</surname> <given-names>H</given-names></name></person-group>. <article-title>Integration of Artificial intelligence and computational thinking in lab-on-a-chip technology for quality improvement in healthcare.</article-title> In: <person-group person-group-type="author"><name><surname>Parihar</surname> <given-names>A</given-names></name> <name><surname>Mehta</surname> <given-names>P</given-names></name></person-group> <role>editors</role>. <source><italic>Lab-on-a-chip Devices for Advanced Biomedicines.</italic></source> <publisher-loc>London</publisher-loc>: <publisher-name>Royal Society of Chemistry</publisher-name> (<year>2024</year>). p. <fpage>272</fpage>&#x2013;<lpage>309</lpage>.</citation></ref>
<ref id="B58"><label>58.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doganay</surname> <given-names>M</given-names></name> <name><surname>Chakraborty</surname> <given-names>P</given-names></name> <name><surname>Bommakanti</surname> <given-names>S</given-names></name> <name><surname>Jammalamadaka</surname> <given-names>S</given-names></name> <name><surname>Battalapalli</surname> <given-names>D</given-names></name> <name><surname>Madabhushi</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Artificial intelligence performance in testing microfluidics for point-of-care.</article-title> <source><italic>Lab Chip.</italic></source> (<year>2024</year>) <volume>24</volume>:<fpage>4998</fpage>&#x2013;<lpage>5008</lpage>. <pub-id pub-id-type="doi">10.1039/d4lc00671b</pub-id> <pub-id pub-id-type="pmid">39360887</pub-id></citation></ref>
<ref id="B59"><label>59.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname> <given-names>Z</given-names></name> <name><surname>Bhalla</surname> <given-names>N</given-names></name></person-group>. <article-title>Point-of-care diagnostics for sepsis using clinical biomarkers and microfluidic technology.</article-title> <source><italic>Biosens Bioelectron.</italic></source> (<year>2023</year>) <volume>227</volume>:<fpage>115181</fpage>. <pub-id pub-id-type="doi">10.1016/j.bios.2023.115181</pub-id> <pub-id pub-id-type="pmid">36867959</pub-id></citation></ref>
<ref id="B60"><label>60.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nowak</surname> <given-names>R</given-names></name> <name><surname>O&#x2019;Neill</surname> <given-names>J</given-names></name> <name><surname>Ashburn</surname> <given-names>N</given-names></name> <name><surname>Snavely</surname> <given-names>A</given-names></name> <name><surname>Paradee</surname> <given-names>B</given-names></name> <name><surname>Allen</surname> <given-names>B</given-names></name><etal/></person-group> <article-title>Patients with known coronary artery disease who are ruled out for acute myocardial infarction using a high sensitivity troponin T 0/1-hour algorithm have increased 30-day major adverse cardiac events.</article-title> <source><italic>Eur Heart J.</italic></source> (<year>2022</year>):<volume>43</volume>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehac544.1337</pub-id></citation></ref>
<ref id="B61"><label>61.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname> <given-names>M</given-names></name></person-group>. <article-title>Biomarkers for early disease detection: Advancements in predictive medicine and diagnostic testing.</article-title> <source><italic>Universal Res Rep.</italic></source> (<year>2024</year>) <volume>11</volume>:<fpage>8</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.36676/urr.v11.i3.1281</pub-id></citation></ref>
<ref id="B62"><label>62.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rajendran</surname> <given-names>K</given-names></name> <name><surname>Krishnan</surname> <given-names>U</given-names></name></person-group>. <article-title>Biomarkers in Alzheimer&#x2019;s disease.</article-title> <source><italic>Clin Chim Acta.</italic></source> (<year>2024</year>) <volume>562</volume>:<fpage>119857</fpage>. <pub-id pub-id-type="doi">10.1016/j.cca.2024.119857</pub-id> <pub-id pub-id-type="pmid">38986861</pub-id></citation></ref>
<ref id="B63"><label>63.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>R</given-names></name> <name><surname>Bansal</surname> <given-names>R</given-names></name> <name><surname>Shergill</surname> <given-names>H</given-names></name> <name><surname>Garg</surname> <given-names>P</given-names></name></person-group>. <article-title>Prevalence of thyroid dysfunction in pregnancy and its association with feto-maternal outcomes: A prospective observational study from a tertiary care institute in Northern India.</article-title> <source><italic>Clinical Epidemiol Global Health.</italic></source> (<year>2023</year>) <volume>19</volume>:<fpage>101201</fpage>. <pub-id pub-id-type="doi">10.1016/j.cegh.2022.101201</pub-id></citation></ref>
<ref id="B64"><label>64.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paschou</surname> <given-names>S</given-names></name> <name><surname>Bletsa</surname> <given-names>E</given-names></name> <name><surname>Papazisi</surname> <given-names>M</given-names></name> <name><surname>Mili</surname> <given-names>N</given-names></name> <name><surname>Kanouta</surname> <given-names>F</given-names></name> <name><surname>Kassi</surname> <given-names>G</given-names></name><etal/></person-group> <article-title>Screening and management of major endocrinopathies during pregnancy: An update.</article-title> <source><italic>Endocrine.</italic></source> (<year>2023</year>) <volume>80</volume>:<fpage>10</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s12020-022-03237-y</pub-id> <pub-id pub-id-type="pmid">36327019</pub-id></citation></ref>
<ref id="B65"><label>65.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yanachkova</surname> <given-names>V</given-names></name> <name><surname>Staynova</surname> <given-names>R</given-names></name> <name><surname>Naseva</surname> <given-names>E</given-names></name></person-group>. <article-title>Defining trimester-specific reference intervals for thyroid hormones: Insights from a Bulgarian monocenter study.</article-title> <source><italic>Medicina (Kaunas).</italic></source> (<year>2024</year>) <volume>60</volume>:<fpage>801</fpage>. <pub-id pub-id-type="doi">10.3390/medicina60050801</pub-id> <pub-id pub-id-type="pmid">38792984</pub-id></citation></ref>
<ref id="B66"><label>66.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Osinga</surname> <given-names>J</given-names></name> <name><surname>Derakhshan</surname> <given-names>A</given-names></name> <name><surname>Korevaar</surname> <given-names>T</given-names></name></person-group>. <article-title>SAT456 validation and optimization Of TSH And FT4 reference interval definitions during pregnancy.</article-title> <source><italic>J Endocrine Soc.</italic></source> (<year>2023</year>) <volume>7</volume>:<fpage>bvad114.1931</fpage>. <pub-id pub-id-type="doi">10.1210/jendso/bvad114.1931</pub-id></citation></ref>
<ref id="B67"><label>67.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname> <given-names>J</given-names></name> <name><surname>Shanoo</surname> <given-names>A</given-names></name> <name><surname>Patel</surname> <given-names>N</given-names></name> <name><surname>Gupta</surname> <given-names>A</given-names></name></person-group>. <article-title>From conception to delivery: A comprehensive review of thyroid disorders and their far-reaching impact on feto-maternal health.</article-title> <source><italic>Cureus.</italic></source> (<year>2024</year>) <volume>16</volume>:<fpage>e53362</fpage>. <pub-id pub-id-type="doi">10.7759/cureus.53362</pub-id> <pub-id pub-id-type="pmid">38435202</pub-id></citation></ref>
<ref id="B68"><label>68.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Uytfanghe</surname> <given-names>K</given-names></name> <name><surname>Ehrenkranz</surname> <given-names>J</given-names></name> <name><surname>Halsall</surname> <given-names>D</given-names></name> <name><surname>Hoff</surname> <given-names>K</given-names></name> <name><surname>Loh</surname> <given-names>T</given-names></name> <name><surname>Spencer</surname> <given-names>C</given-names></name><etal/></person-group> <article-title><italic>Thyroid</italic> stimulating hormone and thyroid hormones (Triiodothyronine and Thyroxine): An American thyroid association-commissioned review of current clinical and laboratory status.</article-title> <source><italic>Thyroid.</italic></source> (<year>2023</year>) <volume>33</volume>:<fpage>1013</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1089/thy.2023.0169</pub-id> <pub-id pub-id-type="pmid">37655789</pub-id></citation></ref>
<ref id="B69"><label>69.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panteghini</surname> <given-names>M</given-names></name></person-group>. <article-title>An improved implementation of metrological traceability concepts is needed to benefit from standardization of laboratory results.</article-title> <source><italic>Clin Chem Lab Med.</italic></source> (<year>2024</year>) <volume>63</volume>:<fpage>270</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1515/cclm-2024-0428</pub-id> <pub-id pub-id-type="pmid">38687497</pub-id></citation></ref>
<ref id="B70"><label>70.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rangareddy</surname> <given-names>H</given-names></name></person-group>. <article-title>Harmonization in laboratory medicine: The big picture.</article-title> <source><italic>J Clin Biomed Sci.</italic></source> (<year>2023</year>) <volume>13</volume>:<fpage>1</fpage>&#x2013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.58739/jcbs/v13i1.119.editorial</pub-id></citation></ref>
<ref id="B71"><label>71.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname> <given-names>S</given-names></name> <name><surname>Nguyen</surname> <given-names>D</given-names></name> <name><surname>Morris</surname> <given-names>V</given-names></name> <name><surname>Mroz</surname> <given-names>K</given-names></name> <name><surname>Kwange</surname> <given-names>S</given-names></name> <name><surname>Patel</surname> <given-names>J</given-names></name></person-group>. <article-title>Integrating pharmacogenomic results in the electronic health record to facilitate precision medicine at a large multisite health system.</article-title> <source><italic>Jaccp J Am Coll Clin Pharm.</italic></source> (<year>2024</year>) <volume>7</volume>:<fpage>845</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1002/jac5.1996</pub-id></citation></ref>
<ref id="B72"><label>72.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname> <given-names>A</given-names></name> <name><surname>Mallett</surname> <given-names>A</given-names></name> <name><surname>Stark</surname> <given-names>Z</given-names></name> <name><surname>Sullivan</surname> <given-names>C</given-names></name></person-group>. <article-title>It is in our DNA: Bringing electronic health records and genomic data together for precision medicine.</article-title> <source><italic>JMIR Bioinform Biotechnol</italic>.</source> (<year>2024</year>) <volume>5</volume>:<fpage>e55632</fpage>. <pub-id pub-id-type="doi">10.2196/55632</pub-id> <pub-id pub-id-type="pmid">38935958</pub-id></citation></ref>
<ref id="B73"><label>73.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tigistu-Sahle</surname> <given-names>F</given-names></name> <name><surname>Mekuria</surname> <given-names>Z</given-names></name> <name><surname>Satoskar</surname> <given-names>A</given-names></name> <name><surname>Sales</surname> <given-names>G</given-names></name> <name><surname>Gebreyes</surname> <given-names>W</given-names></name> <name><surname>Oliveira</surname> <given-names>C</given-names></name></person-group>. <article-title>Challenges and opportunities of molecular epidemiology: Using omics to address complex one health issues in tropical settings.</article-title> <source><italic>Front Trop Dis.</italic></source> (<year>2023</year>) <volume>4</volume>:<fpage>1151336</fpage>. <pub-id pub-id-type="doi">10.3389/fitd.2023.1151336</pub-id></citation></ref>
<ref id="B74"><label>74.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H</given-names></name> <name><surname>Ouyang</surname> <given-names>Z</given-names></name> <name><surname>Zhang</surname> <given-names>W</given-names></name></person-group>. <article-title>Advances in mass spectrometry for clinical analysis: Data acquisition, interpretation and information integration.</article-title> <source><italic>TrAC Trends Anal Chem.</italic></source> (<year>2023</year>) <volume>169</volume>:<fpage>117380</fpage>. <pub-id pub-id-type="doi">10.1016/j.trac.2023.117380</pub-id></citation></ref>
<ref id="B75"><label>75.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ochoa-Leite</surname> <given-names>C</given-names></name> <name><surname>Rodrigues</surname> <given-names>S</given-names></name> <name><surname>Ramos</surname> <given-names>A</given-names></name> <name><surname>Ribeiro</surname> <given-names>F</given-names></name> <name><surname>Barbosa</surname> <given-names>J</given-names></name> <name><surname>Jer&#x00F3;nimo</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>Metabolomics and proteomics in occupational medicine: A comprehensive systematic review.</article-title> <source><italic>J Occup Med Toxicol.</italic></source> (<year>2024</year>) <volume>19</volume>:<fpage>38</fpage>. <pub-id pub-id-type="doi">10.1186/s12995-024-00436-3</pub-id> <pub-id pub-id-type="pmid">39407251</pub-id></citation></ref>
<ref id="B76"><label>76.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vogeser</surname> <given-names>M</given-names></name> <name><surname>Bendt</surname> <given-names>A</given-names></name></person-group>. <article-title>From research cohorts to the patient - A role for &#x0026;quot;omics&#x0026;quot; In diagnostics and laboratory medicine?</article-title> <source><italic>Clin Chem Lab Med.</italic></source> (<year>2023</year>) <volume>61</volume>:<fpage>974</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1515/cclm-2022-1147</pub-id> <pub-id pub-id-type="pmid">36592431</pub-id></citation></ref>
<ref id="B77"><label>77.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kadirkulov</surname> <given-names>K</given-names></name> <name><surname>Ismailova</surname> <given-names>A</given-names></name> <name><surname>Beissegul</surname> <given-names>A</given-names></name> <name><surname>Serikbayeva</surname> <given-names>S</given-names></name> <name><surname>Kazimova</surname> <given-names>D</given-names></name> <name><surname>Tazhigulova</surname> <given-names>G</given-names></name></person-group>. <article-title>Interpretation of laboratory results through comprehensive automation of medical laboratory using OpenAI.</article-title> <source><italic>Eastern Eur J Enterprise Technol.</italic></source> (<year>2023</year>) <volume>4</volume>:<fpage>26</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.15587/1729-4061.2023.286338</pub-id></citation></ref>
<ref id="B78"><label>78.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lassen</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>T</given-names></name> <name><surname>Nielsen</surname> <given-names>K</given-names></name> <name><surname>Hasselstr&#x00F8;m</surname> <given-names>J</given-names></name> <name><surname>Johannsen</surname> <given-names>M</given-names></name> <name><surname>Villesen</surname> <given-names>P</given-names></name></person-group>. <article-title>Large-Scale metabolomics: Predicting biological age using 10,133 routine untargeted LC-MS measurements.</article-title> <source><italic>Aging Cell.</italic></source> (<year>2023</year>) <volume>22</volume>:<fpage>e13813</fpage>. <pub-id pub-id-type="doi">10.1111/acel.13813</pub-id> <pub-id pub-id-type="pmid">36935524</pub-id></citation></ref>
<ref id="B79"><label>79.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname> <given-names>M</given-names></name> <name><surname>Nassar</surname> <given-names>H</given-names></name> <name><surname>Espinosa</surname> <given-names>C</given-names></name> <name><surname>Stelzer</surname> <given-names>I</given-names></name> <name><surname>Feyaerts</surname> <given-names>D</given-names></name> <name><surname>Berson</surname> <given-names>E</given-names></name><etal/></person-group> <article-title>Large-scale correlation network construction for unraveling the coordination of complex biological systems.</article-title> <source><italic>Nat Comput Sci.</italic></source> (<year>2023</year>) <volume>3</volume>:<fpage>346</fpage>&#x2013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1038/s43588-023-00429-y</pub-id> <pub-id pub-id-type="pmid">38116462</pub-id></citation></ref>
<ref id="B80"><label>80.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kosnik</surname> <given-names>M</given-names></name> <name><surname>Planchart</surname> <given-names>A</given-names></name> <name><surname>Marvel</surname> <given-names>S</given-names></name> <name><surname>Reif</surname> <given-names>D</given-names></name> <name><surname>Mattingly</surname> <given-names>C</given-names></name></person-group>. <article-title>Integration of curated and high-throughput screening data to elucidate environmental influences on disease pathways.</article-title> <source><italic>Comput Toxicol.</italic></source> (<year>2019</year>) <volume>12</volume>:<fpage>100094</fpage>. <pub-id pub-id-type="doi">10.1016/j.comtox.2019.100094</pub-id> <pub-id pub-id-type="pmid">31453412</pub-id></citation></ref>
<ref id="B81"><label>81.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname> <given-names>Y</given-names></name> <name><surname>Kim</surname> <given-names>J</given-names></name> <name><surname>Jung</surname> <given-names>S</given-names></name> <name><surname>Woerner</surname> <given-names>J</given-names></name> <name><surname>Suh</surname> <given-names>E</given-names></name> <name><surname>Lee</surname> <given-names>D</given-names></name><etal/></person-group> <article-title>Harnessing artificial intelligence in multimodal omics data integration: paving the path for the next frontier in precision medicine.</article-title> <source><italic>Annu Rev Biomed Data Sci.</italic></source> (<year>2024</year>) <volume>7</volume>:<fpage>225</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biodatasci-102523-103801</pub-id> <pub-id pub-id-type="pmid">38768397</pub-id></citation></ref>
<ref id="B82"><label>82.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amaka</surname> <given-names>O</given-names></name> <name><surname>Jeremiah Olawumi</surname> <given-names>A</given-names></name> <name><surname>Chinyere</surname> <given-names>O</given-names></name> <name><surname>Ifeoma Pamela</surname> <given-names>O</given-names></name> <name><surname>Evangel Chinyere</surname> <given-names>A</given-names></name> <name><surname>Andrew Ifesinachi</surname> <given-names>D</given-names></name></person-group>. <article-title>Big data analytics in healthcare: A review of recent advances and potential for personalized medicine.</article-title> <source><italic>Int Med Sci Res J.</italic></source> (<year>2024</year>) <volume>4</volume>:<fpage>170</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.51594/imsrj.v4i2.810</pub-id></citation></ref>
<ref id="B83"><label>83.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hulsen</surname> <given-names>T</given-names></name> <name><surname>Friedeck&#x00FD;</surname> <given-names>D</given-names></name> <name><surname>Renz</surname> <given-names>H</given-names></name> <name><surname>Melis</surname> <given-names>E</given-names></name> <name><surname>Vermeersch</surname> <given-names>P</given-names></name> <name><surname>Fernandez-Calle</surname> <given-names>P</given-names></name></person-group>. <article-title>From big data to better patient outcomes.</article-title> <source><italic>Clin Chem Lab Med.</italic></source> (<year>2023</year>) <volume>61</volume>:<fpage>580</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1515/cclm-2022-1096</pub-id> <pub-id pub-id-type="pmid">36539928</pub-id></citation></ref>
<ref id="B84"><label>84.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>L</given-names></name> <name><surname>Reddy</surname> <given-names>K</given-names></name> <name><surname>Van Iseghem</surname> <given-names>T</given-names></name> <name><surname>Pierce</surname> <given-names>W</given-names></name></person-group>. <article-title>Enhancing data practices for Whole health: Strategies for a transformative future.</article-title> <source><italic>Learn Health Syst.</italic></source> (<year>2024</year>) <volume>8</volume>:<fpage>e10426</fpage>. <pub-id pub-id-type="doi">10.1002/lrh2.10426</pub-id> <pub-id pub-id-type="pmid">38883871</pub-id></citation></ref>
<ref id="B85"><label>85.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jitendra Saraswat</surname> <given-names>P</given-names></name></person-group>. <article-title>Revolutionizing diagnostics: Innovations in medical lab technology.</article-title> <source><italic>J Propulsion Technol.</italic></source> (<year>2023</year>) <volume>44</volume>:<fpage>55</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.52783/tjjpt.v44.i1.1317</pub-id></citation></ref>
<ref id="B86"><label>86.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sailaja</surname> <given-names>A</given-names></name> <name><surname>Manisha</surname> <given-names>B</given-names></name></person-group>. <article-title>Micro electro-mechanical systems (MEMS) and its subset devices in the field of biotechnology and medical sciences. fostering cross-industry sustainability with intelligent technologies.</article-title> <source><italic>Practice Progr Proficiency Sustainabil.</italic></source> (<year>2024</year>):<fpage>221</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.4018/979-8-3693-1638-2.ch014</pub-id></citation></ref>
<ref id="B87"><label>87.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Federici</surname> <given-names>G</given-names></name> <name><surname>Ciaccio</surname> <given-names>M</given-names></name></person-group>. <article-title>Mass spectrometry in clinical biochemistry and laboratory medicine.</article-title> In: <person-group person-group-type="editor"><name><surname>Ciaccio</surname> <given-names>M</given-names></name></person-group> <role>editor.</role> <source><italic>Clinical and Laboratory Medicine Textbook.</italic></source> <publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer</publisher-name> (<year>2023</year>). p. <fpage>631</fpage>&#x2013;<lpage>40</lpage>.</citation></ref>
<ref id="B88"><label>88.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vadakedath</surname> <given-names>S</given-names></name> <name><surname>Kandi</surname> <given-names>V</given-names></name> <name><surname>Godishala</surname> <given-names>V</given-names></name> <name><surname>Sami Alkafaas</surname> <given-names>S</given-names></name> <name><surname>Sami Eikafas</surname> <given-names>S</given-names></name></person-group>. <article-title>The principle, types, and applications of mass spectrometry: A comprehensive review.</article-title> <source><italic>Biomed Biotechnol.</italic></source> (<year>2022</year>) <volume>7</volume>:<fpage>6</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.12691/bb-7-1-2</pub-id></citation></ref>
<ref id="B89"><label>89.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clore</surname> <given-names>G</given-names></name></person-group>. <article-title>NMR spectroscopy, excited states and relevance to problems in cell biology - Transient pre-nucleation tetramerization of huntingtin and insights into Huntington&#x2019;s disease.</article-title> <source><italic>J Cell Sci.</italic></source> (<year>2022</year>) <volume>135</volume>:<fpage>jcs258695</fpage>. <pub-id pub-id-type="doi">10.1242/jcs.258695</pub-id> <pub-id pub-id-type="pmid">35703323</pub-id></citation></ref>
<ref id="B90"><label>90.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>D</given-names></name> <name><surname>Thi</surname> <given-names>Y</given-names></name> <name><surname>Chu</surname> <given-names>D</given-names></name></person-group>. <article-title>Next generation sequencing in healthcare.</article-title> In: <person-group person-group-type="author"><name><surname>Singh</surname> <given-names>V</given-names></name> <name><surname>Kumar</surname> <given-names>A</given-names></name></person-group> <role>editors</role>. <source><italic>Advances in Bioinformatic.</italic></source> <publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer</publisher-name> (<year>2024</year>). p. <fpage>137</fpage>&#x2013;<lpage>47</lpage>.</citation></ref>
<ref id="B91"><label>91.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duanginta</surname> <given-names>W</given-names></name> <name><surname>Apiratmateekul</surname> <given-names>N</given-names></name> <name><surname>Kost</surname> <given-names>G</given-names></name> <name><surname>Tran</surname> <given-names>N</given-names></name> <name><surname>Kongros</surname> <given-names>K</given-names></name> <name><surname>Shearman</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Challenges of in vitro glycation when producing blood materials for hemoglobin A1C immunoassays.</article-title> <source><italic>Clin Lab.</italic></source> (<year>2023</year>) <volume>69</volume>:<fpage>220619</fpage>. <pub-id pub-id-type="doi">10.7754/Clin.Lab.2022.220619</pub-id> <pub-id pub-id-type="pmid">37057946</pub-id></citation></ref>
<ref id="B92"><label>92.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boonprasert</surname> <given-names>K</given-names></name> <name><surname>Tharavanij</surname> <given-names>T</given-names></name> <name><surname>Pechyen</surname> <given-names>C</given-names></name> <name><surname>Ponsanti</surname> <given-names>K</given-names></name> <name><surname>Tangnorawich</surname> <given-names>B</given-names></name> <name><surname>Viyanant</surname> <given-names>V</given-names></name><etal/></person-group> <article-title>Validation of an electrochemical sensor based on gold nanoparticles as a point-of-care test for quantitative determination of glycated hemoglobin.</article-title> <source><italic>PLoS One.</italic></source> (<year>2023</year>) <volume>18</volume>:<fpage>e0276949</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0276949</pub-id> <pub-id pub-id-type="pmid">37384652</pub-id></citation></ref>
<ref id="B93"><label>93.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Camarena-Hidalgo</surname> <given-names>M</given-names></name> <name><surname>Meaney</surname> <given-names>E</given-names></name> <name><surname>Ortiz-Vilchis</surname> <given-names>P</given-names></name></person-group>. <article-title>Fundamentos de la hemoglobina glicada. Valor y ventajas en la pr&#x00E1;ctica cl&#x00ED;nica.</article-title> <source><italic>Cardiovasc Metab Sci.</italic></source> (<year>2023</year>) <volume>34</volume>:<fpage>119</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.35366/112761</pub-id></citation></ref>
<ref id="B94"><label>94.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname> <given-names>S</given-names></name> <name><surname>Yadav</surname> <given-names>P</given-names></name> <name><surname>Ray</surname> <given-names>S</given-names></name> <name><surname>Jadhav</surname> <given-names>A</given-names></name> <name><surname>Wakode</surname> <given-names>S</given-names></name></person-group>. <article-title>Clinical risk assessment and comparison of bias between laboratory methods for estimation of HbA1c for glycated hemoglobin in hyperglycemic patients.</article-title> <source><italic>Curr Diabetes Rev.</italic></source> (<year>2024</year>) <volume>20</volume>:<fpage>e261023222764</fpage>. <pub-id pub-id-type="doi">10.2174/0115733998257140231011102518</pub-id> <pub-id pub-id-type="pmid">37921160</pub-id></citation></ref>
<ref id="B95"><label>95.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>Y</given-names></name> <name><surname>Xu</surname> <given-names>A</given-names></name> <name><surname>Wang</surname> <given-names>M</given-names></name> <name><surname>Shi</surname> <given-names>J</given-names></name> <name><surname>Fu</surname> <given-names>W</given-names></name> <name><surname>Ji</surname> <given-names>L</given-names></name><etal/></person-group> <article-title>Evaluation of effects from hemoglobin variants on HbA1c measurements by different methods.</article-title> <source><italic>Clin Chem Lab Med.</italic></source> (<year>2024</year>) <volume>62</volume>:<fpage>2082</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1515/cclm-2024-0186</pub-id> <pub-id pub-id-type="pmid">38563053</pub-id></citation></ref>
<ref id="B96"><label>96.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>M</given-names></name> <name><surname>Ge</surname> <given-names>S</given-names></name> <name><surname>Shu</surname> <given-names>X</given-names></name> <name><surname>Wu</surname> <given-names>X</given-names></name> <name><surname>Liu</surname> <given-names>H</given-names></name> <name><surname>Xu</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Interference of hemoglobin variants with HbA1c measurements by six commonly used HbA1c methods.</article-title> <source><italic>Lab Med.</italic></source> (<year>2024</year>) <volume>55</volume>:<fpage>708</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1093/labmed/lmae034</pub-id> <pub-id pub-id-type="pmid">38801245</pub-id></citation></ref>
<ref id="B97"><label>97.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhusal</surname> <given-names>A</given-names></name> <name><surname>Bhandari</surname> <given-names>S</given-names></name> <name><surname>Sah</surname> <given-names>R</given-names></name></person-group>. <article-title>Can HPLC be used as an ideal methodology instead of Hb Electrophoresis for the diagnosis of hemoglobinopathies in a routine clinical laboratory of under-resource country like Nepal? Is the change necessary?</article-title> <source><italic>Ann Med Surg (Lond).</italic></source> (<year>2022</year>) <volume>82</volume>:<fpage>104367</fpage>. <pub-id pub-id-type="doi">10.1016/j.amsu.2022.104367</pub-id> <pub-id pub-id-type="pmid">36268313</pub-id></citation></ref>
<ref id="B98"><label>98.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname> <given-names>F</given-names></name> <name><surname>Zhao</surname> <given-names>L</given-names></name> <name><surname>Zhang</surname> <given-names>D</given-names></name> <name><surname>Yu</surname> <given-names>M</given-names></name> <name><surname>Zhou</surname> <given-names>W</given-names></name> <name><surname>Jin</surname> <given-names>J</given-names></name></person-group>. <article-title>Serum metabolomics detected by LDI-TOF-MS can be used to distinguish between diabetic patients with and without diabetic kidney disease.</article-title> <source><italic>FEBS Open Bio.</italic></source> (<year>2023</year>) <volume>13</volume>:<fpage>1844</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1002/2211-5463.13683</pub-id> <pub-id pub-id-type="pmid">37525631</pub-id></citation></ref>
<ref id="B99"><label>99.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mandali</surname> <given-names>P</given-names></name> <name><surname>Prabakaran</surname> <given-names>A</given-names></name> <name><surname>Annadurai</surname> <given-names>K</given-names></name> <name><surname>Krishnan</surname> <given-names>U</given-names></name></person-group>. <article-title>Trends in quantification of HbA1c using electrochemical and point-of-care analyzers.</article-title> <source><italic>Sensors (Basel).</italic></source> (<year>2023</year>) <volume>23</volume>:<fpage>1901</fpage>. <pub-id pub-id-type="doi">10.3390/s23041901</pub-id> <pub-id pub-id-type="pmid">36850502</pub-id></citation></ref>
<ref id="B100"><label>100.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giachino</surname> <given-names>M</given-names></name> <name><surname>Vetter</surname> <given-names>B</given-names></name> <name><surname>Perone</surname> <given-names>S</given-names></name> <name><surname>Correia</surname> <given-names>J</given-names></name> <name><surname>Erkosar</surname> <given-names>B</given-names></name> <name><surname>Heller</surname> <given-names>O</given-names></name><etal/></person-group> <article-title>Performance and usability of cardiometabolic point of care devices in Nepal: A prospective, quantitative, accuracy study.</article-title> <source><italic>PLoS Glob Public Health.</italic></source> (<year>2024</year>) <volume>4</volume>:<fpage>e0003760</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgph.0003760</pub-id> <pub-id pub-id-type="pmid">39361597</pub-id></citation></ref>
<ref id="B101"><label>101.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pyatak</surname> <given-names>E</given-names></name> <name><surname>Ali</surname> <given-names>A</given-names></name> <name><surname>Khurana</surname> <given-names>A</given-names></name> <name><surname>Lee</surname> <given-names>P</given-names></name> <name><surname>Sideris</surname> <given-names>J</given-names></name> <name><surname>Fox</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>Research design and baseline participant characteristics of the resilient, empowered, active living with diabetes - Telehealth (REAL-T) Study: A randomized controlled trial for young adults with type 1 diabetes.</article-title> <source><italic>Contemp Clin Trials.</italic></source> (<year>2023</year>) <volume>135</volume>:<fpage>107386</fpage>. <pub-id pub-id-type="doi">10.1016/j.cct.2023.107386</pub-id> <pub-id pub-id-type="pmid">37931702</pub-id></citation></ref>
<ref id="B102"><label>102.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abildgaard</surname> <given-names>A</given-names></name> <name><surname>Knudsen</surname> <given-names>C</given-names></name> <name><surname>Bjerg</surname> <given-names>L</given-names></name> <name><surname>Lund</surname> <given-names>S</given-names></name> <name><surname>St&#x00F8;y</surname> <given-names>J</given-names></name></person-group>. <article-title>Reply to letter from Mayfield et al. regarding &#x201C;Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage&#x2122; HbA1c POCT instrument in a true clinical setting&#x201D;.</article-title> <source><italic>Clin Chem Lab Med.</italic></source> (<year>2023</year>) <volume>61</volume>:<fpage>e8</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1515/cclm-2022-0915</pub-id> <pub-id pub-id-type="pmid">36281702</pub-id></citation></ref>
<ref id="B103"><label>103.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname> <given-names>A</given-names></name> <name><surname>Hussain</surname> <given-names>W</given-names></name> <name><surname>Shum</surname> <given-names>H</given-names></name> <name><surname>Hassan</surname> <given-names>S</given-names></name></person-group>. <article-title>Point-of-care testing: A critical analysis of the market and future trends.</article-title> <source><italic>Front Lab Chip Technol.</italic></source> (<year>2024</year>) <volume>3</volume>:<fpage>1394752</fpage>. <pub-id pub-id-type="doi">10.3389/frlct.2024.1394752</pub-id></citation></ref>
<ref id="B104"><label>104.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ashkani</surname> <given-names>E</given-names></name> <name><surname>McKenna</surname> <given-names>B</given-names></name> <name><surname>Bryant</surname> <given-names>J</given-names></name> <name><surname>Trevisan-Silva</surname> <given-names>D</given-names></name> <name><surname>Sherman</surname> <given-names>N</given-names></name> <name><surname>Chianese-Bullock</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Stability of multi-peptide vaccines in conditions enabling accessibility in limited resource settings.</article-title> <source><italic>Int J Peptide Res Therapeutics.</italic></source> (<year>2024</year>) <volume>30</volume>:<fpage>42</fpage>. <pub-id pub-id-type="doi">10.1007/s10989-024-10620-y</pub-id></citation></ref>
<ref id="B105"><label>105.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Avari</surname> <given-names>P</given-names></name> <name><surname>Lumb</surname> <given-names>A</given-names></name> <name><surname>Flanagan</surname> <given-names>D</given-names></name> <name><surname>Rayman</surname> <given-names>G</given-names></name> <name><surname>Misra</surname> <given-names>S</given-names></name> <name><surname>Dhatariya</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Continuous glucose monitoring within hospital: A scoping review and summary of guidelines from the joint british diabetes societies for inpatient care.</article-title> <source><italic>J Diabetes Sci Technol.</italic></source> (<year>2023</year>) <volume>17</volume>:<fpage>611</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1177/19322968221137338</pub-id> <pub-id pub-id-type="pmid">36444418</pub-id></citation></ref>
<ref id="B106"><label>106.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bergenstal</surname> <given-names>R</given-names></name> <name><surname>&#x00C1;sbj&#x00F6;rnsd&#x00F3;ttir</surname> <given-names>B</given-names></name> <name><surname>Watt</surname> <given-names>S</given-names></name> <name><surname>Lingvay</surname> <given-names>I</given-names></name> <name><surname>Mader</surname> <given-names>J</given-names></name> <name><surname>Nishida</surname> <given-names>T</given-names></name><etal/></person-group> <article-title>Continuous glucose monitoring-based metrics and the duration of hypoglycaemia events with once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-naive type 2 diabetes: An exploratory analysis of ONWARDS 1.</article-title> <source><italic>Lancet Diabetes Endocrinol.</italic></source> (<year>2024</year>) <volume>12</volume>:<fpage>799</fpage>&#x2013;<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1016/S2213-8587(24)00220-1</pub-id> <pub-id pub-id-type="pmid">39374601</pub-id></citation></ref>
<ref id="B107"><label>107.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alva</surname> <given-names>S</given-names></name> <name><surname>Brazg</surname> <given-names>R</given-names></name> <name><surname>Castorino</surname> <given-names>K</given-names></name> <name><surname>Kipnes</surname> <given-names>M</given-names></name> <name><surname>Liljenquist</surname> <given-names>D</given-names></name> <name><surname>Liu</surname> <given-names>H</given-names></name></person-group>. <article-title>Accuracy of the third generation of a 14-Day continuous glucose monitoring system.</article-title> <source><italic>Diabetes Ther.</italic></source> (<year>2023</year>) <volume>14</volume>:<fpage>767</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1007/s13300-023-01385-6</pub-id> <pub-id pub-id-type="pmid">36877403</pub-id></citation></ref>
<ref id="B108"><label>108.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Misra</surname> <given-names>S</given-names></name> <name><surname>Avari</surname> <given-names>P</given-names></name> <name><surname>Lumb</surname> <given-names>A</given-names></name> <name><surname>Flanagan</surname> <given-names>D</given-names></name> <name><surname>Choudhary</surname> <given-names>P</given-names></name> <name><surname>Rayman</surname> <given-names>G</given-names></name><etal/></person-group> <article-title>How can point-of-care technologies support in-hospital diabetes care?</article-title> <source><italic>J Diabetes Sci Technol.</italic></source> (<year>2023</year>) <volume>17</volume>:<fpage>509</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1177/19322968221137360</pub-id> <pub-id pub-id-type="pmid">36880565</pub-id></citation></ref>
<ref id="B109"><label>109.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aliu Olalekan</surname> <given-names>O</given-names></name> <name><surname>Janet Aderonke</surname> <given-names>O</given-names></name> <name><surname>Chukwudi Cosmos</surname> <given-names>M</given-names></name> <name><surname>Tolulope Olagoke</surname> <given-names>K</given-names></name> <name><surname>Samira</surname> <given-names>A</given-names></name></person-group>. <article-title>Revolutionizing infectious disease management in low-resource settings: The impact of rapid diagnostic technologies and portable devices.</article-title> <source><italic>Int J Appl Res Soc Sci.</italic></source> (<year>2024</year>) <volume>6</volume>:<fpage>1417</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.51594/ijarss.v6i7.1332</pub-id></citation></ref>
<ref id="B110"><label>110.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cibinel</surname> <given-names>G</given-names></name></person-group>. <article-title>POCUS infectious disease management: Point-of-care ultrasound in the integrated management of infectious diseases.</article-title> <source><italic>Italian J Emerg Med.</italic></source> (<year>2023</year>) <volume>12</volume>:<fpage>67</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.23736/s2532-1285.23.00190-8</pub-id></citation></ref>
<ref id="B111"><label>111.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>N</given-names></name> <name><surname>Zhang</surname> <given-names>J</given-names></name> <name><surname>Xiao</surname> <given-names>B</given-names></name> <name><surname>Chen</surname> <given-names>A</given-names></name></person-group>. <article-title>Microfluidic-assisted integrated nucleic acid test strips for POCT.</article-title> <source><italic>Talanta.</italic></source> (<year>2024</year>) <volume>267</volume>:<fpage>125150</fpage>. <pub-id pub-id-type="doi">10.1016/j.talanta.2023.125150</pub-id> <pub-id pub-id-type="pmid">37672986</pub-id></citation></ref>
<ref id="B112"><label>112.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vealan</surname> <given-names>K</given-names></name> <name><surname>Joseph</surname> <given-names>N</given-names></name> <name><surname>Alimat</surname> <given-names>S</given-names></name> <name><surname>Karumbati</surname> <given-names>A</given-names></name> <name><surname>Thilakavathy</surname> <given-names>K</given-names></name></person-group>. <article-title>Lateral flow assay: A promising rapid point-of-care testing tool for infections and non-communicable diseases.</article-title> <source><italic>Asian Biomed (Res Rev News).</italic></source> (<year>2023</year>) <volume>17</volume>:<fpage>250</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.2478/abm-2023-0068</pub-id> <pub-id pub-id-type="pmid">38161347</pub-id></citation></ref>
<ref id="B113"><label>113.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>S</given-names></name> <name><surname>Niu</surname> <given-names>L</given-names></name> <name><surname>Zhou</surname> <given-names>R</given-names></name> <name><surname>Wang</surname> <given-names>C</given-names></name> <name><surname>Zheng</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>D</given-names></name><etal/></person-group> <article-title>Significance of the antibody orientation for the lateral flow immunoassays: A mini-review.</article-title> <source><italic>Int J Biol Macromol.</italic></source> (<year>2024</year>) <volume>257</volume>:<fpage>128621</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2023.128621</pub-id> <pub-id pub-id-type="pmid">38070797</pub-id></citation></ref>
<ref id="B114"><label>114.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strohmaier-Nguyen</surname> <given-names>D</given-names></name> <name><surname>Horn</surname> <given-names>C</given-names></name> <name><surname>Baeumner</surname> <given-names>A</given-names></name></person-group>. <article-title>Membrane-free lateral flow assay with the active control of fluid transport for ultrasensitive cardiac biomarker detection.</article-title> <source><italic>Anal Chem.</italic></source> (<year>2024</year>) <volume>96</volume>:<fpage>7014</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.4c00142</pub-id> <pub-id pub-id-type="pmid">38659215</pub-id></citation></ref>
<ref id="B115"><label>115.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Su</surname> <given-names>X</given-names></name> <name><surname>Chen</surname> <given-names>M</given-names></name> <name><surname>Xie</surname> <given-names>Y</given-names></name> <name><surname>Li</surname> <given-names>M</given-names></name></person-group>. <article-title>Self-calibrating surface-enhanced Raman scattering-lateral flow immunoassay for determination of amyloid-&#x03B2; biomarker of Alzheimer&#x2019;s disease.</article-title> <source><italic>Biosens Bioelectron.</italic></source> (<year>2024</year>) <volume>245</volume>:<fpage>115840</fpage>. <pub-id pub-id-type="doi">10.1016/j.bios.2023.115840</pub-id> <pub-id pub-id-type="pmid">37988777</pub-id></citation></ref>
<ref id="B116"><label>116.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pei</surname> <given-names>F</given-names></name> <name><surname>Feng</surname> <given-names>S</given-names></name> <name><surname>Hu</surname> <given-names>W</given-names></name> <name><surname>Liu</surname> <given-names>B</given-names></name> <name><surname>Mu</surname> <given-names>X</given-names></name> <name><surname>Hao</surname> <given-names>Q</given-names></name><etal/></person-group> <article-title>Sandwich mode lateral flow assay for point-of-care detecting SARS-CoV-2.</article-title> <source><italic>Talanta.</italic></source> (<year>2023</year>) <volume>253</volume>:<fpage>124051</fpage>. <pub-id pub-id-type="doi">10.1016/j.talanta.2022.124051</pub-id></citation></ref>
<ref id="B117"><label>117.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>Q</given-names></name> <name><surname>Kamruzzaman</surname> <given-names>M</given-names></name></person-group>. <article-title>Advancements in nanozyme-enhanced lateral flow assay platforms for precision in food authentication.</article-title> <source><italic>Trends Food Sci Technol.</italic></source> (<year>2024</year>) <volume>147</volume>:<fpage>104472</fpage>. <pub-id pub-id-type="doi">10.1016/j.tifs.2024.104472</pub-id></citation></ref>
<ref id="B118"><label>118.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaishampayan</surname> <given-names>V</given-names></name> <name><surname>Kapoor</surname> <given-names>A</given-names></name> <name><surname>Gumfekar</surname> <given-names>S</given-names></name></person-group>. <article-title>Enhancement in the limit of detection of lab-on-chip microfluidic devices using functional nanomaterials.</article-title> <source><italic>Can J Chem Eng.</italic></source> (<year>2023</year>) <volume>101</volume>:<fpage>5208</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1002/cjce.24915</pub-id></citation></ref>
<ref id="B119"><label>119.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>W</given-names></name> <name><surname>Wang</surname> <given-names>M</given-names></name> <name><surname>Cheng</surname> <given-names>P</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>You</surname> <given-names>M</given-names></name></person-group>. <article-title>Recent advances of upconversion nanoparticles-based lateral flow assays for point-of-care testing.</article-title> <source><italic>TrAC Trends Anal Chem.</italic></source> (<year>2024</year>) <volume>176</volume>:<fpage>117641</fpage>. <pub-id pub-id-type="doi">10.1016/j.trac.2024.117641</pub-id></citation></ref>
<ref id="B120"><label>120.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plebani</surname> <given-names>M</given-names></name> <name><surname>Nichols</surname> <given-names>J</given-names></name> <name><surname>Luppa</surname> <given-names>P</given-names></name> <name><surname>Greene</surname> <given-names>D</given-names></name> <name><surname>Sciacovelli</surname> <given-names>L</given-names></name> <name><surname>Shaw</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Point-of-care testing: State-of-the art and perspectives.</article-title> <source><italic>Clin Chem Lab Med.</italic></source> (<year>2024</year>) <volume>63</volume>:<fpage>35</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1515/cclm-2024-0675</pub-id> <pub-id pub-id-type="pmid">38880779</pub-id></citation></ref>
<ref id="B121"><label>121.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manukyan</surname> <given-names>E</given-names></name> <name><surname>Levine</surname> <given-names>B</given-names></name> <name><surname>Manukyan</surname> <given-names>A</given-names></name> <name><surname>Lulejian</surname> <given-names>A</given-names></name></person-group>. <article-title>Integration of laboratory data into a national electronic health record (EHR).</article-title> <source><italic>Stud Health Technol Inform.</italic></source> (<year>2023</year>) <volume>305</volume>:<fpage>491</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.3233/SHTI230540</pub-id> <pub-id pub-id-type="pmid">37387074</pub-id></citation></ref>
<ref id="B122"><label>122.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pournik</surname> <given-names>O</given-names></name> <name><surname>Mukherjee</surname> <given-names>T</given-names></name> <name><surname>Ghalichi</surname> <given-names>L</given-names></name> <name><surname>Arvanitis</surname> <given-names>T</given-names></name></person-group>. <article-title>How interoperability challenges are addressed in healthcare IoT projects.</article-title> <source><italic>Stud Health Technol Inform.</italic></source> (<year>2023</year>) <volume>309</volume>:<fpage>121</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.3233/SHTI230754</pub-id> <pub-id pub-id-type="pmid">37869820</pub-id></citation></ref>
<ref id="B123"><label>123.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Fede</surname> <given-names>O</given-names></name> <name><surname>La Mantia</surname> <given-names>G</given-names></name> <name><surname>Cimino</surname> <given-names>M</given-names></name> <name><surname>Campisi</surname> <given-names>G</given-names></name></person-group>. <article-title>Protection of patient data in digital oral and general health care: A scoping review with respect to the current regulations.</article-title> <source><italic>Oral.</italic></source> (<year>2023</year>) <volume>3</volume>:<fpage>155</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.3390/oral3020014</pub-id></citation></ref>
<ref id="B124"><label>124.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhaiyya</surname> <given-names>M</given-names></name> <name><surname>Panigrahi</surname> <given-names>D</given-names></name> <name><surname>Rewatkar</surname> <given-names>P</given-names></name> <name><surname>Haick</surname> <given-names>H</given-names></name></person-group>. <article-title>Role of machine learning assisted biosensors in point-of-care-testing for clinical decisions.</article-title> <source><italic>ACS Sens.</italic></source> (<year>2024</year>) <volume>9</volume>:<fpage>4495</fpage>&#x2013;<lpage>519</lpage>. <pub-id pub-id-type="doi">10.1021/acssensors.4c01582</pub-id> <pub-id pub-id-type="pmid">39145721</pub-id></citation></ref>
<ref id="B125"><label>125.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chokkalla</surname> <given-names>A</given-names></name> <name><surname>Recio</surname> <given-names>B</given-names></name> <name><surname>Devaraj</surname> <given-names>S</given-names></name></person-group>. <article-title>Best practices for effective management of point of care testing.</article-title> <source><italic>EJIFCC.</italic></source> (<year>2023</year>) <volume>34</volume>:<fpage>245</fpage>&#x2013;<lpage>9</lpage>.</citation></ref>
<ref id="B126"><label>126.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>M</given-names></name> <name><surname>Watts</surname> <given-names>M</given-names></name> <name><surname>Samuel</surname> <given-names>L</given-names></name></person-group>. <article-title>FDA&#x2019;s proposed rule for the regulation of laboratory-developed tests.</article-title> <source><italic>J Clin Microbiol.</italic></source> (<year>2024</year>) <volume>62</volume>:<fpage>e0148823</fpage>. <pub-id pub-id-type="doi">10.1128/jcm.01488-23</pub-id> <pub-id pub-id-type="pmid">38206042</pub-id></citation></ref>
<ref id="B127"><label>127.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramsey</surname> <given-names>G</given-names></name> <name><surname>Anderson</surname> <given-names>C</given-names></name></person-group>. <article-title>Regulatory issues in laboratory medicine.</article-title> <source><italic>Clin Lab Manag.</italic></source> (<year>2024</year>):<fpage>25</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1002/9781683673941.ch2</pub-id></citation></ref>
<ref id="B128"><label>128.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kahles</surname> <given-names>A</given-names></name> <name><surname>Goldschmid</surname> <given-names>H</given-names></name> <name><surname>Volckmar</surname> <given-names>A</given-names></name> <name><surname>Ploeger</surname> <given-names>C</given-names></name> <name><surname>Kazdal</surname> <given-names>D</given-names></name> <name><surname>Penzel</surname> <given-names>R</given-names></name><etal/></person-group> <article-title>Regulation (EU) 2017/746 (IVDR): Practical implementation of annex I in pathology.</article-title> <source><italic>Pathologie (Heidelb).</italic></source> (<year>2023</year>) <volume>44</volume>:<fpage>86</fpage>&#x2013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1007/s00292-023-01274-6</pub-id> <pub-id pub-id-type="pmid">38047950</pub-id></citation></ref>
<ref id="B129"><label>129.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hallersten</surname> <given-names>A</given-names></name> <name><surname>Decker</surname> <given-names>N</given-names></name> <name><surname>Huang</surname> <given-names>Y</given-names></name></person-group>. <article-title>Principles of ideal diagnostic regulation and the IVDR.</article-title> <source><italic>Clin Chem Lab Med.</italic></source> (<year>2023</year>) <volume>61</volume>:<fpage>599</fpage>&#x2013;<lpage>607</lpage>. <pub-id pub-id-type="doi">10.1515/cclm-2022-1206</pub-id> <pub-id pub-id-type="pmid">36544267</pub-id></citation></ref>
<ref id="B130"><label>130.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lubbers</surname> <given-names>B</given-names></name> <name><surname>Dombrink</surname> <given-names>I</given-names></name> <name><surname>Kalina</surname> <given-names>T</given-names></name> <name><surname>Hofmans</surname> <given-names>M</given-names></name> <name><surname>Bruun</surname> <given-names>M</given-names></name> <name><surname>Stanworth</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>Experience With IVDR implementation in three diagnostic laboratories: Messages to EU health institutions, diagnostic healthcare payers, and authorities.</article-title> <source><italic>Hemasphere.</italic></source> (<year>2023</year>) <volume>7</volume>:<fpage>e865</fpage>. <pub-id pub-id-type="doi">10.1097/HS9.0000000000000865</pub-id> <pub-id pub-id-type="pmid">36911048</pub-id></citation></ref>
<ref id="B131"><label>131.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baghal Behyar</surname> <given-names>M</given-names></name> <name><surname>Nilghaz</surname> <given-names>A</given-names></name> <name><surname>Bahari</surname> <given-names>H</given-names></name> <name><surname>Hasanzadeh</surname> <given-names>M</given-names></name> <name><surname>Shadjou</surname> <given-names>N</given-names></name></person-group>. <article-title>Recent advances on nanomaterials for personalized diagnostics in multiplex point-of-care testing.</article-title> <source><italic>TrAC Trends Anal Chem.</italic></source> (<year>2024</year>) <volume>176</volume>:<fpage>117761</fpage>. <pub-id pub-id-type="doi">10.1016/j.trac.2024.117761</pub-id></citation></ref>
<ref id="B132"><label>132.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tania Cyrielle</surname> <given-names>N</given-names></name> <name><surname>Serge Andigema</surname> <given-names>A</given-names></name> <name><surname>Lethicia Dana&#x00EB;lle</surname> <given-names>M</given-names></name> <name><surname>Ekwelle</surname> <given-names>E</given-names></name></person-group>. <article-title>Harnessing the power of artificial intelligence for enhanced point-of-care quality control in healthcare.</article-title> <source><italic>Asian J Med Technol.</italic></source> (<year>2024</year>) <volume>4</volume>:<fpage>22</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.32896/ajmedtech.v4n1.22-33</pub-id></citation></ref>
<ref id="B133"><label>133.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vo</surname> <given-names>D</given-names></name> <name><surname>Trinh</surname> <given-names>K</given-names></name></person-group>. <article-title>Advances in wearable biosensors for healthcare: Current trends, applications, and future perspectives.</article-title> <source><italic>Biosensors (Basel).</italic></source> (<year>2024</year>) <volume>14</volume>:<fpage>560</fpage>. <pub-id pub-id-type="doi">10.3390/bios14110560</pub-id> <pub-id pub-id-type="pmid">39590019</pub-id></citation></ref>
<ref id="B134"><label>134.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Macovei</surname> <given-names>D</given-names></name> <name><surname>Irimes</surname> <given-names>M</given-names></name> <name><surname>Hosu</surname> <given-names>O</given-names></name> <name><surname>Cristea</surname> <given-names>C</given-names></name> <name><surname>Tertis</surname> <given-names>M</given-names></name></person-group>. <article-title>Point-of-care electrochemical testing of biomarkers involved in inflammatory and inflammatory-associated medical conditions.</article-title> <source><italic>Anal Bioanal Chem.</italic></source> (<year>2023</year>) <volume>415</volume>:<fpage>1033</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1007/s00216-022-04320-z</pub-id> <pub-id pub-id-type="pmid">36102973</pub-id></citation></ref>
<ref id="B135"><label>135.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haghayegh</surname> <given-names>F</given-names></name> <name><surname>Norouziazad</surname> <given-names>A</given-names></name> <name><surname>Haghani</surname> <given-names>E</given-names></name> <name><surname>Feygin</surname> <given-names>A</given-names></name> <name><surname>Rahimi</surname> <given-names>R</given-names></name> <name><surname>Ghavamabadi</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>Revolutionary point-of-care wearable diagnostics for early disease detection and biomarker discovery through intelligent technologies.</article-title> <source><italic>Adv Sci (Weinh).</italic></source> (<year>2024</year>) <volume>11</volume>:<fpage>e2400595</fpage>. <pub-id pub-id-type="doi">10.1002/advs.202400595</pub-id> <pub-id pub-id-type="pmid">38958517</pub-id></citation></ref>
<ref id="B136"><label>136.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hemdan</surname> <given-names>M</given-names></name> <name><surname>Ali</surname> <given-names>M</given-names></name> <name><surname>Doghish</surname> <given-names>A</given-names></name> <name><surname>Mageed</surname> <given-names>S</given-names></name> <name><surname>Elazab</surname> <given-names>I</given-names></name> <name><surname>Khalil</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Innovations in biosensor technologies for healthcare diagnostics and therapeutic drug monitoring: Applications, recent progress, and future research challenges.</article-title> <source><italic>Sensors (Basel).</italic></source> (<year>2024</year>) <volume>24</volume>:<fpage>5143</fpage>. <pub-id pub-id-type="doi">10.3390/s24165143</pub-id> <pub-id pub-id-type="pmid">39204840</pub-id></citation></ref>
<ref id="B137"><label>137.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>Y</given-names></name> <name><surname>Jin</surname> <given-names>K</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Sheng</surname> <given-names>K</given-names></name> <name><surname>Huang</surname> <given-names>W</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name></person-group>. <article-title>Flexible and stretchable electrochemical sensors for biological monitoring.</article-title> <source><italic>Adv Mater.</italic></source> (<year>2023</year>):<fpage>e2305917</fpage>. <pub-id pub-id-type="doi">10.1002/adma.202305917</pub-id> <pub-id pub-id-type="pmid">37639636</pub-id> <comment>Online ahead of print</comment>.</citation></ref>
<ref id="B138"><label>138.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Munshi</surname> <given-names>M</given-names></name></person-group>. <article-title>Continuous glucose monitoring use in older adults for optimal diabetes management.</article-title> <source><italic>Diabetes Technol Ther.</italic></source> (<year>2023</year>) <volume>25</volume>:<fpage>S56</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1089/dia.2023.0111</pub-id> <pub-id pub-id-type="pmid">37306446</pub-id></citation></ref>
<ref id="B139"><label>139.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname> <given-names>B</given-names></name> <name><surname>Riaz</surname> <given-names>Z</given-names></name> <name><surname>Ahmad</surname> <given-names>R</given-names></name> <name><surname>Khoo</surname> <given-names>B</given-names></name></person-group>. <article-title>Advancements in wearable sensors for cardiovascular disease detection for health monitoring.</article-title> <source><italic>Mater Sci Eng. R Rep.</italic></source> (<year>2024</year>) <volume>159</volume>:<fpage>100804</fpage>. <pub-id pub-id-type="doi">10.1016/j.mser.2024.100804</pub-id></citation></ref>
<ref id="B140"><label>140.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faham</surname> <given-names>S</given-names></name> <name><surname>Faham</surname> <given-names>S</given-names></name> <name><surname>Sepehri</surname> <given-names>B</given-names></name></person-group>. <article-title>Wearable optical sensors: Toward machine learning-enabled biomarker monitoring.</article-title> <source><italic>Chem Africa.</italic></source> (<year>2024</year>) <volume>7</volume>:<fpage>4175</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1007/s42250-024-01047-5</pub-id></citation></ref>
<ref id="B141"><label>141.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Zheng</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name> <name><surname>Pan</surname> <given-names>J</given-names></name> <name><surname>Thean</surname> <given-names>A</given-names></name></person-group>. <article-title>Hybrid integration of wearable devices for physiological monitoring.</article-title> <source><italic>Chem Rev.</italic></source> (<year>2024</year>) <volume>124</volume>:<fpage>10386</fpage>&#x2013;<lpage>434</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.3c00471</pub-id> <pub-id pub-id-type="pmid">39189683</pub-id></citation></ref>
<ref id="B142"><label>142.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>A</given-names></name> <name><surname>Li</surname> <given-names>R</given-names></name> <name><surname>Tse</surname> <given-names>Z</given-names></name></person-group>. <article-title>Reshaping healthcare with wearable biosensors.</article-title> <source><italic>Sci Rep.</italic></source> (<year>2023</year>) <volume>13</volume>:<fpage>4998</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-022-26951-z</pub-id> <pub-id pub-id-type="pmid">36973262</pub-id></citation></ref>
<ref id="B143"><label>143.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ehizogie Paul</surname> <given-names>A</given-names></name> <name><surname>Chioma Anthonia</surname> <given-names>O</given-names></name> <name><surname>Olumuyiwa Tolulope</surname> <given-names>O</given-names></name></person-group>. <article-title>A review of wearable technology in healthcare: Monitoring patient health and enhancing outcomes.</article-title> <source><italic>Open Access Res J Multidisciplinary Stud.</italic></source> (<year>2024</year>) <volume>7</volume>:<fpage>142</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.53022/oarjms.2024.7.1.0019</pub-id></citation></ref>
<ref id="B144"><label>144.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wasilewski</surname> <given-names>T</given-names></name> <name><surname>Kamysz</surname> <given-names>W</given-names></name> <name><surname>G&#x0119;bicki</surname> <given-names>J</given-names></name></person-group>. <article-title>AI-assisted detection of biomarkers by sensors and biosensors for early diagnosis and monitoring.</article-title> <source><italic>Biosensors (Basel).</italic></source> (<year>2024</year>) <volume>14</volume>:<fpage>356</fpage>. <pub-id pub-id-type="doi">10.3390/bios14070356</pub-id> <pub-id pub-id-type="pmid">39056632</pub-id></citation></ref>
<ref id="B145"><label>145.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Z</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Niu</surname> <given-names>X</given-names></name></person-group>. <article-title>Application of artificial intelligence for improving early detection and prediction of therapeutic outcomes for gastric cancer in the era of precision oncology.</article-title> <source><italic>Semin Cancer Biol.</italic></source> (<year>2023</year>) <volume>93</volume>:<fpage>83</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2023.04.009</pub-id> <pub-id pub-id-type="pmid">37116818</pub-id></citation></ref>
<ref id="B146"><label>146.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhabad</surname> <given-names>S</given-names></name> <name><surname>Lamkhade</surname> <given-names>D</given-names></name> <name><surname>Koyate</surname> <given-names>S</given-names></name> <name><surname>Karanjkhele</surname> <given-names>K</given-names></name> <name><surname>Kale</surname> <given-names>V</given-names></name> <name><surname>Doke</surname> <given-names>R</given-names></name></person-group>. <article-title>Transformative trends: A comprehensive review on role of artificial intelligence in healthcare and pharmaceutical research.</article-title> <source><italic>IP Int J Comprehensive Adv Pharmacol.</italic></source> (<year>2023</year>) <volume>8</volume>:<fpage>210</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.18231/j.ijcaap.2023.034</pub-id></citation></ref>
<ref id="B147"><label>147.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Z</given-names></name> <name><surname>Xu</surname> <given-names>T</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name></person-group>. <article-title>Empowerment of AI algorithms in biochemical sensors.</article-title> <source><italic>TrAC Trends Anal Chem.</italic></source> (<year>2024</year>) <volume>173</volume>:<fpage>117613</fpage>. <pub-id pub-id-type="doi">10.1016/j.trac.2024.117613</pub-id></citation></ref>
<ref id="B148"><label>148.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bello</surname> <given-names>B</given-names></name> <name><surname>Bundey</surname> <given-names>Y</given-names></name> <name><surname>Bhave</surname> <given-names>R</given-names></name> <name><surname>Khotimchenko</surname> <given-names>M</given-names></name> <name><surname>Baran</surname> <given-names>S</given-names></name> <name><surname>Chakravarty</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Integrating AI/ML models for patient stratification leveraging omics dataset and clinical biomarkers from COVID-19 patients: A promising approach to personalized medicine.</article-title> <source><italic>Int J Mol Sci.</italic></source> (<year>2023</year>) <volume>24</volume>:<fpage>6250</fpage>. <pub-id pub-id-type="doi">10.3390/ijms24076250</pub-id> <pub-id pub-id-type="pmid">37047222</pub-id></citation></ref>
<ref id="B149"><label>149.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Athar</surname> <given-names>M</given-names></name></person-group>. <article-title>Potentials of artificial intelligence in familial hypercholesterolemia: Advances in screening, diagnosis, and risk stratification for early intervention and treatment.</article-title> <source><italic>Int J Cardiol.</italic></source> (<year>2024</year>) <volume>412</volume>:<fpage>132315</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2024.132315</pub-id> <pub-id pub-id-type="pmid">38972488</pub-id></citation></ref>
<ref id="B150"><label>150.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdallah</surname> <given-names>S</given-names></name> <name><surname>Almadhoun</surname> <given-names>M</given-names></name> <name><surname>Khawar</surname> <given-names>M</given-names></name> <name><surname>Shaikh</surname> <given-names>U</given-names></name> <name><surname>Balabel</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>The impact of artificial intelligence on optimizing diagnosis and treatment plans for rare genetic disorders.</article-title> <source><italic>Cureus.</italic></source> (<year>2023</year>) <volume>15</volume>:<fpage>e46860</fpage>. <pub-id pub-id-type="doi">10.7759/cureus.46860</pub-id> <pub-id pub-id-type="pmid">37954711</pub-id></citation></ref>
<ref id="B151"><label>151.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Wei</surname> <given-names>M</given-names></name> <name><surname>Li</surname> <given-names>G</given-names></name></person-group>. <article-title>Innovation and challenges of artificial intelligence technology in personalized healthcare.</article-title> <source><italic>Sci Rep.</italic></source> (<year>2024</year>) <volume>14</volume>:<fpage>18994</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-024-70073-7</pub-id> <pub-id pub-id-type="pmid">39152194</pub-id></citation></ref>
<ref id="B152"><label>152.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dash</surname> <given-names>B</given-names></name></person-group>. <article-title>Harnessing artificial intelligence in drug discovery: Revolutionizing chemical and biochemical sciences.</article-title> <source><italic>African J Biol Sci.</italic></source> (<year>2024</year>) <volume>6</volume>:<fpage>496</fpage>&#x2013;<lpage>507</lpage>. <pub-id pub-id-type="doi">10.48047/afjbs.6.3.2024.496-507</pub-id></citation></ref>
<ref id="B153"><label>153.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karalis</surname> <given-names>V</given-names></name></person-group>. <article-title>Artificial intelligence in drug discovery and clinical practice.</article-title> In: <person-group person-group-type="author"><name><surname>Pippa</surname> <given-names>N</given-names></name> <name><surname>Demetzos</surname> <given-names>C</given-names></name> <name><surname>Chountoulesi</surname> <given-names>M</given-names></name></person-group> <role>editors</role>. <source><italic>From Current to Future Trends in Pharmaceutical Technology.</italic></source> <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name> (<year>2024</year>). p. <fpage>215</fpage>&#x2013;<lpage>55</lpage>.</citation></ref>
<ref id="B154"><label>154.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karar</surname> <given-names>M</given-names></name> <name><surname>El-Fishawy</surname> <given-names>N</given-names></name> <name><surname>Radad</surname> <given-names>M</given-names></name></person-group>. <article-title>Automated classification of urine biomarkers to diagnose pancreatic cancer using 1-D convolutional neural networks.</article-title> <source><italic>J Biol Eng.</italic></source> (<year>2023</year>) <volume>17</volume>:<fpage>28</fpage>. <pub-id pub-id-type="doi">10.1186/s13036-023-00340-0</pub-id> <pub-id pub-id-type="pmid">37069681</pub-id></citation></ref>
<ref id="B155"><label>155.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salam</surname> <given-names>A</given-names></name> <name><surname>Ullah</surname> <given-names>F</given-names></name> <name><surname>Amin</surname> <given-names>F</given-names></name> <name><surname>Ahmad Khan</surname> <given-names>I</given-names></name> <name><surname>Garcia Villena</surname> <given-names>E</given-names></name> <name><surname>Kuc Castilla</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Efficient prediction of anticancer peptides through deep learning.</article-title> <source><italic>PeerJ Comput Sci.</italic></source> (<year>2024</year>) <volume>10</volume>:<fpage>e2171</fpage>. <pub-id pub-id-type="doi">10.7717/peerj-cs.2171</pub-id> <pub-id pub-id-type="pmid">39145253</pub-id></citation></ref>
<ref id="B156"><label>156.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname> <given-names>T</given-names></name> <name><surname>Todd</surname> <given-names>A</given-names></name> <name><surname>Orringer</surname> <given-names>D</given-names></name> <name><surname>Levenson</surname> <given-names>R</given-names></name></person-group>. <article-title>Applications of artificial intelligence for image enhancement in pathology.</article-title> <source><italic>Artificial Intell Pathol.</italic></source> (<year>2025</year>) <fpage>183</fpage>&#x2013;<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1016/b978-0-323-95359-7.00010-8</pub-id></citation></ref>
<ref id="B157"><label>157.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Demetriou</surname> <given-names>D</given-names></name> <name><surname>Hull</surname> <given-names>R</given-names></name> <name><surname>Kgoebane-Maseko</surname> <given-names>M</given-names></name> <name><surname>Lockhat</surname> <given-names>Z</given-names></name> <name><surname>Dlamini</surname> <given-names>Z</given-names></name></person-group>. <article-title>AI-enhanced digital pathology and radiogenomics in precision oncology.</article-title> In: <person-group person-group-type="editor"><name><surname>Dlamini</surname> <given-names>Z</given-names></name></person-group> <role>editor.</role> <source><italic>Artificial Intelligence and Precision Oncology.</italic></source> <publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer</publisher-name> (<year>2023</year>). p. <fpage>93</fpage>&#x2013;<lpage>113</lpage>.</citation></ref>
<ref id="B158"><label>158.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rojas-Carabali</surname> <given-names>W</given-names></name> <name><surname>Agrawal</surname> <given-names>R</given-names></name> <name><surname>Gutierrez-Sinisterra</surname> <given-names>L</given-names></name> <name><surname>Baxter</surname> <given-names>S</given-names></name> <name><surname>Cifuentes-Gonz&#x00E1;lez</surname> <given-names>C</given-names></name> <name><surname>Wei</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>Natural Language Processing in medicine and ophthalmology: A review for the 21st-century clinician.</article-title> <source><italic>Asia Pac J Ophthalmol (Phila).</italic></source> (<year>2024</year>) <volume>13</volume>:<fpage>100084</fpage>. <pub-id pub-id-type="doi">10.1016/j.apjo.2024.100084</pub-id> <pub-id pub-id-type="pmid">39059557</pub-id></citation></ref>
<ref id="B159"><label>159.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mencacci</surname> <given-names>A</given-names></name> <name><surname>De Socio</surname> <given-names>G</given-names></name> <name><surname>Pirelli</surname> <given-names>E</given-names></name> <name><surname>Bondi</surname> <given-names>P</given-names></name> <name><surname>Cenci</surname> <given-names>E</given-names></name></person-group>. <article-title>Laboratory automation, informatics, and artificial intelligence: Current and future perspectives in clinical microbiology.</article-title> <source><italic>Front Cell Infect Microbiol.</italic></source> (<year>2023</year>) <volume>13</volume>:<fpage>1188684</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2023.1188684</pub-id> <pub-id pub-id-type="pmid">37441239</pub-id></citation></ref>
<ref id="B160"><label>160.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname> <given-names>K</given-names></name> <name><surname>Yousef</surname> <given-names>M</given-names></name> <name><surname>Mohammed</surname> <given-names>S</given-names></name> <name><surname>Al-Dewik</surname> <given-names>N</given-names></name> <name><surname>Qoronfleh</surname> <given-names>M</given-names></name></person-group>. <article-title>Optimizing clinical workflow using precision medicine and advanced data analytics.</article-title> <source><italic>Processes.</italic></source> (<year>2023</year>) <volume>11</volume>:<fpage>939</fpage>. <pub-id pub-id-type="doi">10.3390/pr11030939</pub-id></citation></ref>
<ref id="B161"><label>161.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname> <given-names>H</given-names></name> <name><surname>Zhang</surname> <given-names>R</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name></person-group>. <article-title>Artificial intelligence in the clinical laboratory.</article-title> <source><italic>Clin Chim Acta.</italic></source> (<year>2024</year>) <volume>559</volume>:<fpage>119724</fpage>. <pub-id pub-id-type="doi">10.1016/j.cca.2024.119724</pub-id> <pub-id pub-id-type="pmid">38734225</pub-id></citation></ref>
<ref id="B162"><label>162.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giorgini</surname> <given-names>F</given-names></name> <name><surname>Di Dalmazi</surname> <given-names>G</given-names></name> <name><surname>Diciotti</surname> <given-names>S</given-names></name></person-group>. <article-title>Artificial intelligence in endocrinology: A comprehensive review.</article-title> <source><italic>J Endocrinol Invest.</italic></source> (<year>2024</year>) <volume>47</volume>:<fpage>1067</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1007/s40618-023-02235-9</pub-id> <pub-id pub-id-type="pmid">37971630</pub-id></citation></ref>
<ref id="B163"><label>163.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amponsah</surname> <given-names>S</given-names></name> <name><surname>Kwaku Ofori</surname> <given-names>E</given-names></name> <name><surname>Pathak</surname> <given-names>Y.</given-names></name></person-group> <source><italic>Current Trends in the Diagnosis and Manag Metab Disord.</italic></source> <publisher-loc>Milton Park</publisher-loc>: <publisher-name>Routledge</publisher-name> (<year>2023</year>).</citation></ref>
<ref id="B164"><label>164.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doudesis</surname> <given-names>D</given-names></name> <name><surname>Lee</surname> <given-names>K</given-names></name> <name><surname>Boeddinghaus</surname> <given-names>J</given-names></name> <name><surname>Bularga</surname> <given-names>A</given-names></name> <name><surname>Ferry</surname> <given-names>A</given-names></name> <name><surname>Tuck</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>Machine learning for diagnosis of myocardial infarction using cardiac troponin concentrations.</article-title> <source><italic>Nat Med.</italic></source> (<year>2023</year>) <volume>29</volume>:<fpage>1201</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-023-02325-4</pub-id> <pub-id pub-id-type="pmid">37169863</pub-id></citation></ref>
<ref id="B165"><label>165.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Than</surname> <given-names>M</given-names></name> <name><surname>Pickering</surname> <given-names>J</given-names></name> <name><surname>Mair</surname> <given-names>J</given-names></name> <name><surname>Mills</surname> <given-names>N</given-names></name></person-group>. <article-title>Clinical decision support using machine learning and cardiac troponin for the diagnosis of myocardial infarction.</article-title> <source><italic>Eur Heart J Acute Cardiovasc Care.</italic></source> (<year>2024</year>) <volume>13</volume>:<fpage>634</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/ehjacc/zuae085</pub-id> <pub-id pub-id-type="pmid">39026425</pub-id></citation></ref>
<ref id="B166"><label>166.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname> <given-names>J</given-names></name> <name><surname>Gottfried</surname> <given-names>D</given-names></name> <name><surname>Lee</surname> <given-names>D</given-names></name> <name><surname>Navarrete</surname> <given-names>S</given-names></name></person-group>. <article-title>Understanding and addressing regulatory concerns in research.</article-title> In: <person-group person-group-type="author"><name><surname>Musahl</surname> <given-names>V</given-names></name> <name><surname>Karlsson</surname> <given-names>J</given-names></name> <name><surname>Hirschmann</surname> <given-names>MT</given-names></name></person-group> <role>editors</role>. <source><italic>Basic Methods Handbook for Clinical Orthopaedic Research.</italic></source> <publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer</publisher-name> (<year>2019</year>). p. <fpage>515</fpage>&#x2013;<lpage>31</lpage>.</citation></ref>
<ref id="B167"><label>167.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Massella</surname> <given-names>M</given-names></name> <name><surname>Dri</surname> <given-names>D</given-names></name> <name><surname>Gramaglia</surname> <given-names>D</given-names></name></person-group>. <article-title>Regulatory considerations on the use of machine learning based tools in clinical trials.</article-title> <source><italic>Health Technol (Berl).</italic></source> (<year>2022</year>) <volume>12</volume>:<fpage>1085</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1007/s12553-022-00708-0</pub-id> <pub-id pub-id-type="pmid">36373014</pub-id></citation></ref>
<ref id="B168"><label>168.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yuba</surname> <given-names>M</given-names></name> <name><surname>Iwasaki</surname> <given-names>K</given-names></name></person-group>. <article-title>Systematic analysis of the test design and performance of AI/ML-based medical devices approved for triage/detection/diagnosis in the USA and Japan.</article-title> <source><italic>Sci Rep.</italic></source> (<year>2022</year>) <volume>12</volume>:<fpage>16874</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-022-21426-7</pub-id> <pub-id pub-id-type="pmid">36207474</pub-id></citation></ref>
<ref id="B169"><label>169.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>D</given-names></name> <name><surname>Dadhich</surname> <given-names>D</given-names></name></person-group>. <article-title>Regulatory frameworks for artificial intelligence in law: Ensuring accountability and fairness.</article-title> <source><italic>NUJS J Regulatory Stud.</italic></source> (<year>2024</year>) <volume>9</volume>:<fpage>13</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.69953/njrs.v9i2.7</pub-id></citation></ref>
<ref id="B170"><label>170.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Altayyar</surname> <given-names>S</given-names></name></person-group>. <article-title>Medical devices and patient safety.</article-title> <source><italic>J Anal Pharm Res.</italic></source> (<year>2016</year>) <volume>2</volume>:<fpage>60</fpage>&#x2013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.15406/japlr.2016.02.00034</pub-id></citation></ref>
<ref id="B171"><label>171.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname> <given-names>A</given-names></name> <name><surname>Gamta</surname> <given-names>V</given-names></name> <name><surname>Luthra</surname> <given-names>G</given-names></name></person-group>. <article-title>Ensuring patient safety and trust: The critical importance of regulatory compliance in healthcare.</article-title> <source><italic>J Pharm Res Int.</italic></source> (<year>2023</year>) <volume>35</volume>:<fpage>1</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.9734/jpri/2023/v35i187390</pub-id></citation></ref>
<ref id="B172"><label>172.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dil</surname> <given-names>A</given-names></name> <name><surname>Eikelenboom</surname> <given-names>A</given-names></name></person-group>. <article-title>Whisking the digital health compliance.</article-title> In: <person-group person-group-type="author"><name><surname>Mirzaei</surname> <given-names>A</given-names></name> <name><surname>Rijcken</surname> <given-names>C</given-names></name></person-group> <role>editors</role>. <source><italic>Pharmaceutical Care in Digital Revolution.</italic></source> <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name> (<year>2023</year>). p. <fpage>261</fpage>&#x2013;<lpage>77</lpage>.</citation></ref>
<ref id="B173"><label>173.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalra</surname> <given-names>N</given-names></name> <name><surname>Verma</surname> <given-names>P</given-names></name> <name><surname>Verma</surname> <given-names>S</given-names></name></person-group>. <article-title>Advancements in AI based healthcare techniques with FOCUS ON diagnostic techniques.</article-title> <source><italic>Comput Biol Med.</italic></source> (<year>2024</year>) <volume>179</volume>:<fpage>108917</fpage>. <pub-id pub-id-type="doi">10.1016/j.compbiomed.2024.108917</pub-id> <pub-id pub-id-type="pmid">39059212</pub-id></citation></ref>
<ref id="B174"><label>174.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Isha</surname> <given-names>M</given-names></name> <name><surname>Vedika</surname> <given-names>K</given-names></name> <name><surname>Ritu</surname> <given-names>P</given-names></name></person-group>. <article-title>Revolutionizing healthcare: The impact and growth of artificial intelligence(AI).</article-title> <source><italic>Int Res J Adv Eng Hub (IRJAEH).</italic></source> (<year>2024</year>) <volume>2</volume>:<fpage>1875</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.47392/irjaeh.2024.0257</pub-id></citation></ref>
<ref id="B175"><label>175.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adeel</surname> <given-names>N</given-names></name> <name><surname>Fatima</surname> <given-names>N</given-names></name></person-group>. <article-title>Innovations in healthcare through computational intelligence- A study of smart technologies and AI.</article-title> <source><italic>Int J Innov Res Comput Sci Technol.</italic></source> (<year>2024</year>) <volume>12</volume>:<fpage>38</fpage>&#x2013;<lpage>42</lpage>.</citation></ref>
<ref id="B176"><label>176.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>L</given-names></name> <name><surname>Liu</surname> <given-names>D</given-names></name> <name><surname>Lian</surname> <given-names>J</given-names></name> <name><surname>Yang</surname> <given-names>M</given-names></name></person-group>. <article-title>Application of flipped classroom combined with virtual simulation platform in clinical biochemistry practical course.</article-title> <source><italic>BMC Med Educ.</italic></source> (<year>2023</year>) <volume>23</volume>:<fpage>771</fpage>. <pub-id pub-id-type="doi">10.1186/s12909-023-04735-x</pub-id> <pub-id pub-id-type="pmid">37845661</pub-id></citation></ref>
<ref id="B177"><label>177.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Magnoler</surname> <given-names>P</given-names></name> <name><surname>Pacquola</surname> <given-names>M</given-names></name></person-group>. <article-title>Approaches to training in companies.</article-title> <source><italic>Res Educ Media.</italic></source> (<year>2016</year>) <volume>8</volume>:<fpage>42</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1515/rem-2016-0017</pub-id></citation></ref>
<ref id="B178"><label>178.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>&#x042F;&#x043A;&#x0443;&#x0431;&#x0443;&#x043A;</surname> <given-names>O</given-names></name></person-group>. <article-title>Interdisciplinary interaction in laboratory medicine. Relationship between clinical diagnostic laboratory staff and clinicians with consideration of specific professional activities of clinical laboratory diagnostics physicians.</article-title> <source><italic>&#x041B;&#x0430;&#x0431;&#x043E;&#x0440;&#x0430;&#x0442;&#x043E;&#x0440;&#x043D;&#x0430;&#x044F; &#x0434;&#x0438;&#x0430;&#x0433;&#x043D;&#x043E;&#x0441;&#x0442;&#x0438;&#x043A;&#x0430; &#x0412;&#x043E;&#x0441;&#x0442;&#x043E;&#x0447;&#x043D;&#x0430;&#x044F; &#x0415;&#x0432;&#x0440;&#x043E;&#x043F;&#x0430;.</italic></source> (<year>2023</year>) <volume>2</volume>:<fpage>185</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.34883/pi.2023.12.2.003</pub-id></citation></ref>
<ref id="B179"><label>179.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sergeeva</surname> <given-names>O</given-names></name> <name><surname>Chursin</surname> <given-names>A</given-names></name> <name><surname>Podoprigora</surname> <given-names>A</given-names></name> <name><surname>Boev</surname> <given-names>D</given-names></name> <name><surname>Zhuromskaya</surname> <given-names>A</given-names></name></person-group>. <article-title>The importance of professional retraining in the taught specialties for the staff of the simulation training department.</article-title> <source><italic>Virtual Technol Med.</italic></source> (<year>2023</year>).</citation></ref>
<ref id="B180"><label>180.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watkins</surname> <given-names>S</given-names></name></person-group>. <article-title>Simulation-based training for assessment of competency, certification, and maintenance of certification. comprehensive healthcare simulation: interprofessional team training and simulation.</article-title> In: <person-group person-group-type="author"><name><surname>Kutzin</surname> <given-names>JM</given-names></name> <name><surname>Waxman</surname> <given-names>K</given-names></name> <name><surname>Lopez</surname> <given-names>CM</given-names></name></person-group> <role>editors</role>. <source><italic>Comprehensive Healthcare Simulation: Nursing.</italic></source> <publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer</publisher-name> (<year>2020</year>). p. <fpage>225</fpage>&#x2013;<lpage>45</lpage>.</citation></ref>
<ref id="B181"><label>181.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rakhra</surname> <given-names>A</given-names></name> <name><surname>Hooley</surname> <given-names>C</given-names></name> <name><surname>Fort</surname> <given-names>M</given-names></name> <name><surname>Weber</surname> <given-names>M</given-names></name> <name><surname>Price</surname> <given-names>L</given-names></name> <name><surname>Nguyen</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>Training in eight low-and middle-income countries: Lessons learned from a pilot study using the WHO-TDR dissemination and implementation massive open online course.</article-title> <source><italic>Front Health Serv.</italic></source> (<year>2023</year>) <volume>3</volume>:<fpage>1217619</fpage>. <pub-id pub-id-type="doi">10.3389/frhs.2023.1217619</pub-id> <pub-id pub-id-type="pmid">38313329</pub-id></citation></ref>
<ref id="B182"><label>182.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lavanya</surname> <given-names>C</given-names></name> <name><surname>Murthy</surname> <given-names>J</given-names></name></person-group>. <article-title>Assessment and attainment of course outcomes and program outcomes.</article-title> <source><italic>J Eng Educ Transformations.</italic></source> (<year>2022</year>) <volume>35</volume>:<fpage>104</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.16920/jeet/2022/v35i4/22109</pub-id></citation></ref>
<ref id="B183"><label>183.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shankar</surname> <given-names>NG</given-names></name></person-group>. <article-title>Structured evaluation of laboratory course content for better attainment of program outcomes.</article-title> <source><italic>Procedia Comput Sci.</italic></source> (<year>2020</year>) <volume>172</volume>:<fpage>869</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.procs.2020.05.125</pub-id></citation></ref>
<ref id="B184"><label>184.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dall&#x2019;Acqua</surname> <given-names>L</given-names></name></person-group>. <article-title>Ethical and social concerns using artificial intelligence in the medical setting.</article-title> <source><italic>Adv Med Educ Res Ethics.</italic></source> (<year>2024</year>) <fpage>122</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.4018/979-8-3693-2667-1.ch007</pub-id></citation></ref>
<ref id="B185"><label>185.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Negri-Ribalta</surname> <given-names>C</given-names></name> <name><surname>Lombard-Platet</surname> <given-names>M</given-names></name> <name><surname>Salinesi</surname> <given-names>C</given-names></name></person-group>. <article-title>Understanding the GDPR from a requirements engineering perspective&#x2014;A systematic mapping study on regulatory data protection requirements.</article-title> <source><italic>Requirements Eng.</italic></source> (<year>2024</year>) <volume>29</volume>:<fpage>523</fpage>&#x2013;<lpage>49</lpage>.</citation></ref>
<ref id="B186"><label>186.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wa&#x0142;doch</surname> <given-names>K</given-names></name></person-group>. <article-title>Informed consent for the use of AI in the process of providing medical services.</article-title> <source><italic>Rev Eur Comp Law.</italic></source> (<year>2024</year>) <volume>57</volume>:<fpage>121</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.31743/recl.17239</pub-id></citation></ref>
<ref id="B187"><label>187.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singhal</surname> <given-names>S</given-names></name></person-group>. <article-title>Data privacy, compliance, and security including AI ML. Practical applications of data processing, algorithms, and modeling.</article-title> In: <person-group person-group-type="editor"><name><surname>Sugumaran</surname> <given-names>V</given-names></name></person-group> <role>editor.</role> <source><italic>Advances in Systems Analysis, Software Engineering, and High Performance Computing.</italic></source> <publisher-loc>Pennsylvania</publisher-loc>: <publisher-name>IGI Global</publisher-name> (<year>2024</year>). p. <fpage>111</fpage>&#x2013;<lpage>26</lpage>.</citation></ref>
<ref id="B188"><label>188.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeyaraman</surname> <given-names>M</given-names></name> <name><surname>Balaji</surname> <given-names>S</given-names></name> <name><surname>Jeyaraman</surname> <given-names>N</given-names></name> <name><surname>Yadav</surname> <given-names>S</given-names></name></person-group>. <article-title>Unraveling the ethical enigma: Artificial intelligence in healthcare.</article-title> <source><italic>Cureus.</italic></source> (<year>2023</year>) <volume>15</volume>:<fpage>e43262</fpage>. <pub-id pub-id-type="doi">10.7759/cureus.43262</pub-id> <pub-id pub-id-type="pmid">37692617</pub-id></citation></ref>
<ref id="B189"><label>189.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pathak</surname> <given-names>A</given-names></name> <name><surname>Serrer</surname> <given-names>L</given-names></name> <name><surname>Zapata</surname> <given-names>D</given-names></name> <name><surname>King</surname> <given-names>R</given-names></name> <name><surname>Mirel</surname> <given-names>L</given-names></name> <name><surname>Sukalac</surname> <given-names>T</given-names></name><etal/></person-group> <article-title>Privacy preserving record linkage for public health action: Opportunities and challenges.</article-title> <source><italic>J Am Med Inform Assoc.</italic></source> (<year>2024</year>) <volume>31</volume>:<fpage>2605</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1093/jamia/ocae196</pub-id> <pub-id pub-id-type="pmid">39047294</pub-id></citation></ref>
<ref id="B190"><label>190.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oluwatosin</surname> <given-names>I</given-names></name> <name><surname>Tolulope Olagoke</surname> <given-names>K</given-names></name> <name><surname>Janet Aderonke</surname> <given-names>O</given-names></name></person-group>. <article-title>Ethical dilemmas in healthcare management: A comprehensive review.</article-title> <source><italic>Int Med Sci Res J.</italic></source> (<year>2024</year>) <volume>4</volume>:<fpage>703</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.51594/imsrj.v4i6.1251</pub-id></citation></ref>
<ref id="B191"><label>191.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanna</surname> <given-names>M</given-names></name> <name><surname>Pantanowitz</surname> <given-names>L</given-names></name> <name><surname>Jackson</surname> <given-names>B</given-names></name> <name><surname>Palmer</surname> <given-names>O</given-names></name> <name><surname>Visweswaran</surname> <given-names>S</given-names></name> <name><surname>Pantanowitz</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Ethical and bias considerations in artificial intelligence/machine learning.</article-title> <source><italic>Mod Pathol.</italic></source> (<year>2024</year>) <volume>38</volume>:<fpage>100686</fpage>. <pub-id pub-id-type="doi">10.1016/j.modpat.2024.100686</pub-id> <pub-id pub-id-type="pmid">39694331</pub-id></citation></ref>
<ref id="B192"><label>192.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franklin</surname> <given-names>G</given-names></name> <name><surname>Stephens</surname> <given-names>R</given-names></name> <name><surname>Piracha</surname> <given-names>M</given-names></name> <name><surname>Tiosano</surname> <given-names>S</given-names></name> <name><surname>Lehouillier</surname> <given-names>F</given-names></name> <name><surname>Koppel</surname> <given-names>R</given-names></name><etal/></person-group> <article-title>The sociodemographic biases in machine learning algorithms: A biomedical informatics perspective.</article-title> <source><italic>Life (Basel).</italic></source> (<year>2024</year>) <volume>14</volume>:<fpage>652</fpage>. <pub-id pub-id-type="doi">10.3390/life14060652</pub-id> <pub-id pub-id-type="pmid">38929638</pub-id></citation></ref>
<ref id="B193"><label>193.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hassija</surname> <given-names>V</given-names></name> <name><surname>Chamola</surname> <given-names>V</given-names></name> <name><surname>Mahapatra</surname> <given-names>A</given-names></name> <name><surname>Singal</surname> <given-names>A</given-names></name> <name><surname>Goel</surname> <given-names>D</given-names></name> <name><surname>Huang</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Interpreting black-box models: A review on explainable artificial intelligence.</article-title> <source><italic>Cogn Comput.</italic></source> (<year>2023</year>) <volume>16</volume>:<fpage>45</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1007/s12559-023-10179-8</pub-id></citation></ref>
<ref id="B194"><label>194.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hulsen</surname> <given-names>T</given-names></name></person-group>. <article-title>Explainable artificial intelligence (XAI): Concepts and challenges in healthcare.</article-title> <source><italic>Ai.</italic></source> (<year>2023</year>) <volume>4</volume>:<fpage>652</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.3390/ai4030034</pub-id></citation></ref>
<ref id="B195"><label>195.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname> <given-names>S</given-names></name> <name><surname>Prybutok</surname> <given-names>V</given-names></name></person-group>. <article-title>Balancing privacy and progress: A review of privacy challenges, systemic oversight, and patient perceptions in AI-Driven healthcare.</article-title> <source><italic>Appl Sci.</italic></source> (<year>2024</year>) <volume>14</volume>:<fpage>675</fpage>. <pub-id pub-id-type="doi">10.3390/app14020675</pub-id></citation></ref>
<ref id="B196"><label>196.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>K</given-names></name></person-group>. <article-title>Artificial intelligence &#x0026; cloud in healthcare: Analyzing challenges and solutions within regulatory boundaries.</article-title> <source><italic>Int J Comput Sci Eng.</italic></source> (<year>2023</year>) <volume>10</volume>:<fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.14445/23488387/IJCSE-V10I9P101</pub-id></citation></ref>
<ref id="B197"><label>197.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>S</given-names></name> <name><surname>Datta</surname> <given-names>S</given-names></name> <name><surname>Singh</surname> <given-names>V</given-names></name> <name><surname>Datta</surname> <given-names>D</given-names></name> <name><surname>Kumar Singh</surname> <given-names>S</given-names></name> <name><surname>Sharma</surname> <given-names>R</given-names></name></person-group>. <article-title>Applications, challenges, and future directions of human-in-the-loop learning.</article-title> <source><italic>IEEE Access.</italic></source> (<year>2024</year>) <volume>12</volume>:<fpage>75735</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1109/ACCESS.2024.3401547</pub-id></citation></ref>
<ref id="B198"><label>198.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aponte</surname> <given-names>J</given-names></name> <name><surname>Silva</surname> <given-names>P</given-names></name> <name><surname>Ramos</surname> <given-names>K</given-names></name></person-group>. <article-title>Multianalyte tests in clinical care.</article-title> In: <person-group person-group-type="editor"><name><surname>Ramos</surname> <given-names>KS</given-names></name></person-group> <role>editor.</role> <source><italic>Comprehensive Precision Medicine.</italic></source> <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name> (<year>2024</year>). p. <fpage>221</fpage>&#x2013;<lpage>37</lpage>.</citation></ref>
<ref id="B199"><label>199.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Birhanu</surname> <given-names>A</given-names></name></person-group>. <article-title>Mass spectrometry-based proteomics as an emerging tool in clinical laboratories.</article-title> <source><italic>Clin Proteomics.</italic></source> (<year>2023</year>) <volume>20</volume>:<fpage>32</fpage>. <pub-id pub-id-type="doi">10.1186/s12014-023-09424-x</pub-id> <pub-id pub-id-type="pmid">37633929</pub-id></citation></ref>
<ref id="B200"><label>200.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choudhury</surname> <given-names>Y</given-names></name> <name><surname>Pinweha</surname> <given-names>P</given-names></name> <name><surname>Poh</surname> <given-names>J</given-names></name> <name><surname>Lim</surname> <given-names>J</given-names></name> <name><surname>Tan</surname> <given-names>M</given-names></name></person-group>. <article-title>Early detection of cancer using cell-free DNA (cfDNA) size analysis on a multiplexed amplicon-based next-generation sequencing (NGS) platform.</article-title> <source><italic>J Clin Oncol.</italic></source> (<year>2022</year>) <volume>40</volume>:<fpage>3041</fpage>. <pub-id pub-id-type="doi">10.1200/JCO.2022.40.16_suppl.3041</pub-id></citation></ref>
<ref id="B201"><label>201.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hesse</surname> <given-names>A.</given-names></name></person-group> <source><italic>Clinical Next-Generation Sequencing for Somatic Mutation Detection- Advancements and Commercialization Strategies.</italic></source> <publisher-loc>India</publisher-loc>: <publisher-name>Omics online publishing</publisher-name> (<year>2016</year>). <pub-id pub-id-type="doi">10.4172/2572-5645.1000101</pub-id></citation></ref>
<ref id="B202"><label>202.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hristova</surname> <given-names>J</given-names></name> <name><surname>Svinarov</surname> <given-names>D</given-names></name></person-group>. <article-title>Enhancing precision medicine through clinical mass spectrometry platform.</article-title> <source><italic>Biotechnol Biotechnol Equipment.</italic></source> (<year>2022</year>) <volume>36</volume>:<fpage>107</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1080/13102818.2022.2053342</pub-id></citation></ref>
<ref id="B203"><label>203.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalra</surname> <given-names>J</given-names></name></person-group>. <article-title>The future of diagnostic laboratory testing in healthcare.</article-title> <source><italic>Am J Biomed Sci Res.</italic></source> (<year>2019</year>) <volume>5</volume>:<fpage>89</fpage>&#x2013;<lpage>91</lpage>.</citation></ref>
<ref id="B204"><label>204.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shuroog Hassn</surname> <given-names>A</given-names></name> <name><surname>Ali Aqeel</surname> <given-names>A</given-names></name> <name><surname>Ohuod Khalied</surname> <given-names>Q</given-names></name> <name><surname>Nouf Ebrahim</surname> <given-names>A</given-names></name> <name><surname>Soleman Ismaile</surname> <given-names>A</given-names></name></person-group>. <article-title>Revolutionizing Healthcare: The Technological Transformation of Medical Laboratory Outcomes.</article-title> <source><italic>EPH Int J Hum Soc Sci.</italic></source> (<year>2022</year>) <volume>8</volume>:<fpage>1</fpage>&#x2013;<lpage>8</lpage>.</citation></ref>
<ref id="B205"><label>205.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Samara</surname> <given-names>V</given-names></name> <name><surname>Chan</surname> <given-names>C</given-names></name> <name><surname>Kanegusuku</surname> <given-names>A</given-names></name> <name><surname>Yeo</surname> <given-names>K.</given-names></name></person-group> <source><italic>Automation in the Clinical Laboratory. Encyclopedia of Analytical Chemistry.</italic></source> <publisher-loc>Hoboken, NJ</publisher-loc>: <publisher-name>Wiley</publisher-name> (<year>2024</year>). p. <fpage>1</fpage>&#x2013;<lpage>13</lpage>.</citation></ref>
<ref id="B206"><label>206.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bakan</surname> <given-names>E</given-names></name> <name><surname>Bakan</surname> <given-names>N</given-names></name></person-group>. <article-title>Prevention of extra-analytical phase errors by non-analytical automation in clinical laboratory.</article-title> <source><italic>Turkish J Biochem.</italic></source> (<year>2021</year>) <volume>46</volume>(<issue>3</issue>):<fpage>235</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1515/tjb-2020-0483</pub-id></citation></ref>
<ref id="B207"><label>207.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhihao</surname> <given-names>W</given-names></name> <name><surname>Nurutdinova</surname> <given-names>F</given-names></name> <name><surname>Madjidov</surname> <given-names>A</given-names></name> <name><surname>Rasulova</surname> <given-names>Y</given-names></name> <name><surname>Amonova</surname> <given-names>N</given-names></name> <name><surname>Amonova</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>Improvement of laboratory courses in biochemistry for medical students using an electronic textbook.</article-title> <source><italic>BIO Web of Conferences.</italic></source> (<year>2024</year>): <volume>121</volume>.</citation></ref>
<ref id="B208"><label>208.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coskun</surname> <given-names>A</given-names></name> <name><surname>Lippi</surname> <given-names>G</given-names></name></person-group>. <article-title>The impact of physiological variations on personalized reference intervals and decision limits: An in-depth analysis.</article-title> <source><italic>Clin Chem Lab Med.</italic></source> (<year>2024</year>) <volume>62</volume>:<fpage>2140</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1515/cclm-2024-0009</pub-id> <pub-id pub-id-type="pmid">38452477</pub-id></citation></ref>
<ref id="B209"><label>209.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coskun</surname> <given-names>A</given-names></name> <name><surname>Ertaylan</surname> <given-names>G</given-names></name> <name><surname>Pusparum</surname> <given-names>M</given-names></name> <name><surname>Van Hoof</surname> <given-names>R</given-names></name> <name><surname>Kaya</surname> <given-names>Z</given-names></name> <name><surname>Khosravi</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Advancing personalized medicine: Integrating statistical algorithms with omics and nano-omics for enhanced diagnostic accuracy and treatment efficacy.</article-title> <source><italic>Biochim Biophys Acta Mol Basis Dis.</italic></source> (<year>2024</year>) <volume>1870</volume>:<fpage>167339</fpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2024.167339</pub-id> <pub-id pub-id-type="pmid">38986819</pub-id></citation></ref>
<ref id="B210"><label>210.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olejarz</surname> <given-names>W</given-names></name> <name><surname>Sadowski</surname> <given-names>K</given-names></name> <name><surname>Szulczyk</surname> <given-names>D</given-names></name> <name><surname>Basak</surname> <given-names>G</given-names></name></person-group>. <article-title>Advancements in personalized CAR-T therapy: Comprehensive overview of biomarkers and therapeutic targets in hematological malignancies.</article-title> <source><italic>Int J Mol Sci.</italic></source> (<year>2024</year>) <volume>25</volume>:<fpage>7743</fpage>. <pub-id pub-id-type="doi">10.3390/ijms25147743</pub-id> <pub-id pub-id-type="pmid">39062986</pub-id></citation></ref>
<ref id="B211"><label>211.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kotze</surname> <given-names>M</given-names></name> <name><surname>Grant</surname> <given-names>K</given-names></name> <name><surname>Van der Merwe</surname> <given-names>N</given-names></name> <name><surname>Barsdorf</surname> <given-names>N</given-names></name> <name><surname>Kruger</surname> <given-names>M</given-names></name></person-group>. <article-title>Navigating ethical challenges of integrating genomic medicine into clinical practice: Maximising beneficence in precision oncology.</article-title> <source><italic>S Afr J Bioethics Law.</italic></source> (<year>2024</year>).</citation></ref>
<ref id="B212"><label>212.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shine</surname> <given-names>B</given-names></name> <name><surname>Barth</surname> <given-names>J</given-names></name></person-group>. <article-title>Big data in clinical biochemistry.</article-title> <source><italic>Ann Clin Biochem.</italic></source> (<year>2019</year>) <volume>56</volume>:<fpage>308</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1177/0004563218800735</pub-id> <pub-id pub-id-type="pmid">30185056</pub-id></citation></ref>
<ref id="B213"><label>213.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burri</surname> <given-names>V</given-names></name> <name><surname>Mukku</surname> <given-names>L</given-names></name></person-group>. <article-title>Predictive analytics in healthcare: Harnessing Ai for early disease detection.</article-title> <source><italic>Glob J Res Anal.</italic></source> (<year>2024</year>) <volume>13</volume>:<fpage>34</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.36106/gjra/5803759</pub-id></citation></ref>
<ref id="B214"><label>214.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdel galil</surname> <given-names>W</given-names></name></person-group>. <article-title>Applications of artificial intelligence in the field of diagnostic medicine and future prospects.</article-title> <source><italic>Int J Artificial Intell Emerg Technol.</italic></source> (<year>2023</year>) <volume>6</volume>:<fpage>1</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.21608/ijaiet.2024.275176.1005</pub-id></citation></ref>
<ref id="B215"><label>215.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adam</surname> <given-names>H</given-names></name> <name><surname>Gopinath</surname> <given-names>S</given-names></name> <name><surname>Md Arshad</surname> <given-names>M</given-names></name> <name><surname>Adam</surname> <given-names>T</given-names></name> <name><surname>Hashim</surname> <given-names>U</given-names></name> <name><surname>Sauli</surname> <given-names>Z</given-names></name><etal/></person-group> <article-title>Integration of microfluidic channel on electrochemical-based nanobiosensors for monoplex and multiplex analyses: An overview.</article-title> <source><italic>J Taiwan Institute Chem Eng.</italic></source> (<year>2023</year>) <volume>146</volume>:<fpage>34</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtice.2023.104814</pub-id></citation></ref>
<ref id="B216"><label>216.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naito</surname> <given-names>T</given-names></name></person-group>. <article-title>Development of microfluidic components for micro total analysis systems.</article-title> <source><italic>Chromatography.</italic></source> (<year>2020</year>) <volume>41</volume>:<fpage>31</fpage>&#x2013;<lpage>7</lpage>.</citation></ref>
<ref id="B217"><label>217.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kobielieva</surname> <given-names>A</given-names></name> <name><surname>Klymentova</surname> <given-names>M.</given-names></name></person-group> <source><italic>Cost-Effectiveness Determinants of the Commercial Potential Manifestation of Scientific-Innovative Technologies. Global Digital Trends and Their Impact on National Economic Progress.</italic></source> <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>World Bank</publisher-name> (<year>2024</year>). <pub-id pub-id-type="doi">10.46489/gdtatione-05-24-26</pub-id></citation></ref>
<ref id="B218"><label>218.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guijt</surname> <given-names>R</given-names></name> <name><surname>Manz</surname> <given-names>A</given-names></name></person-group>. <article-title>Miniaturised total chemical-analysis systems (&#x03BC;TAS) that periodically convert chemical into electronic information.</article-title> <source><italic>Sens Actuators B Chem.</italic></source> (<year>2018</year>) <volume>273</volume>:<fpage>1334</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.snb.2018.06.054</pub-id></citation></ref>
<ref id="B219"><label>219.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ar&#x00E9;valo</surname> <given-names>B</given-names></name> <name><surname>Seraf&#x00ED;n</surname> <given-names>V</given-names></name> <name><surname>Garranzo-Asensio</surname> <given-names>M</given-names></name> <name><surname>Barderas</surname> <given-names>R</given-names></name> <name><surname>Y&#x00E1;&#x00F1;ez-Sede&#x00F1;o</surname> <given-names>P</given-names></name> <name><surname>Campuzano</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>Early and differential autoimmune diseases diagnosis by interrogating specific autoantibody signatures with multiplexed electrochemical bioplatforms.</article-title> <source><italic>Biosensors Bioelectronics X.</italic></source> (<year>2023</year>) <volume>13</volume>.</citation></ref>
<ref id="B220"><label>220.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Messner</surname> <given-names>C</given-names></name> <name><surname>Demichev</surname> <given-names>V</given-names></name> <name><surname>Wang</surname> <given-names>Z</given-names></name> <name><surname>Hartl</surname> <given-names>J</given-names></name> <name><surname>Kustatscher</surname> <given-names>G</given-names></name> <name><surname>M&#x00FC;lleder</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Mass spectrometry-based high-throughput proteomics and its role in biomedical studies and systems biology.</article-title> <source><italic>Proteomics.</italic></source> (<year>2023</year>) <volume>23</volume>:<fpage>e2200013</fpage>. <pub-id pub-id-type="doi">10.1002/pmic.202200013</pub-id> <pub-id pub-id-type="pmid">36349817</pub-id></citation></ref>
<ref id="B221"><label>221.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Surappa</surname> <given-names>S</given-names></name> <name><surname>Multani</surname> <given-names>P</given-names></name> <name><surname>Parlatan</surname> <given-names>U</given-names></name> <name><surname>Sinawang</surname> <given-names>P</given-names></name> <name><surname>Kaifi</surname> <given-names>J</given-names></name> <name><surname>Akin</surname> <given-names>D</given-names></name><etal/></person-group> <article-title>Integrated &#x0026;quot;lab-on-a-chip&#x0026;quot; Microfluidic systems for isolation, enrichment, and analysis of cancer biomarkers.</article-title> <source><italic>Lab Chip.</italic></source> (<year>2023</year>) <volume>23</volume>:<fpage>2942</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1039/d2lc01076c</pub-id> <pub-id pub-id-type="pmid">37314731</pub-id></citation></ref>
<ref id="B222"><label>222.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parihar</surname> <given-names>A</given-names></name> <name><surname>Yadav</surname> <given-names>S</given-names></name> <name><surname>Sadique</surname> <given-names>M</given-names></name> <name><surname>Ranjan</surname> <given-names>P</given-names></name> <name><surname>Kumar</surname> <given-names>N</given-names></name> <name><surname>Singhal</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Internet-of-medical-things integrated point-of-care biosensing devices for infectious diseases: Toward better preparedness for futuristic pandemics.</article-title> <source><italic>Bioeng Transl Med.</italic></source> (<year>2023</year>) <volume>8</volume>:<fpage>e10481</fpage>. <pub-id pub-id-type="doi">10.1002/btm2.10481</pub-id> <pub-id pub-id-type="pmid">37206204</pub-id></citation></ref>
<ref id="B223"><label>223.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>C</given-names></name> <name><surname>Meng</surname> <given-names>W</given-names></name> <name><surname>Ding</surname> <given-names>F</given-names></name></person-group>. <article-title>Reform and practice of biochemistry experiment teaching under the background of industry-university-research integration.</article-title> <source><italic>J Educ Hum Soc Sci.</italic></source> (<year>2022</year>) <volume>5</volume>:<fpage>33</fpage>&#x2013;<lpage>7</lpage>.</citation></ref>
<ref id="B224"><label>224.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>J</given-names></name> <name><surname>Pickett</surname> <given-names>T</given-names></name> <name><surname>Langell</surname> <given-names>A</given-names></name> <name><surname>Trane</surname> <given-names>A</given-names></name> <name><surname>Charlesworth</surname> <given-names>B</given-names></name> <name><surname>Loken</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Industry-academic partnerships: An approach to accelerate innovation.</article-title> <source><italic>J Surg Res.</italic></source> (<year>2016</year>) <volume>205</volume>:<fpage>228</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.jss.2016.06.029</pub-id> <pub-id pub-id-type="pmid">27621024</pub-id></citation></ref>
<ref id="B225"><label>225.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minghetti</surname> <given-names>P</given-names></name> <name><surname>Musazzi</surname> <given-names>U</given-names></name> <name><surname>Rocco</surname> <given-names>P</given-names></name></person-group>. <article-title>Regulatory aspects and barriers in using groundbreaking technologies. nano- and microfabrication techniques in drug delivery.</article-title> <source><italic>Advanced Clinical Pharmacy - Research, Development and Practical Applications.</italic></source> <publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer</publisher-name> (<year>2023</year>). p. <fpage>467</fpage>&#x2013;<lpage>91</lpage>.</citation></ref>
<ref id="B226"><label>226.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McNerney</surname> <given-names>R</given-names></name> <name><surname>Sollis</surname> <given-names>K</given-names></name> <name><surname>Peeling</surname> <given-names>R</given-names></name></person-group>. <article-title>Improving access to new diagnostics through harmonised regulation: Priorities for action.</article-title> <source><italic>Afr J Lab Med.</italic></source> (<year>2014</year>) <volume>3</volume>:<fpage>123</fpage>. <pub-id pub-id-type="doi">10.4102/ajlm.v3i1.123</pub-id> <pub-id pub-id-type="pmid">29043177</pub-id></citation></ref>
<ref id="B227"><label>227.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname> <given-names>Q</given-names></name> <name><surname>Qian</surname> <given-names>X</given-names></name></person-group>. <article-title>Ethics: Informed consent, patient privacy.</article-title> <source><italic>Clin Mol Diagnostics.</italic></source> (<year>2021</year>) <fpage>39</fpage>&#x2013;<lpage>44</lpage>. <comment>Online ahead of print</comment>.</citation></ref>
<ref id="B228"><label>228.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>G</given-names></name> <name><surname>Zhao</surname> <given-names>C</given-names></name> <name><surname>Yan</surname> <given-names>M</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name> <name><surname>Zhu</surname> <given-names>L</given-names></name> <name><surname>Liu</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Evaluating the effectiveness of a new student-centred laboratory training strategy in clinical biochemistry teaching.</article-title> <source><italic>BMC Med Educ.</italic></source> (<year>2023</year>) <volume>23</volume>:<fpage>391</fpage>. <pub-id pub-id-type="doi">10.1186/s12909-023-04272-7</pub-id> <pub-id pub-id-type="pmid">37245007</pub-id></citation></ref>
<ref id="B229"><label>229.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michalik</surname> <given-names>B</given-names></name> <name><surname>S&#x0119;k</surname> <given-names>M</given-names></name> <name><surname>Szypu&#x0142;a</surname> <given-names>A</given-names></name> <name><surname>Hajduk-Ma&#x015B;lak</surname> <given-names>K</given-names></name> <name><surname>Sk&#x00F3;ra</surname> <given-names>A</given-names></name> <name><surname>Galasi&#x0144;ska</surname> <given-names>I</given-names></name></person-group>. <article-title>New technological developments in medical education.</article-title> <source><italic>J Educ Health Sport.</italic></source> (<year>2024</year>) <volume>60</volume>:<fpage>204</fpage>&#x2013;<lpage>20</lpage>.</citation></ref>
<ref id="B230"><label>230.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>V&#x00E1;zquez</surname> <given-names>M</given-names></name> <name><surname>Anfossi</surname> <given-names>L</given-names></name> <name><surname>Ben-Yoav</surname> <given-names>H</given-names></name> <name><surname>Di&#x00E9;guez</surname> <given-names>L</given-names></name> <name><surname>Karopka</surname> <given-names>T</given-names></name> <name><surname>Della Ventura</surname> <given-names>B</given-names></name><etal/></person-group> <article-title>Use of some cost-effective technologies for a routine clinical pathology laboratory.</article-title> <source><italic>Lab Chip.</italic></source> (<year>2021</year>) <volume>21</volume>:<fpage>4330</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1039/d1lc00658d</pub-id> <pub-id pub-id-type="pmid">34664599</pub-id></citation></ref>
</ref-list>
</back>
</article>